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Abstract
The purpose of this study was to investigate the epidemiology of thermophilic
Campylobacter infections in Ireland, and to assess antimicrobial resistance among
animal isolates and its relevance to human enteric infection with Campylobacter.
The first part of the study focused on 84 isolates of human, poultry and porcine
origins, isolated between 1996 and 1998 in the Cork region. These isolates were
identified to species level using a combination of biochemical and molecular methods.
Campylobacter jejuni (C. jejuni) was the predominant organism among human and
poultry isolates, whilst all of the porcine isolates examined were identified as C. coli.
DNA amplification fingerprinting (DAT) of the collection demonstrated a high degree
of genomic heterogeneity among isolates. No DAT banding pattern observed for any
of the human isolates matched those profiles observed among the animal-derived
isolates. Furthermore, the genomic diversity of 36 human isolates appeared to
demonstrate 32 possible different sources of infection. Antimicrobial resistance
profiling of the collection showed that higher levels of drug resistance were
encountered among isolates of porcine origin compared with those from either human
or poultry sources.

Antimicrobial resistance occurs through the acquisition of new genes rather than by
mutation events. The former (potential) mechanism was investigated in this study. A
novel class of mobile genetic element, termed integrons, had previously been studied
among pseudomonads and the Enterobacteriaceae. Their presence among
Campylobacter spp. had not been noted to date. A preliminary investigation of the
collection revealed the presence of integron-like structures of varying sizes in all
isolates for the first time. Sequence analysis of three commonly-occurring amplicons

XV

revealed that each contained two partial open reading frames (ORF), one of unknown
function and one of which was homologous with Helicobacter pylori {H pylori)
tRNA synthetase. It was suggested that these structures might, in part, contribute to
the plasticity of the Campylobacter genome, permitting site-specific recombination of
unrelated DNA fragments from the environment by natural means. In this way,
Campylobacter acquires DNA that may ultimately form part of its genetic structure.

The second part of the study focused on a larger collection of 378 strains of human
and poultry origin that had been isolated during the year 2000. This section of the
project was part of the first attempt to describe the molecular epidemiology of
Campylobacter spp. in Ireland. Antimicrobial resistance profiling of a subset of 145
of these 378 isolates revealed a significant increase in resistance rates to ciprofloxacin
and tetracycline when compared to the period 1996-1998. Ciprofloxacin resistance
rates had risen from approximately 2% during the earlier period, to approximately
30% during the year 2000, among human and poultry isolates. A combination of agar
diffusion and molecular methods for the detection of resistance provided a good
correlation and aided our understanding of the underlying mechanism in this case.
Since Campylobacter is primarily a zoonotic organism, it was likely that ciprofloxacin
resistance had a foodborne origin, whether domestic or imported. Our data suggested
the possibility, that Ireland was importing a ciprofloxacin resistance problem via non
domestic poultry product. By application of methods developed during this study it is
clear that molecular investigation can facilitate the statutory functioning of such
national bodies as the Food Safety Authority of Ireland (FSAI), which has
responsibility for the protection of public health.
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Furthermore, tetracycline resistance rates showed an increase from approximately
16% during the period 1996-1998 to approximately 28% during the year 2000, when
tested by agar diffusion methods. Resistance to tetracycline among Campylobacter
spp. is, in the great majority of cases, mediated by the tetO gene, and has been
associated in some studies with a 23-kbp plasmid. Experimental work carried out in
this study investigated the relationship between the presence of plasmids and
resistance to tetracycline, and concluded that the presence or absence of plasmids did
not correlate strongly with resistance. Polymerase chain reaction (PCR) analysis of
the isolates using a primer pair derived from the published sequence of the tetO gene
showed good correlation with phenotypic tetracycline resistance, however, and could
provide a useful additional screening method for tetracycline resistance among
Campylobacter spp. A non-isotopically-labelled tetO probe located the tetO gene to
loci both on the host chromosome and on the 23-kbp plasmid when applied to a subset
of strains and their corresponding plasmids.

A very large collection of isolates like this one also provided an opportunity to explore
the question of transmission of specific genotypes through the food chain. In
particular, this provided the opportunity to evaluate commonly-used phenotypic and
molecular methods for the speciation of Campylobacter. Interestingly, the
interpretation of the hippurate hydrolysis test, a major standard laboratory diagnostic
method applied to differentiate C. jejuni and C coli, failed in some cases to identify
these species correctly. This may be partly explained by the fact that some of the C.
jejuni isolates identified either lacked this marker altogether or contained a marker that
was substantially altered (by mutation). This feature necessitated a re-examination of
conventional approaches to identification, at least to species level.

xvii

Genomic fingerprinting by DAF identified 145 designated profiles within this
collection at 80% similarity, and it was possible to type all isolates by this method.
There were 39 indistinguishable clusters, a number of which were isolated from both
human and poultry sources. The majority of human infections studied, however, did
not represent outbreaks. DAF analysis demonstrated a high degree of heterogeneity
among this collection, in agreement with earlier studies of the 1996-1998 collection of
isolates. However, at 80% similarity, the largest cluster accounted for 20% of the total
collection. Within this cluster, 80% of the isolates were of human origin (the greater
part of the human collection). This may suggest that certain isolates are more
pathogenic to humans than others.

Finally, integron analysis was performed on the collection. Amplicons were detected
in 84.1% of the isolates, which included human and poultry isolates, and both C. jejuni
and C. coli. A total of 67.5% of isolates contained amplicons of not more than 700 bp
in size. A fragment of 1,000 bp (along with additional smaller fragments) was
detected among 15.8% of C. jejuni and C coli isolates, both from human and poultry
sources. Amplicons greater than 1,000 bp in size were detected in two strains only,
both of which were poultry-derived C. coli isolates. In all, several combinations of
amplicons were observed. These ranged in size from approximately 150 to 1,100 bp.
A total of 62 isolates was shown to have a gene cassette structure of approximately
1,000 bp, with the majority being identified as C. jejuni. Sequencing of one 700 bp
fragment and four of the 1,000 bp fragments was performed. The 700 bp fragment
showed a high degree of homology with glycyl tRNA synthetase of H. pylori (similar
to the partial 466 bp ORF previously identified in the 1996-1998 collection).

XVlll

Sequence data from all of the 1,000 bp fragments were identical and the ORF
contained within this gene cassette was identified as an aadA2 gene, previously
unknown in Campylobacter spp. This gene confers resistance to streptomycin and
spectinomycin. Alignment studies of the corresponding deduced amino acid
sequences identified three amino acid substitutions among aadA2 genes studied from
Salmonella serovars and other enteric pathogens such as Aeromonas salmonicida and
Vibrio cholerae. Antimicrobial genes such as this offer the possibility of using these
unique markers to aid epidemiological studies in the future.
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Chapter 1
Introduction

1.1. Campylobacter spp. and human enteritis
1.1.1. Introduction and taxonomy
Campylobacter is currently the most commonly reported bacterial cause of enteritis in
developed countries (Butzler et al, 1992; Pebody et al, 1997). Its taxonomy has been
complicated since the organism was first noted more than one hundred years ago in
the diarrhoeal faeces of children and kittens as a non-culturable, spiral-shaped micro
organism, which Escherich named Vibrio felinus (Kist, 1985). Later, several authors
made similar observations, following the detection of V. fetus as an animal pathogen.
In 1963 these organisms were assigned to a new genus, Campylobacter, (derived from
the Greek for curved rod) on the basis of distinct G-t C ratios of between 28 and 38%
and several other features (Sebald and Veron, 1963). Campylobacter, by their
exacting cultural requirements and their need for a microaerophilic environment for
growth, eluded detection by the usual microbiological techniques until Butzler in 1973
reported the isolation by a filtration technique for vibrios from the faeces of diarrhoeal
patients (Butzler et al, 1973). In 1977 Skirrow, using a simpler isolation technique
based on antibiotics contained in Blood Agar, both confirmed Butzler’s findings and
enabled the routine medical microbiology laboratory to isolate Campylobacter spp.
from faeces samples (Skirrow, 1977). This ability to culture Campylobacter spp. led
to the isolation of many different species, and in 1991 it was proposed that the family
Campylobacteriaceae should include three genera as follows:
1. Campylobacter (19 species, subspecies and biovars)
2. Arcobacter (4 species)
3. Helicobacter (16 speeies) (Vandamme et al., 1991)

The most recent phylogenetic rearrangement, however, based on the percentage 16S
rRNA gene sequence similarity, has placed Helicobacter and Wolinella in a novel
family, Helicobacteriaceae (Vandamme, 2000). In addition to the genera
Campylobacter and Arcobacter, the family Campylobacteriaceae contains the
generically misclassified species Bacteroides ureolyticus and strains originally
described as free-living Campylobacters, now known as Sulphurospirillum spp.
(Schumacher et al., 1992)

Campylobacteriaceae form the epsilon subgroup of the Proto bacteria, well separated,
for example, from the gamma subgroup where many of the other human
enteropathogens such as the salmonellae, Escherichia coli (E. coli) and Shigella spp.
are located (Vandamme et al., 1995).

1.1.2. Genus Campylobacter
The 19 species, subspecies and biovars that comprise the genus Campylobacter are
shown in Table 1.1 together with their significance as human and veterinary
pathogens.

Campylobacter spp. are Gram-negative slender, curved or coccoid organisms (the
coccoid forms tending to occur in older cultures), and may vary between 0.5 and 8 pm
in length and between 0.2 and 0.5 pm in width (Sebald and Veron, 1963). Generally
these organisms have a single polar unsheathed flagellum (monotrichous) or a
flagellum at each end (amphitrichous) (Walker et al, 1986). However, in laboratory
cultures motility is frequently lost (Leach, 1997). The detection of Campylobacter in
the environment is complicated by their ability to enter a form that cannot readily be

Table 1.1. Species in the genus Campylobacter showing the 19 species, subspecies
and subtypes characterised to date. The most significant human pathogens are
highlighted in blue. (Compiled from Pearson and Healing, 1992; Healing et al., 1992;
On, 1996; Vandamme, 2000).________
SPECTRUM OF DISEASE AND COMMON
SPECIES
RESERVOIRS OF THE ORGANISM
Infectious intestinal disease (IID) in humans.
C jejuni suhsp. jejuni
Isolated from poultry, cattle, sheep, pigs.
IID in humans. Isolated from pigs, poultry.
C. coli
C. lari
C. jejuni suhsp. doylei
C. upsaliensis
C. fetus subs. Fetus
C. fetus suhsp. venerealis
C. hyointestinalis
C. concisus
C. mucosalis
C. sputorum biovar sputorum
C. sputorum bv. faecalis
C. sputorum hv. hubulus

IID, bacteraemia in humans. Isolated from
seagulls, dogs, horses, fish, shellfish.
Upper and lower gastrointestinal disease in
humans.
IID, bacteraemia in humans. Isolated from
symptomatic and asymptomatic cats and dogs.
Occasional bacteraemia in man, IID rarely.
Causes sporadic abortion in sheep and cattle.
Causes abortion in cattle. Rare cause of
septicaemia in man.
Rare cause of IID in man. Causes ileitis in
pigs, isolated from bovine faeces.
Associated with periodontal disease in
humans, and with IID, rarely.
Associated with porcine intestinal disease. No
human disease association.
Associated with gingivitis in humans.
Isolated from sheep faeces and bovine genital
tract. No human disease association.
As for C. sputorum bv. faecalis.

C. showae

Associated with persistent IID in cattle. Has
been isolated from diarrhoeic humans,
pathogenicity unknown.
Associated with gingivitis in humans, and soft
tissue abscesses.
As for C. rectus.

C. gracilis

As for C. rectus.

C. helveticus

Isolated from diarrhoeic and asymptomatic
cats and dogs. Has not been isolated from
humans.
Associated with human oral lesions, also
isolated from blood.

C. sputorum hv. paraureolyticus

C. rectus

C. curvus

cultured on laboratory media but which is capable of infecting appropriate hosts
(Rollins and Colwell, 1986). Campylobacter requires a microaerophilic atmosphere
for growth, i.e. 5-10% oxygen (above which concentration oxygen becomes toxic),
and 3-10% carbon dioxide (Griffiths and Park, 1990). Most species capable of
causing human disease have optimal growth temperatures of 37 and 42°C, they are
oxidase positive and are incapable of fermenting or oxidising carbohydrates.
Biochemical tests of the type similar to those used to identify other enteric pathogens
are of very limited use for Campylobacter.

It should be noted, however, that the thermophilic Campylobacters (i.e. those growing
optimally at 42°C), and particularly Campylobacter jejuni subspp.

w«/ and C. coli

are the species most frequently isolated from human enteric disease. C. jejuni and C.
coli were earlier thought to be the same species {C. fetus) since the genotype and
phenotype of both taxa are extremely similar (Vandamme, 2000). The two species
were subsequently distinguished on the basis that C. jejuni hydrolysed hippurate
unlike C. coli (Harvey, 1980). However, it has become apparent more recently that
hippurate, while a useful test, cannot be relied upon to distinguish between all isolates
of C. jejuni and C. coli due to the existence of a minority of hippurate-negative C.
jejuni isolates (Totten et al., 1987; Lucey et al., 2002a). To a lesser extent C. lari and
C. upsaliensis have been reported as causative agents in human enteritis. Although
the majority of Campylobacter strains isolated from cases of human enteritis are
reported simply as Campylobacter spp., available data from the UK suggest that
approximately 90% are C. jejuni, with approximately!0% being C. coli, less than 1%
being C lari, and C. upsaliensis being very rarely isolated (CDSC, 1998).

1.1.3. Laboratory notifications of Campylobacter enteritis
The number of laboratory reports of enterie Campylobacter spp. has steadily risen in
the UK during the last two deeades from about 25 in 1980 to in exeess of 80 per
100,000 of population in England and Wales in 1993 (ACMSF, 1993), and reaehing
105 per 100,000 in 1999 (Whyte and Igoe, 2000). The earlier inerease may have been
due to several factors including better diagnosis, increased reporting efforts and an
increased number of actual cases. In the UK in 1995 there were about 43,000
Campylobacter and about 29,000 Salmonella isolations reported to the Public Health
Laboratory Service (PHLS) (Lior, 1996). In 1999 Campylobacter notifications had
continued to rise in contrast to falling Salmonella notifications in the UK and,
similarly, Campylobacter spp. surpassed Salmonella in importance as a cause of
foodbome illness in Denmark, Finland, Ireland and Sweden (CDC, 1999). It has been
claimed, however, that the number of reported cases of Campylobacter is much lower
than the actual number infected, with a calculated projection of 1% of the population
per annum becoming infected (Skirrow and Blaser, 1992). The data available from
Infoscan (Communicable Disease Reports for the area covered by the Southern and
South-Eastern Health Board areas of Ireland) between 1995 and 2001 has shown an
increase in the number of Campylobacter notifications over each yearly period
between 1995 and 1999 as seen in Figure 1.1. This is likely to be a genuine increase
in the number of actual cases of Campylobacter enteritis for this period, as the
laboratory isolation methods have remained the same, and the mechanism for
reporting notifiable diseases, which was already well established by the earlier date,
has not changed.

Figure 1.1. Infoscan Campylohaclerno\\^\Q2^:\ons 1995-2001: quarterly distribution.

Table 1.2. Infoscan Campylobacter yearly notifications 1995-2001.
Year

Notifications

1995
1996
1997
1998
1999
2000
2001

289
331
425
550
824
637
440

As seen in Table 1.2 Infoscan notifications of Campylobacter enteritis showed an
annual increase between the years 1995 and 1999, and subsequently underwent a
decline during the years 2000 and 2001.

The distribution of isolations showed an increase in the second quarter of each year,
with the exception of 1998. During these years the peak fell gradually over the third
quarter to a lower incidence during the colder months of the year. These figures
correlate with the seasonal patterns shown for other temperate climates (Butzler et al.,
1992).

Figure 1.2 shows that the peak ineidence of Campylobacter infeetion in Ireland
oeeurs in children under five years of age, constituting 31.3% of the infected
population. This corresponds with studies in other developed countries (Lior, 1996).
Factors contributing to the prevalence of notified infection among this age group may
include susceptibility on first exposure and the low threshold for seeking medical care
for infants (European Commission, 2000), and the buffering capacity of milk and
water which facilitates the survival of Campylobacter in the stomach.

The age group 25-34 years showed the second highest rate of infection, accounting for
16.1% of infection. Reasons for the peak in incidence among adults of this age group
have not been fully elucidated, but may include poor food preparation skills and
increased foreign travel.
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Figure 1.2. Distribution by age-group of Campylobacter enteritis notifications in
Ireland for 1999 (Whyte and Igoe, 2000).

1.1.4. Transmission and sources of infection
Campylobacter spp. are environmental and zoonotic organisms, as shown
schematically in Figure 1.3, The principal reservoir for Campylobacter, however,
appears to be food sources. Most infections are sporadic (Pebody et al, 1997), and
chicken has been shown to be the most common cause of infection in sporadic cases,
while raw milk and untreated surface water have been commonly linked
(epidemiologically and microbiologically) to large community outbreaks (JacobsReitsma, 2000). Sporadic infection may result from the consumption of undercooked
chicken, or may be due to domestic cross-contamination of hands, kitchen utensils,
cutting boards and raw' vegetables (Lior, 1996). Furthermore, the isolation rate of
Campylobacter from poultry meat has been shown to fluctuate throughout the year,
showing highest isolation rates during the summer months (Hanninen et al., 1998a).
This may in part explain the seasonality of human Campylobacter enteritis as shown
in Figure 1.1. Table 1.3 shows the prevalence of thermophilic Campylobacter spp. in
a number of meat and dairy product sources from different countries.

Environment

Animal reservoirs

Domestic pets

Farm animals/poultry/wild birds

Surface water

♦
Unpasteurised milk/birdpecked milk bottle tops
Handling of raw meat

Inadequatelytreated water

t
Drinking water

V

Direct contact

Consuming raw or
undercooked products

1

i
Consumer

Figure 1.3. Modes of human transmission for thermophilic enteritis-causing
Campylobacter spp. (Adapted from Butzler et al. 1992.)

There are few studies to show the prevalence of Campylobacter spp. in vegetables.
One such study in Canada, however, by Park and Saunders (1992), examined 1,564
fresh samples of ten vegetable types from supermarkets and outdoor markets. No

Campylobacter was detected from 1,031 supermarket samples, but detection rates
ranging from 1.6 to 3.3% were observed in spinach, lettuce, radish, onion, parsley and
potato samples from the outdoor markets. Campylobacter was not isolated from
celery, cabbage, carrot or cucumber in this study. It was concluded that there was a
strong possibility of vegetable contamination occurring as a result of the use of animal
manure as fertiliser.

Table 1.3. Presence of thermophilic Campylobacter spp. in food animal sources.
%of
positive
samples
19

Country

Year

Reference

At retail

No. of
samples
examined
630

Germany

1996

Geilhausen et
al., 1996

Chicken wings

At retail

153

65

1994

Turkey meat

At retail

311

25

N.
Ireland
Denmark

Raw cows’ milk

69

1.4

France

1997

62

10

Belgium

1998

Beef meat

Bulk
tanks
After
chilling
At retail

50

0

1998

Pork

At retail

158

18.4

N.
Ireland
UK

Pork sausages

At retail

42

2.4

Italy

1996

Raw meat
products

At retail

2330

0.6

UK

1998

Flynn et al.,
1994
Hald et al., 1998
(Danish
Ministry of
Food, etc.)
Deamasures et
ai, 1997
Korsak et ai,
1998
Madden et al.,
1998
Fricker et al.,
1989
Zanetti et ai,
1996
Little and de
Louvois, 1998

Product

Stage of
process

Chicken breasts

Beef carcasses

1997

1989

In the case of outbreaks, milk, particularly in the unpasteurised form, is commonly
reported as a vehicle of transmission (Pearson and Healing, 1992). Outbreaks of
infection have also been associated with the pecking of the foil tops of milk bottles by
jackdaws and magpies, and this is believed to account for several thousand cases of
infection in the UK during the months of May and June each year (Stuart et ai, 1997).
Water has also been associated with outbreaks of Campylobacter enteritis. The
results of a Finnish study which monitored the survival of C. jejuni and C. coli in
surface waters showed that C. jejuni was capable of surviving for longer than C. coli,
at both 4 and 20°C (Korhonen and Martikainen, 1991). This study also showed that
both species survived better in filtered than in untreated water.

Transmission of Campylobacter enteritis by infected puppies has been documented
and it has been estimated that about 5% of human cases originate from domestic dogs.
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Human infections have also been associated with sick kittens and healthy cats (Lior,
1996).

Additionally, Campylobacter has been found to be an important source of travellers’
diarrhoea. A study of the increased incidence of Campylobacter isolates in winter in
England, Switzerland, Sweden, Japan and Finland showed that 3-60% of patients
affected acquired their infection abroad (Taylor, 1992a).

Despite its widespread distribution, the organism does not grow below 30°C (Park et
al, 1987), and therefore will not multiply on food at room temperature. Person-toperson transmission seems to be unusual. Family clusters are seldom seen and
secondary transmission after point source outbreaks is also rare (Cowden, 1992). This
is paradoxical: the infective dose may be as small as 500 organisms (Walker, 1986),
and diarrhoeic faeces can contain as many as 10^ - 10^ organisms per gram (Blaser et
al., 1980).

1.1.5. Clinical features of Campylobacter enteritis
A diagnosis of Campylobacter infection cannot be made solely on a clinical basis.
Enteric Campylobacters cause a broad spectrum of disease, from mild secretory
diarrhoea lasting for 24 hours to severe inflammatory diarrhoea lasting for at least a
week, as shown in Table 1.4. The incubation period ranges from 1-7 days, during
which time symptoms may include fever and malaise. The profuse diarrhoea, which
frequently lasts 2-3 days, is usually accompanied by acute abdominal pain. Faeces
consisting mainly of blood and inflammatory exudates, mimicking acute ulcerative
colitis, often accompanies the more severe diarrhoea, seen especially in developed
11

countries. Vomiting is rare (Butzler e/«/., 1992). Symptoms, particularly abdominal
pain, recur in about 25% of patients, lasting for up to three months after infection
(Pearson and Healing, 1992). Campylobacter enteritis is usually self-limiting.
Antibiotics have little effect on the duration of illness or the severity of the symptoms,
but can prevent relapse.

Table 1.5 shows a comparison of the features of C. jejuni infections in developed
countries with those in developing countries.

Table 1.4. Symptoms of Campylobacter enteritis (Butzler et al., 1992; Skirrow and
Blaser 1992; Skirrow and Blaser, 2000).
Disease phase

Duration

Symptoms

Prodromal

Malaise, headache, dizziness, anorexia, myalgia,
arthralgia, fever

Few hours to few days

Diarrhoeic

Abdominal cramps, profuse diarrhoea, watery
or slimy stools containing inflammatory
exudate, leukocytes and fresh blood, vomiting in
some cases

2-10 days

Recovery

Abdominal pain may persist; dehydration in some
cases

3 days-3 weeks

Complications Appendicular syndrome, cholecystitis, peritonitis,
arthritis, erythema nodosum, bacteraemia,
meningitis, Guillain-Barr6 syndrome, haemolyticuraemic syndrome
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Table 1.5. Comparison of the features of C. jejuni infections in developed countries
with those in developing countries (adapted from Blaser, 1997).
Developed
countries
5

Developing
countries
15-40

Isolation rate among well persons (%)

<1

15-40

Average no. of infections per lifetime

0-1

>5

Widespread immunity among adults

Absent

Present

<5, 20-35

<2

Inflammatory
diarrhoea
Severe

Simple
diarrhoea
Mild

Bloody diarrhoea (%)

50

15

Epidemics reported

Yes

No

Seasonal increase in incidence

Yes

No

16

8

Feature
Isolation rate among persons with diarrhoea (%)

Affected age groups (yr)
Principal manifestation of illness
Illness severity

Duration of excretion (days)

In developed and developing countries approximately 1% of patients with
Campylobacter enteritis develop Guillain-Barre Syndrome (GBS) (Skirrow and
Blaser, 1992). GBS, which is characterised by an acute inflammatory polyneuropathy,
is one of the most serious sequelae of infection with C. jejuni (Pearson and Healing,
1992). Approximately two-thirds of all cases develop during a one- to three-week
period following gastrointestinal infection. Many infectious agents have been
implicated in the development of GBS which, since the eradication of polio in most
parts of the world, has become the most common cause of acute flaccid paralysis
(Nachamkin et al, 1998a). However, in recent years there is strong evidence to
suggest that 14% of cases have serological evidence of antecedent infection with
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Campylobacter and that some serotypes of C. jejuni are more likely to cause GBS
than others, particularly serotype 0:19 (Mishu and Blaser, 1993). Antigenic cross
reactivity has been demonstrated between C. jejuni and human myelin proteins
(Fujimoto and Amako, 1990). The disease is usually self-limiting, with partial or total
recovery taking place within months (Nachamkin et al., 1998a). However, GBS
carries a mortality rate of 3% in developed countries, and a further 15-20% of patients
with the syndrome are left with severe neurological defects (Ropper, 1986; de Jager
and Sluiter, 1991).

1.1.6. Pathology of Campylobacter enteritis
Campylobacter causes a predominantly foodbome illness to which humans are
particularly susceptible. In its other animal hosts the organism appears to have the
role of commensal, and permanently colonises the gut with little demonstrable illeffect (Stem, 1992). Interestingly, human Campylobacter enteritis has been shown to
manifest itself as secretory rather than inflammatory diarrhoea in developing
countries, as shown in Table 1.5. Furthermore, in human volunteer studies the same
strain has been shown to cause different grades of illness in different people, showing
that host factors are important in the epidemiology of the disease (Taylor, 1992a). In
particular, the inflammatory response to Campylobacter infection has been found to
contribute to the disease state by causing a net fluid loss into the intestine (Ketley,
1997).

Additionally, a number of pathogenic mechanisms have been elucidated for
Campylobacter. These include flagella (adapted to penetrating mucus gel overlying
the intestinal epithelium), chemotaxis, adhesins, cellular invasion, toxins, iron14

scavenging systems and resistance to oxidative damage (Ketley, 1997).
Campylobacter spp., having a requirement for a microaerophilic atmosphere, have
mechanisms for limiting the damage mediated by the highly reactive chemicals
derived from oxygen, such as peroxides, superoxide and hydroxyl radicals (Leach,
1997). In particular, the presence of the enzyme iron superoxide dismutase has been
shown to be potentially important in colonisation and disease (Cawthraw et ai, 1996).

1.1.7. The laboratory isolation and identification of thermophilic Campylobacter
spp.
Figure 1.4 outlines the procedure for the isolation of therm.ophilic Campylobacter
spp. from human and animal sources. Samples should be as fresh as possible to
maximise the survival of the organism.

Most clinical laboratories identify Campylobacter to the genus level only, on the basis
of colonial and microscopic morphology and the ability to grow thermophilically. As
a result, the understanding of the epidemiology of Campylobacter enteritis remains
limited. It may be argued, however, that there is a need for increased research of the
epidemiology of this organism. In doing so the health and financial burdens of
Campylobacter infection may be reduced.

As a result of the biochemical similarity known to exist between C. jejuni and C. coli,
the hippurate hydrolysis test is often relied upon to differentiate the two species. This
test, however, has some acknowledged technical limitations, is dependent on
inoculum size and results can be difficult to interpret accurately (On and Holmes,
1991). Furthermore, while C. jejuni isolates possess the hippuricase gene (Chan et al.,
15

2000) it is not expressed by all C. jejuni isolates. For this reason, eertain polymerase
ehain reaction (PCR) -based species identification methods, both for C. jejuni and C
coli and for the other thermophilic species, provide a more reliable identification
method, also helping to highlight mixed species cultures should they occur. However,
even with these methods, false negatives or non-specifically amplified products can
occur in a minority of isolates tested due to genomic anomalies. Thus a second
molecular identification method may be required in these circumstances. Gonzalez et
al. (1997) developed a species-specific PCR assay for the identification of C. jejuni
and C. coli based on the ceuE gene, which is involved in siderophore transport. Using
this method two primer sets are employed in separate PCR amplification reactions.
Another method, developed by Eyers et al. (1993), performs PCR amplification of
23S rRNA gene fragments, based on regions specific for C. jejuni, C. coli, C. lari and
C. upsaliensis. In addition, Hani and Chan (1995) developed a PCR assay that
detected and amplified the hippuricase gene. The latter molecular approach may offer
a more reliable means of identifying C. jejuni strains compared to the use of the
phenotypic hippurate hydrolysis test alone.

16

Intestinal tissue from chicken,
pork, or other meat sample

Faeces sample
10 pL of sample

Rinse tissue in 20 ml of Oxoid Broth no. 2
containing 5% lysed horse blood (LHB)

Incubate broth (with loosened caps) for 2 h
at room temperature, followed by 48 h at
37°C in an Oxoid Campylobacter Gas
Generating Kit (BR056A)

Inoculate 10 pL of broth onto appropriate
culture medium

Medium
Skirrows

Base
Blood Agar Base No. 2
(Oxoid CM271)

Selective agent
Vancomycin 10 mg/L
Polymyxin B 2500 iu/L
Trimethoprim 5 mg/L

Supplements
Lysed horse
blood 50
ml/L

Reference
Skirrow (1977)

Preston

Preston Medium CM689

Rifampicin 10 mg/L
Polymyxin B 5000 iu/L
Trimethoprim 10 mg/L
Cyclohexamide 100 mg/L

Lysed horse
blood 50
ml/L

Bolton &
Robertson
(1982)

Modified
CCDA

Blood Free selective Agar
Base (Oxoid CM331)

Cefoperazone 32 mg/L

Hutchinson &
Bolton (1983)

Incubate at 42°C for 48 h in a microaerophilic atmosphere using
an Oxoid Campylobacter Gas Generating Kit (BR056A)

Examine cultures for typical colonial morphology, followed by
Carbol Fuchsin staining for typical microscopic appearance.
Subculture onto non-selective blood-containing medium for
performance of biochemical tests.
Perform oxidase, catalase tests, hippurate (hip) hydrolysis test.
Hip" = C. jejuni.
Identify hip' isolates to species level by species-specific PCR.
May also use commercial biochemical tests e.g. API Campy

Figure 1.4. The isolation and identification of thermophilic Campylobacter spp.
from human and animal sources.
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1.1.8. Methods for the epidemiological analysis of thermophilic Campylobacter
spp.
Epidemiological typing methods currently in use for Campylobacter spp. include
phenotypic methods such as biotyping and serotyping, and genotypic methods
including DNA Amplification Fingerprinting (DAF), Pulsed-Field Gel
Electrophoresis (PFGE), Ribotyping, and Restriction Fragment Length Polymorphism
(RFLP) analysis of the flagellin A-encoding gene {flaA).

Biotyping may be automatically combined with species differentiation by using the
same biochemical tests for both purposes, and a number of methods have been
devised, some incorporating resistotyping, or estimating resistance to a number of
antimicrobial agents and chemical compounds (Skirrow and Benjamin, 1980; Bolton
et al., 1984; Lior, 1984). A commercial biotyping scheme by Mast (Mast Diagnostics,
UK) uses a combination of biochemical and resistotyping tests for identification and
biotyping of C. jejuni, C. coU, C. lari and C. upsaliensis. Advantages of this method
include standardisation of tests and relative ease of performance. Disadvantages
include the necessity of using a second typing method for sufficient discrimination of
strains, some difficulty in interpreting results due to intermediate sensitivity zones,
and lack of reproducibility (Owen et al., 1997). Furthermore, phenotypic
characteristics may or may not be expressed consistently, and susceptibility to certain
compounds may be influenced by the gain or loss of mobile genetic elements (e.g.
plasmids).

Serotyping remains primarily a reference laboratory protocol owing to the time and
expense needed to maintain high-quality antisera. Furthermore, there is a high
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percentage of untypeable strains, and the standard serotyping systems such as the Lior
and Penner schemes are both time-consuming and technically demanding (Wassenaar
and Newell, 2000). With the exception of GBS, virulence has not been linked to
serotype (Leach, 1997). Serotyping remains the gold standard for typing C. jejuni and
C. coli isolates, however, and may facilitate inter-laboratory comparisons for both
outbreak-related and non-related strains. The Penner serotyping scheme has been
used as the basis for the scheme recently developed in the Laboratory of Enteric
Pathogens, Public Health Laboratory Service, UK, and this new scheme forms the
basis for reference typing in the UK (Frost et aL, 1998). The lack of typeability of
many strains may be overcome by defining nev/ serotypes.

Table 1.6 outlines the criteria by which molecular typing methods should be assessed
prior to use. The weight given to each criterion may vary from laboratory to
laboratory. It would be advantageous to combine more than one method, but this
must be balanced against the increased costs incurred. It has been shown that
Campylobacter isolates are highly polymorphic (Hanninen et aL, 1999), having the
ability to undergo recombinant restructuring. This is beneficial in yielding high
discriminatory power for most of the potential techniques used for typing. However,
it also results in poor association of types with clinical syndromes or environmental
niches (Meinersmann, 1997). This problem could be addressed if the mechanism for
the genesis of the polymorphism were understood, which would allow the
relationships between certain strains to be traced accurately. It seems reasonable to
suggest, however, that certain portions of the Campylobacter chromosome may be
more stable than others.
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Table 1.6. Criteria for molecular typing methods (taken from Meinersmann, 1997).
Criterion

Factors affecting criterion

Economy

Personnel, equipment, material supplies,
time.

Accessibility/Availability

Controls and meaningful databases readily
available.

Cross-comparability

Reproducible, calibration standards
universally available.

Typeability

Proportion of a population of distinct
strains that can by typed by the method.

Discrimination

Where poor reproducibility within method,
more differences needed.

Stability

Strains should not change too rapidly, i.e.
strains of an outbreak should have the
same character.

Epidemiological relevance

Associations may be dependent on quality
of databases allied with typing system.

Phylogenetic relevance

Frequent recombination events.
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DNA Amplification Fingerprinting (DAF) is a PCR-based typing method which
typically uses randomly-designed 10-mer primers under conditions that allow some
base-pair mismatches, to increase the number of primer-binding sites. Primer binding
throughout the genome generates an array of DNA amplicons of varying lengths and
intensities, producing a genomic fingerprint. Inter-strain variation is dependent on the
number, location and degree of mismatches tolerated when the primer binds to the
genome. Advantages of this technique include a high degree of typeability, ease of
performance, cost effectiveness and ready availability of reagents and equipment.
Furthermore, this technique does not require a prior knowledge of the target DNA
sequence. A number of investigators have used this technique, using a variety of
primer sequences. A comparative study by Endtz et al. (1993) used serotyping and
DAF PCR to characterise C. jejuni isolates from patients with reeurrent
Campylobacter infection. It was concluded that PCR provided a relatively rapid and
simple means to discriminate further between C. jejuni strains that appeared related by
eonventional typing methods. DAF analysis has been applied to the typing of C.
jejuni, C. coli and C. lari from a range of human, animal and environmental sources
(Madden et al, 1996; Hernandez et al., 1995; Lucey et al., 2000a).

In a recent study of 378 Campylobacter isolates, from human and poultry sources,
only one isolate proved untypeable with DAF analysis (unpublished data), using the
primer HLWL85 (Mazurier et al., 1992). One factor which may have influenced the
high degree of typeability when using this technique was the inactivation of the
DNAse activity characteristic of certain strains of Campylobacter spp. (Lior, 1984),
prior to DNA extraction. A technique for inaetivation of DNAse activity using
Formaldehyde fixation of the bacterial cells before DNA manipulation was described
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initially for use with PFGE analysis (Gibson et al., 1994), but the technique has
equally useful applications for DAF analysis. As a typing method DAF analysis has
proven to be highly discriminatory when primers are carefully selected. A
disadvantage of the method is the need to perform each PCR in duplicate (or
triplicate), using separate runs, to ensure reproducibility. Furthermore, it is necessary
to use the same type of thermocycler and the same brand of reagents for each assay
(unpublished observation).

Pulsed-Field Gel Electrophoresis (PFGE) is a molecular typing technique that uses
rare cutting restriction endonucleases to cleave bacterial genomes, producing a small
number of very large DNA fragments. These DNA fragments can only be resolved
and visualised by PFGE methods. Despite some obvious technical considerations
such as the labour-intensive nature of the process involved, PFGE is a method that
offers a high degree of reproducibility and typeability, with the production of highly
discriminatory profiles, and the possibility of inter-laboratory comparisons if methods
are standardised. The PulseNet system of standardised epidemiological typing, which
is generated by the Centres for Disease Control and Prevention (CDC) in the US, is an
example of such standardisation of methods and equipment (Swaminathan et al,
2000). Subtyping may be performed by repeating the procedure and using a different
restriction enzyme. Compared to DAF, PFGE requires specialised equipment and is
more expensive to run on a routine basis (Wassenaar and Newell, 2000).

Ribotyping is a method based on rDNA sequence polymorphisms, that utilises
multiple copies of highly conserved 16S and 23S rRNA at different loci throughout
the bacterial genome for typing purposes (Owen et al., 1995). Most Campylobacter
22

strains have only three ribosomal gene eopies, which limits the discriminatory power
of the technique (Newell et aL, 2000). A commonly used method for ribotyping is
Southern blot hybridisation of genomic DNA, which has been previously digested
with a restriction enzyme and hybridised with a common rRNA probe. The method is
labour-intensive and because of its relatively low discriminatory power is generally
limited in its usefulness. The development of the automated “RiboPrinter” system,
however, allows normalisation of rRNA fingerprints to a set of molecular markers,
followed by comparison with a database of characterised fingerprints, which may
allow species identification in addition to epidemiological analysis (Wassenaar and
Newell, 2000). Advantages of this automated system include greater ease of
perfomance and the possibility of inter-laboratory standardisation of results.
Disadvantages include the relatively small throughput of samples and the high cost
per sample. The low discriminatory power of the method also suggests the need to
use a second typing method in parallel.

The motility of C. jejuni is achieved through the presence of a single polar flagellum
at one or both ends of the cell, and the flagellar filaments are composed of repeats of a
flagellin subunit encoded by a gene designated fla. However, Campylobacter isolates
have two flagellar genes,

and flaB (Guerry et aL, 1991). The fla-KYC? typing

protocol was developed because both highly conserved and variable regions are
present in the

-encoding gene (Newell et aL, 2000). RFLP analysis of ih^ flaA

gene consists of PCR amplification of the flaA gene, followed by restriction digestion
of the PCR product with the enzyme of choice. The resulting fragments are separated
by conventional agarose gel electrophoresis and their patterns are then analysed. This
method has been used successfully for C. jejuni, C. coli, C. lari and C. helveticus
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(Wassenaar and Newell, 2000). One disadvantage of this typing method is its lack of
inter-laboratory standardisation to date. A further disadvantage relates to genomic
instability, and one study has detected both intergcnomic recombination between
genes of different strains, and intragenomic recombination within a single strain
(Harrington et a/., 1997). The use of a second typing method to substantiate/7fl-RFLP
therefore seems advisable.

A study by Moller Nielsen et al (2000) compared the effectiveness of six typing
methods for use on a population of 90 Campylobacter isolates of human, bovine and
poultry origins (comprising outbreak-related and non-related strains). 1 he methods
included were Penner heat-stable serotyping, automated ribotyping, DAF analysis,
PFGE, RFLP of the

-encoding gene, and Denaturing Gradient Gel Electrophoresis

oiflaA. RAPD and PFGE were shown to be the most discriminating methods, whose
effectiveness the authors ascribed to their ability to determine polymorphisms across
the entire bacterial genome. Serotyping was found to be the least discriminating of
the methods.

The use of computer-aided analysis of complex profiles has revolutionised the
interpretation of epidemiological results. Its advantages include greater ease and
speed of interpretation, increased standardisation of results and less subjective
analyses. Perhaps the greatest advantage that computer analysis may offer in the
future is the ability (where the laboratory typing method is completely standardised) to
communicate data in numerical form to a central location, and thereby allow the
development of a worldwide database. Laboratory-generated databases can benefit
public health when electronic data arrive at analysis sites so rapidly that outbreaks can
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be detected, responses initiated, and interventions implemented in time to prevent
cases that would otherwise occur (Bean and Martin, 2001).

1.1.9. The development of PulseNet
The selection by each laboratory of its own protocols for molecular typing and
designation of resultant molecular types does not allow inter-laboratory comparison,
which diminishes the power of molecular subtyping methods. The introduction of a
workshop by CDC in 1996 on standardised methods to perform PFGE for foodbome
pathogenic bacteria, was followed by the provision (by CDC) of funding for
participating state laboratories (Swaminathan et al, 2000). Analysis of data from a
reproducibility study proved that when a highly standardised protocol is followed by
participating laboratories, the inter-laboratory results are highly reproducible.
Protocols were initially developed for E. coli 0157; H7, and Salmonella enterica
serotype Typhimurium, with later additions for Listeria monocytogenes, Shigella spp.
and Clostridium perfringens. It was anticipated that the identification of an increase
in a specific subtype of a pathogen could be an early indication of an outbreak
(Swaminathan et al., 2001). This initiative by CDC led to the foundation of PulseNet,
which has a continually expanding membership. A one-day standardised laboratory
protocol for the molecular subtyping of Campylobacter spp. by PFGE (adapted for
Campylobacter spp. from the PulseNet Method for non-typhoidal Salmonella) was
subsequently introduced in the year 2000. However, outbreaks of Campylobacter
enteritis are rarely reported to the CDC (Swaminathan et aL, 2000). This may be due
to the heterogeneity of Campylobacter spp. as reported, for example, in poultry
(Madden et aL, 1998; Lucey et aL, 2000a), and to reports of genetic instability among
this genus (On, 1998; Wassenaar et aL, 1998). Nevertheless, the implementation of
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PulseNet protocols and surveillance measures for Campylobacter should help to
broaden our understanding of the global epidemiology of human Campylobacter
infeetion in relation to its sources, transmission, seasonality and the greater
pathogenicity of certain strains.

1.1.10. Biological data analysis software
PulseNet laboratories use Contour-elamped Homogeneous Eleetric Field (CHEF)
systems: CHEF-DRII, CHEF-DRIII, or CHEF-Mapper (Bio-Rad Laboratories,
Hereules, Calif.) for PFGE of restrieted bacterial DNA (Swaminathan et ai, 2001).
The PFGE gels obtained after eleetrophoresis are eaptured in a TIFF format
(uncompressed .tif file) by using a GelDoe 1000 (or equivalent) high-resolution image
eapture system. The analysis of the resulting uneompressed TIFF files requires BioRad software sold as GelCompar in Europe (and sold as Moleeular Analyst
Fingerprinting Plus with Data Sharing Tools in the US). This software programme is
supplied to Bio-Rad by Applied Maths BVBA, Belgium, where it is described as
BioNumeries software. It is eapable of managing a wide variety of biologieal data,
and including all types of fingerprints. In addition to database and image proeessing
eapabilities, the programme ean perform elustering analyses and phylogenetic
inference. Further capabilities of GelCompar inelude the generation of libraries and
the identification of any new isolates in relation to the library generated, in addition to
inter-laboratory sharing of databases. Therefore, each PulseNet laboratory has the
eapaeity to normalise fingerprints by eomparison with standards, whieh may then be
compared to other patterns. In this way it is feasible to maintain loeal or inter
laboratory databases of PFGE patterns for each bacterial pathogen of interest.
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Figure 1.5 shows the main BioNumerics database window. The left-hand pane
describes all the database entries, each corresponding to a particular fingerprint. In
this Campylobacter study, there are 378 entries, after DAF analysis, of a collection of
isolates. The Files pane lists the gels, and the Comparisons pane lists the created
dendrograms, both per gel and in total. In order to generate a dendrogram however,
there are a number of selections to be made.

Firstly, there are four separate binary coefficients which measure the similarity of
different strains based on common and different bands, namely Jacard, Dice,
Jeffrey’s X and Ochiai. V/ith these coefficients it is also possible to enable fuzzy
logic. This permits the programme to allow the matching value to decrease in
accordance with the distance between bands in different lanes.

Secondly, an Area Sensitive option is possible. This takes into account differences in
area between the two matching bands as the more the areas differ the lower the
similarity will be.

Thirdly, for dendrogram types the programme offers five algorithms, namely
UPGMA (Unweighted Pair Group Method using Arithmetic Averages), Ward,
Neighbour Joining, Single Linkage (UPGMA variant) and Complete Linkage
(UPGMA variant).
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Fourthly, the Position Tolerance option allows the analyst to specify the maximum
distance between two bands, within which the programme may consider the bands as
matching. In general the position tolerance is set at 1%.

Figure 1.6 demonstrates the third stage of the four-stage procedure necessary for each
gel to be processed. Each gel may usually be composed of up to 20 lanes or
fingerprints, and each of these lanes corresponds to a database entry. This screen
depicts the stage where the gel is normalised, i.e. the reference lanes are marked out.
I'his then allows any or all of the lanes on the gel to be selected for analysis.

Figure 1.7 demonstrates the fourth and last processing stage before the cluster
analysis of the collection of isolates is performed. At this stage each unique band on
the gel has been identified and, depending on the preferred comparison settings
chosen, a band-based similarity coefficient is invoked to carry out the comparison.
The inter-gel compilation of isolate data permits the generation of a dendrogram for
any collection of isolates, irrespective of the number of gels analysed, once the
reference lanes for each gel have been defined and normalised.

Figure 1.8 shows a section of the dendrogram created from the database of 378
Campylobacter entries. Jeffrey’s band-based similarity coefficient was used to build
the comparison, using a position tolerance of 1% and enabling fuzzy logic.

There are many isolates that are obviously indistinguishable from each other and
group into similar clusters and, as is usual in phylogenetic studies, the straight bar
identifies 100% similarity between isolates. In these cases it may be useful to perform
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a further epidemiological analysis of a sub-collection of the isolates using a different
typing method. The fingerprints generated may then be captured, stored and analysed
in a manner identical to that used for DAF, to allow subtyping of the indistinguishable
isolates.

When the typing method has been completely standardised, as for PulseNet PFGE of
certain species, it is possible to submit results to a central database. In this case, for
each isolate the presence or absence of a band of DNA (depending on its location on a
gel relative to the defined reference positions) is calculated as a number between 0
and 1. The resultant database can be incorporated in a central location to generate an
inter-laboratory dendrogram, or to provide a library within which all future isolates
may be compared.
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1.2. Campylobacter spp. and antimicrobial chemotherapy
1.2.1. Treatment strategies for enteric Campylobacter infection
Campylobacter enteritis is considered to be a zoonotic disease and domestic animals
such as poultry, cattle and pigs can act as sources of infection. Transmission to man
usually results in sporadic infection and is often associated with improper handling or
cooking of food. The majority of cases of clinical Campylobacter enteritis are
sufficiently mild or self-limiting not to require antimicrobial chemotherapy (Alios and
Blaser, 1995). Nevertheless, in severe or recurrent cases where antibiotics are
required, susceptibility testing is important to ensure appropriate and timely treatment.
Macrolides remain the agents of choice for such cases and resistance rates to
erythromycin remain comparatively low (Nachamkin et al., 2000). Since the 1980s,
however, the development of fluoroquinolones, which are effective against most
enteric pathogens, have offered an effective therapy to treat acute bacterial diarrhoea,
and ciprofloxacin is now used extensively as prophylaxis for travellers (Gibreel et al.,
1998).

The emergence of resistance to these agents, however, has made their efficacy less
certain in the interim (Nachamkin et al., 1998b). Resistance was reported to develop
among patients following treatment with fluoroquinolones (Adler-Mosca et al., 1991),
and was also found to coincide with the introduction of these agents in veterinary
medicine (Endtz et al., 1991). Tetracyclines have been suggested as an alternative
choice in the treatment of clinical Campylobacter enteritis, but in practice are rarely
used for these infections.
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Increased foreign travel and globalisation of food products has meant that
antimierobial policies worldwide can influence the efficacy of these agents for the
treatment of human enteric infection.

1.2.2. Antimicrobial susceptibility testing in Campylobacter spp.
As with other baeteria, antimierobial suseeptibility testing may be carried out by
diffusion or dilution methods, using either a single concentration of antibiotic to
which the isolate is deemed either sensitive, intermediate or resistant, or, alternatively,
by using varying eoncentrations of an anti biotie from which the Minimum Inhibitory
Coneentration (MIC) ean be determined.

MICs may be performed using agar or broth dilution methods, or by agar diffusion,
using the E-test or Epsilometer gradient diffusion test (AB Biodisc, Solna, Sweden).
The use of either IsoSensitest Agar or Mueller-Hinton Agar with 5% sheep or horse
blood added for agar diffusion and agar dilution methods has been noted; for broth
dilution methods Mueller-Hinton Broth supplemented with 5% sheep or horse blood
has been used. A cell suspension equivalent to a 0.5 MeFarland turbidity standard is
required for agar diffusion methods, and a 1:10 dilution of this suspension is required
for agar and broth dilution methods. Plates and tubes are ineubated
mieroaerophilically at 37°C for 24 or 48 h, depending on the rate of growth of a strain.
The susceptibility eriteria most eommonly used for diffusion and dilution methods,
and the drug concentrations in the discs, are those of the National Committee for
Clinieal Laboratory Standards (NCCLS, 1981 - 1999). Zones of inhibition are
measured using ealipers and zone sizes are compared to the NCCLS guidelines.
However, it should be noted that susceptibility testing for Campylobacter spp. is not
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standardised internationally (Lucey et al., 2002b), and the NCCLS guidelines apply
only to “bacteria that grow aerobically”. This limitation may pose interpretative
difficulties when applied to microaerophilic organisms, particularly as the NCTC
(National Collection of Type Cultures) control strains recommended for comparison
are aerobic bacteria. Furthermore, despite using a McFarland turbidity standard for
bacterial suspensions, test isolates may show variability in colonial morphology and
confluence of growth, often making interpretation difficult, unless sensitivity testing is
repeated to increase accuracy and precision. Combinations of susceptibility testing
methods for an antibiotic may also offer an advantage.

As an alternative to the NCCLS guidelines, a set of guidelines is available from the
Working Party of the British Society for Antimicrobial Chemotherapy (BSAC), which
has published MIC values for control NCTC Campylobacter isolates and breakpoints
used in resistance screening (Working Party of the BSAC, 1996). An exception is
erythromycin for which no guidelines are shown for Gram-negative isolates in the
BSAC report. A study by Gaudreau and Gilbert (1997) has shown a high degree of
correlation between disc diffusion and agar dilution methods for the susceptibility
testing of C. jejuni and C. coli to common antimicrobial agents. Furthermore, the Etest has been shown to correlate well with agar dilution methods for most agents
except for the macrolide antibiotic clindamycin (Huang et al., 1992).

Molecular techniques offer an alternative means of assessing antimicrobial resistance
among bacterial isolates. One such technique has been successfully applied to the
detection of ciprofloxacin resistance in C. jejuni and C. coli, where, as in other Gram
negative bacteria, fluoroquinolones operate by interfering with type II topoisomerase
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DNA gyrase, and topoisomerase IV (Drlica and Zhao, 1997). The predominant
mechanism of resistance to ciprofloxacin in C. jejuni and C. coli has been shown to
result from a mutation in the gyrA gene, whereby all isolates tested demonstrated a
Thr-86-Ile substitution in the A-subunit of DNA gyrase (Zimstein et aL, 1999;
Zimstein et al., 2000). A specific PCR assay. Mismatch Amplification Mutation
Assay (MAMA-PCR) has been demonstrated to be a useful screening method for
ciprofloxacin resistance among each of these isolates (Zimstein et al., 1999; Zimstein
et al., 2000; Lucey et al., 2002b). Methods for C. jejuni and C. coli use a conserved,
forward primer and a reverse, diagnostic primer, which generate a product that is a
positive indication of the presence of the Thr-86-Ile amino acid substitution consistent
with resistance to ciprofloxacin.

The use of molecular methods to detect antimicrobial resistance depends on a prior
knowledge of the genetic basis for that resistance. The advantages of using these
methods include the possibility of direct detection from a sample without having to
wait for the organism to grow on culture media (Cockerill, 1999). Molecular methods
can permit sensitivity testing of organisms that may be sublethally damaged and
difficult to grow in culture, and they may also offer the possibility of screening large
numbers of isolates for a specific mutation within a single assay. The disadvantages
of using such molecular detection strategies include the failure to detect resistance if a
new, unexpected, or rare resistance mechanism is present (Nachamkin et al., 2000),
and the necessity to perform a separate assay for each antimicrobial agent tested.
Furthermore, no standards exist for performing gene testing methods (Cockerill,
1999). For these reasons it may be most useful to combine phenotypic and genotypic
methods of susceptibility testing.
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1.2.3. Surveillance of antimicrobial resistance in Campylobacter spp.
The use of antimicrobial agents on farm animals, both to treat infection and as growth
promoters, has recently been highlighted as a cause of concern, and the increasing
rates of resistance to these agents among Campylobacter spp. appear to make a
conservative policy on the use of antibiotics in farm animals advisable. Antibiotics of
the macrolide-lincosamide group have been used in treating these animals worldwide
for several decades. Their uses have included the control of dysentery and
Mycoplasma infections in swine, and the treatment of mastitis in cattle (Engberg et
al., 2001). The use of macrolides for growth promotion has been banned, however, in
all European Union countries since July 1999.

Several fluoroquinolones are available for treating farm animals in many countries,
and Table 1.7 shows the veterinary licensing of this group of antibiotics in a number
of European countries. It is difficult to evaluate the actual usage of these agents in
animals, but it is noteworthy that fluoroquinolone treatment of Campylobactercolonised broiler chickens has induced fluoroquinolone resistance under experimental
conditions (Jacobs-Reitsma et al., 1994).

Supplementing animal feed with antibiotics is estimated to constitute more than half
of the total antimicrobial use worldwide (Wegener et al., 1999). It has been reported
that in Denmark the consumption (per animal) of antibiotics such as macrolides and
tetracyclines in agriculture was 2-4 times higher than consumption (per patient) in
human medicine (Aarestrup et al., 1998). The widespread development of
antimicrobial resistance among zoonotic pathogens has led to the development of a
continuous surveillance system of antimicrobial resistance among bacteria isolated
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from pigs, cattle and broilers in Denmark. The Danish Integrated Antimicrobial
Monitoring Programme (DANMAP) has set out to establish a baseline for comparison
with future prospective studies to enable the determination of trends over time
(Aarestrup et al., 1998; Engberg et al., 2001). Monitoring strategies such as this may
have a positive impact on the effective treatment of human enteric Campylobacter
infection. To date, with the exception of ciprofloxacin resistance developing postveterinary and post-clinical use, there is a scarcity of scientific evidence for the
transmission of antimicrobial resistance as a direct result of the use of antimicrobial
agents in veterinary medicine.

Table 1.7. Veterinary licensing of fluoroquinolones in selected European countries.
(Data taken from The European Agency for the Evaluation of Medical Products,
1999.)
Country

Substance

Licensing year

Animal species

Ireland*

Enrofloxacin

Prior to 1987

Cattle, pigs, poultry

UK

Enrofloxacin
Danofloxacin
Marbofloxacin
Difloxacin

1993
1993
1995
1998

Cattle, pigs, poultr>'
Poultry
Cattle
Poultry

Denmark

Enrofloxacin
Danofloxacin
Difloxacin
Marbofloxacin

1991
1993
1998
1998

Cattle, pigs, poultry
Poultry
Poultry, turkey
Cattle, pigs, dogs, cats

Spain

Enrofloxacin
Difloxacin

1986
1998

Cattle, pigs, poultry
Poultry

The Netherlands

Enrofloxacin
Difloxacin

1987
1998

Cattle, pigs, poultry
Poultry

France

Enrofloxacin
Danofloxacin
Marbofloxacin
Difloxacin

1991
1996
1993
1998

Cattle, poultry
Cattle
Cattle
Poultry

* Personal communication with the Irish Medicines Board, Dublin.
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For this reason, it is understandable that widespread use of valuable elinical
antimierobial agents eontinues in veterinary medicine.

It is important to monitor the susceptibilities of Campylobacter spp. to a panel of
antimicrobial agents for a number of reasons. Firstly, there are increasing rates of
resistance to the agents of choice used in the treatment of clinical enteric infection.
This suggests a need to supply alternative antimicrobial sensitivities. Secondly, the
emergence of multidrug-resistant organisms should be monitored carefully. Finally,
mechanisms for the transfer of resistance both within Campylobacter spp. and
between different genera of enteric organisms by means of mobile genetic elements
may present a threat to the continued efficacy of antimicrobial chemotherapy.
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1.3. Mobile genetic elements and antimicrobial resistance
1.3.1. The acquisition of foreign DNA
When antibiotics were first used in the 1940s to treat clinical microbial infections,
bacterial geneticists predicted that the development of antimicrobial resistance during
therapy was highly unlikely due to the low frequency with which mutations occurred.
While antibiotics have reduced the mortality from infectious diseases they have not
markedly reduced their prevalence, and the level of antibiotic usage has far exceeded
all early expectations; in hospitals, in the community and in the veterinary industry
where antibiotics are used both to treat infection and as growth promoters. This has
resulted in a strong selective pressure among bacteria to survive antimicrobial
onslaught. Antimicrobial resistance is frequently caused by the acquisition of genes,
however, rather than by mutation (Recchia and Hall, 1997). Bacteria can acquire
foreign DNA by three mechanisms: transduction, transformation and conjugation.

The process of transduction depends on the presence of bacteriophages (phages), i.e.
viruses that have a bacterial host. Phages can be divided into two main types, namely
virulent phages and temperate or lysogenic phages.

Virulent phages grow lytically during which time the host cell is completely
reprogrammed and becomes dedicated to replicating the infecting phage. This
ultimately ends in lysis of the host cell and the release of many progeny phages (Smith
and Rees, 1999).
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Temperate or lysogenic phages may either lyse or lysogenise infected cells. Lysogeny
is the state where a host cell contains a prophage in which the lytic genes are repressed
by the phage-encoded repressor. The phage nucleic acid is reproduced in a stable
fashion, often within the host chromosome (Towner, 1995). However, a culture of
lysogenic cells contains free phages due to the spontaneous conversion to the lytic
cycle once in every few thousand cell divisions (Smith and Rees, 1999).

The role in nature of transduction may be limited to closely related species by the high
degree of specificity of the adsorption step in bacteriophage invasion (Courvalin,
1996). This process involves the accidental incorporation of bacterial DNA, from
either the chromosome or a plasmid, into a bacteriophage particle during the phage
lytic cycle. The phage particle then acts as a vector and transfers the bacterial DNA to
the next cell which it infects (Towner, 1995). More than 170 bacteriophages have
been described as being infective to Campylobacter^ but there are no data available
concerning chromosomal insertion of phage DNA (Sails et al., 1998). Nonetheless,
this may only be a matter of time, as in the case of Salmonella enterica Serotype
Typhimurium. P22-like phages have been shown to invade drug-sensitive isolates,
transferring a complete “resistance island” (Schmieger and Schickmaier, 1999). This
situation may be further enhanced in environmental settings; wherein large groups of
animals are gathered (e.g. abattoirs).

Transformation involves lysis of a bacterial cell and the release of naked DNA into
the surrounding environment. Under certain circumstances, intact bacterial cells in
the vicinity can acquire some of this DNA. Transformation systems appear to fall into
two groups, one typical of Gram-positive organisms and the other found in some
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Gram-negative baeteria (Smith et al, 1981). In many Gram-positive organisms a
single eompetent eell can bind and take up a large number of free DNA moleeules
regardless of their sources. During the uptake process one strand of the DNA is
degraded while the complementary strand is transported into the cell (Smith el al.,
1981; Stewart and Carlson, 1986). For the Gram-negative transformation process
DNA uptake tends to involve recognition of a specific DNA sequence of
approximately 10-15 base pairs in length. Furthermore, only a few molecules of
homologous DNA can be taken up by a competent cell, and heterologous DNA can be
taken up only at an even lower frequency (Goodgal, 1982). Natural transformation of
plasmid DNA is normally rare in both Gram-positive and Gram-negative bacteria
because the duplex DNA is nicked and partially degraded during both binding to and
entry into the cell (Stewart and Carlson, 1986). Studies on the ability of
Campylobacter spp. to undergo natural transformation are few. It has been observed
however, by Wang and Taylor (1990), that most C. coll and some C. jejuni strains are
naturally competent during the logarithmic phase of growth, and that they show strong
selectivity for taking up their own DNA. It was also observed that E. coli DNA was
taken up very poorly by Campylobacter spp. A further study demonstrated the ability
of C. coli to acquire plasmids with little or no homology to the chromosome by
natural transformation, and the capacity to maintain them by chromosomal integration
following illegitimate recombination (Richardson and Park, 1997). How this situation
relates to other forms of mobile element (e.g. integrons) remains to be established
(Lucey et al., 2000b).

Conjugation involves physical contact between two bacterial cells, whereby the cells
adhere to one another and the DNA passes unidirectionally from one cell (the
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donor/male) to another (the recipient/female). This is a more efficient mechanism for
the transfer of genetic material compared with either transduction or transformation
and, in addition, the donor ceil is not destroyed in the process. The ability to
conjugate depends on carriage of an appropriate plasmid or transposon which contains
the genetic information for conjugation by the donor cell (Courvaliri, 1996).

The acquisition of genes is most efficiently carried out therefore, by means of mobile
genetic elements, such as promiscuous plasmids, conjugative transposons or
transposons carried by conjugative plasmids (Davies, 1994), as shown schematically
in Figure 1.9. These genetic elements were present in bacteria prior to the advent of
antibiotics, (Datta, 1985), and proved well adapted to serve as agents of resistance
gene transfer in the antibiotic era that followed (O’Brien el al, 1985).

44

Antibiotic resistance gene pool
Antibiotic producing strains
Antibiotic resistant strains
Resistance-encoding DNA

Uptake of
resistanceencoding DNA by
bacteria

Disseminaton of'
resistance genes
through intra- and
inter-specific transfer

R plasmids and
conjugative
transposons

t

Resistance genes in
bacterial cytoplasm

Increasing antibiotic selection pressure
Formation of rnultidrugresistant structures by
nonhomologous recombination

Incorporation
into replicons

Intcgrons or similar
structures

Resistance
eene cassettes

Cycle of antibiotic resistance acquisition
Figure 1.9. Schematic representation of the route by which antibiotic resistance genes
are acquired by bacteria in response to the selective pressure of antibiotic use.
(Adapted from Davies, 1994). The resistance gene pool represents all potential
sources of DNA encoding antibiotic resistance determinants in the environment.
After uptake of single- or double-stranded DNA by the bacterial host, the
incorporation of the resistance genes into stable replicons may take place by several
different means. The involvement of integrons has been well characterised for a large
class of transposable elements in the Enterobacteriaceae and the pseudomonads. The
resulting resistance plasmids could exist in linear or circular form in bacterial hosts.
The spread of resistance genes is brought about by one or more of the gene transfer
mechanisms.
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1.3.2. Plasmids
Plasmids have been defined as autonomous extrachromosomal replicons, consisting of
double-stranded DNA (Radnedge and Richards, 1999). I hese structures range in size
from less than 10 kbp to greater than 400 kbp, and are common in bacteria (Timmis et
al. 1986). They are able to maintain themselves in the cytoplasm of a bacterium for
many generations, usually present at a constant cellular concentration, typically of 140 copies per chromosome. Plasmids were initially thought to be universally circular,
until the isolation of linear plasmids by Kinashi et al, (1987). These structures have
been described as mini-chromosomes that can be isolated from bacterial cells and then
re-introduced into other ceils by conjugation or transformation (Radnedge and
Richards, 1999). In addition to the transfer of antimicrobial-encoding resistance
genes, plasmids may also confer additional metabolic and virulence mechanisms on
the host cell.

Conjugative plasmids differ from non-conjugative plasmids in their requirement for
additional genes that can initiate self-transfer, and also tend to be larger (Thompson,
1986). Non-conjugative plasmids can be conjugally transferred as part of integrated
structures which contain a conjugative plasmid (Guyer, 1978).

The isolation rate of plasmids from Campylobacter spp. has been shown to vary
considerably between 91% and 44% for poultry and clinical isolates respectively, in
one study (Lee et al., 1994); a plasmid isolation rate of 19% was observed in a
separate study (Bacon et al., 2000). As shown in Table 1.8, chloramphenicol,
kanamycin and tetracycline resistance are primarily plasmid-mediated.
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Chloramphenicol resistance appears to be relatively uncommon among
Campylobacter isolates (Moller Aarestrup et al., 1997; Thwaites and Frost, 1999;
Lucey et al., 2000a). The chloramphenicol resistance determinant was cloned and
sequenced from a plasmid that had been isolated from C. coli (Wang and Taylor,
1990). The resistance gene was found to consist of a single gene that was 67%
identical to the chloramphenicol acetyltransferase {cat) genes of Clostridium difficile
and Clostridium perfringens (Wang and Taylor, 1990).

Kanamycin resistance was also relatively low among C. jejuni and C coli, but high
among C. lari isolates (60%) in a UK study by Thwaites and Frost (1999).
Kanamycin resistance is often mediated by a plasmid which also encodes tetracycline
resistance (Lambert et al., 1985; Kotarski et al., 1986; Sagara et al., 1987). It has also
been noted that kanamycin-susceptible tetracycline-resistant isolates carried plasmids
4 kbp smaller than the 59 kbp parental plasmids (Kotarski et al., 1986). The plasmidtransmitted resistance gene from a C. coli isolate was identified as an aphA-3
kanamycin phosphotransferase gene, believed to have been acquired in vivo from a
Gram-positive coccus (Trieu-Cuot et al., 1985). A further study by Tenover and co
workers (1992) reported the characterisation of two small plasmids of 11.5 kbp and
9.5 kbp, each carrying an aphA-7 kanamycin phosphotransferase gene from C. jejuni.
These plasmids could also be mobilised to C. coli recipients. A study in Spain noted
the presence of small plasmids of 4.3, 4.0 and 1.9 kbp in kanamycin-resistant C coli
isolates (Velazquez et al., 1995).

Tetracycline resistance has been particularly well researched and documented. The
tetO gene conferring tetracycline resistance has a G+C content of 40% (Manavathu et
M

aL, 1988), which is close to that of the tetM gene of Streptococcus pneumoniae, to
whieh it is closely related (Manavathu et al., 1990). It is signifieantly higher than that
for C. jejuni and C. coli ehromosomal (32.5 mol%) and plasmid (33 mol%) DNAs
(Taylor et al., 1983; Manavathu et al., 1988). Based on this evidence, Taylor and
Courvalin (1988), have suggested that the tetO gene was aequired by Campylobacter
spp. from a Gram-positive eoeeus, and that the estimated 25% divergence oecurred
over time. A study by Lee et al. (1994) in Taiwan, investigating the location of the
tetO gene, reported that 98% of poultry-derived C. jejuni and C. coli isolates
hybridised with a tetO probe, and that 87% of hybridisation reaetions oeeurred on
plasmids, while 11 % oecurred on the chromosome. It was interesting to note that
88% of the elinieal C. jejuni and C. coli isolates hybridised with the tetO probe, but
that only 47% of hybridisation reactions occurred on plasmids, with the remaining
41 % oeeurring on the ehromosome.

1.3.3. Transposons
Transposable genetie elements ean transloeate from one area of the baeterial
ehromosome to another, or between the ehromosome and a plasmid or bacteriophage
DNA (Mayer et al. 1995), and do not need to share extensive regions of homology
with the replieon into whieh they insert (Towner, 1995). Depending on the transposon
in question, insertion may oceur at either single or multiple sites on the host genome
(Towner, 1995). Most transposable elements have two features in common, namely:
(i) inverted repeats of 18-35 base pairs at their ends, whieh flank (ii) a central
sequenee that contains at least one gene encoding a protein, transposase, whose
funetion is to ereate DNA strand breaks at the boundary of the inverted repeats and the
flanking sequenee of the original donor loeation (Dyson, 1999). There are two types
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of transposable elements, both similar, referred to as transposons and insertion
sequenees (IS). Transposons differ from IS in that they earry a reeognisable
phenotypic characteristic such as an antibiotic resistance marker (Schmitt, 1986).
Transposons and IS are incapable of independent self-replication and are therefore
dependent on the host chromosome, plasmid or bacteriophage for regeneration (Mayer
et al, 1995).

Conjugative transposons differ from non-conjugative transposons in their ability to
move from the chromosome of one bacterium to another without the need to
incorporate into a plasmid or bacteriophage. While they are found primarily in
aerobic and anaerobic Gram-positive organisms (Franke and Clewell, 1981), they are
now known to be found also in a variety of Gram-negative bacteria (Speer et al,
1992). These mobile elements have a broad host range of transfer. Conjugative
transposons are transposon-like in the sense that they excise from, and integrate into,
DNA, but they appear to have a different method of excision and integration which
resembles that of temperate bacteriophages (Salyers et al, 1995). The presence of
chromosomally-bome transposons among Campylobacter spp. had not been reported
prior to 1998. The dfr9 gene encoding trimethoprim resistance has been located to the
remnant of a transposon inserted in the genome of a number of clinical C. jejuni
isolates (Gibreel and Skdld, 1998). The G+C content of dfr9 was found to be 40%,
similar to the tetO gene described earlier, which is considerably higher than that of
Campylobacter spp. and was previously detected in a transposon located in the
genome of porcine isolates of E. coli (Chiou and Jones, 1993). A study by Richardson
and Park (1998) demonstrated an insertion sequence that was flanked by direct repeat
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sequences in the chromosome of certain isolates of C. jejuni, which appeared to be a
non-functional transposable element.

The spread of antibiotic resistance under natural conditions is often due to a
combination of gene transfer systems acting in parallel or in series (Courvalin, 1996).
For example, the highly efficient dissemination among enterococci of high-level
resistance to glycopeptides is due to transposition of elements containing the vanA
operon on self-transferable plasmids followed by inter-and intra-species conjugation
(Arthur et al, 1993). Table 1.8 outlines mechanisms through which Campylobacter
acquires antimicrobial resistance.
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Table 1.8. Mechanisms for antimicrobial resistance detected to date in C. jejuni and
C. coli.
Antibiotic

Mechanism of resistance

Reference

Chromosomal, enzymatic modification of antibiotics.

Trieber and
Taylor, 2000.

Integron, adenyltransferase gene (aad)

O’Halloran et
ai, (CIT)
unpublished
data.

Kanamycin

Maioritv plasmid-bome, remainder chromosomal; resistance
through enzymatic modification of kanamycin.

Sagara et ai,
1987.

P-lactams

Chromosomal, three mechanisms, decreased uptake through
modification of a porin, alteration of a penicillin binding protein,
or production of a P-lactamase

Piddock et ai,
1997

Chloramphenicol

Plasmid-bome, resistance through modification of the target site
(ribosome) or alteration of the antibiotic.

Wang and
Taylor, 1990.

Ciprofloxacin

Chromosomal, modification of DNA gyrase and parC.

Acar and
Goldstein,
1997.

Erythromycin

Chromosomal ly mediated, resistance through modification of the
target site (ribosome).

Taylor, 1992b.

Tetracycline

tetO gene, plasmid-bome in the maiority of cases, resistance
mediated through ribosomal protection.

Taylor and
Chau 1996;
Leyy et al.,
1999.

Trimethoprim

dfri gene, chromosomal, located to the remnants of an integron.
dfr9 gene, chromosomal, located to the remnants of a transposon.
Resistance arising through modification of the trimethoprim
target.

Gibreel and
Skold, 1998.

Multidrugresistance

Efflux pump with a broad specificity, preyenting accumulation of
antibiotics.

Charyalos et
al., 1995.

Aminoglycosides
(with the exception
of kanamycin)
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1.3.4. Integrons and mobile gene cassettes
Antibiotic-resistant genes of Gram-negative bacteria are often situated on plasmids
and transposons. in the early 1980s, studies using restriction mapping and
heteroduplex analysis showed that different sets of antibiotic-resistance genes were
sometimes found in the same location in otherwise closely related plasmids, such as
the IncW group, or transposons of the Tn27 family (Stokes and Hall, 1989; Recchia
and Hall, 1995). Further work showed that this third mechanism of antibioticresistance gene dissemination involved naturally-occurring gene expression elements
called integrons (Stokes and Hall, 1989). These structures operated as vehicles for the
acquisition of resistance genes carried by mobile elements, termed gene cassettes, by a
site-specific recombinational mechanism (Hall and Collis, 1995), as shown in Figure
1.10. While integrons are found on many different plasmids and transposons, only
one integron, Tn402, is known to be itself an active transposon (Bennett, 1999).

1.3.4.1. Structure and function of class 1 integrons
Integrons comprise two conserved segments, the 5’-conserved segment (CS) which is
located upstream from the gene cassette, and is approximately 1.4 kb in size, and the
3’-CS, which is found downstream of the resistance gene, and is approximately 2 kbp.
There is also an internal variable region (Hall et al, 1991), containing the gene
cassette. (See Figure 1.10 for a schematic representation.) The internal variable
region is the target for integration of one or more gene cassettes (that encode antibiotic
resistance determinants) with a recombination site, termed the 59-base element (59be) (Hall et al, 1991). The 5’-CS contains the int gene, which encodes integrase, a
site-specific recombinase. One of its substrates is the 59-be, and the second substrate
is the cassette receptor or integration site {att\) within the integron. Also present on
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the 5’-CS are promoters required for expression of all downstream gene cassettes.
The 3’ conserved segment carries several open reading frames (ORFs), including a
defective gene encoding resistance to ethidium bromide and quaternary' ammonium
compounds (qacEAl) and another encoding resistance to sulphonamide (sull) in class
1 integrons (Paulsen et al, 1993; Recchia and Hall, 1995).

1.3.4.2. Gene cassettes
It is now known that cassette-associated genes could be described as ubiquitous
(Recchia and Hall, 1997) thereby demonstrating the importance of their role in the
development of antimicrobial resistance on a global scale. In fact, gene cassettes are
also known to have been original constituents of the first resistance plasmids reported
in the mid 1960s (Bennett, 1999). It is also interesting to note however that gene
cassettes have been isolated from a strain of Vibrio metschnikovii cultured in 1888,
suggesting that this method of gene acquisition predated the antibiotic era (Mazel et
al, 1998).

These mobile elements or gene cassettes differ from transposons in a number of ways.
Firstly, they do not include any genes encoding their transfer functions to a new
location. Secondly, cassettes are not flanked by inverted repeat sequences, and
thirdly, mobilisation involves a conservative site-specific recombination event rather
than transposition (Recchia and Hall, 1995).

In terms of molecular organisation and compared, for example, with conjugative
transposons, integrative phages and integrating plasmids, gene cassettes are simpler in
structure. Gene cassettes include only a single gene, thus differing from conjugative
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transposons (Salyers et ai, 1995), integrating phages (whieh eneode both phage
proteins and replication functions), and integrating plasmids, (Recchia and Hall,
1995). The integron is able to incorporate an antibiotic resistance gene either
chromosomally or extrachromosomally (Hall and Stokes, 1993). Gene cassettes may
exist as free, circular, non-replicating DNA molecules when moving from one genetic
locus to another, but are normally found as linear sequences that constitute part of the
larger DNA molecule (Collis and Hall, 1992a). It has been noted that the fact that
integrons and gene cassettes are found in a range of bacterial pathogens, particularly
the Enterobacteriaceae and pseudomonads, indicates that inter-species transfer has
occurred (Recchia and Hall, 1997). By 1995, more than 40 different gene cassettes
had been identified, all with the exception of five encoding resistance determinants
(Recchia and Hall, 1995). These cassettes were shown to confer resistance to a
variety of antimicrobial agents, including aminoglycosides, antiseptics, p-lactams,
chloramphenicol, disinfectants, erythromycin, sulphonamides and trimethoprim,
(Reechia and Hall, 1995). Higher levels of expression of the encoded resistance
determinant can be achieved both through the presence of a second promoter on the
integron (Levesque et al, 1994), and also when more than one copy of the particular
determinant is inserted within the integron (Hall, et al, 1994). The preponderance of
antibiotic resistance genes identified may be a function only of the degree of interest
in the development of antimicrobial resistance. In support of this theory, recent
studies of integrons detected from bacteria in an aquatic environment have shown
that, in the absence of selective pressures, integrons which persist appear to exist
preferentially without integrated antibiotic resistance gene cassettes (Rosser and
Young, 1999; Schmidt et al., 2001). While it is more eommon for a gene cassette to
carry a single gene, two or more genes may also be located within the cassette (Tosini
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et aL, 1998; Daly and Fanning, 2000; Schmidt et aL, 2001). These are likely to have
been generated by the fusion of two individual cassettes. There are two means by
which this could occur: (a) through a deletion event with the end-points of both
genes, which may give rise to one or both genes being incomplete, or (b) through the
loss of the 59-be from one cassette while retaining the complete genes (Recchia and
Hall, 1995). The end result of either (a) or (b) is a classical “head-to-tail”
arrangement of the two genes, under the control of a common promoter (Figure 1.10).

1.3.4.3. The 59-base element (59-be)
The 59-bes studied are not highly conserved and have been found to vary in length
from 57-141 bp. These elements can be identified by their location downstream of the
cassette gene(s) and by the relationship of over 20 bp at their outer ends to consensus
sequences that are imperfect inverted repeats. The recombination cross-over point
which is located at the 3’-end of the 59-be has the sequence -GTT-, followed by either
-RRRY- (R = any purine, Y == any pyrimidine) or -AGGC- concensus bases (Hall et
ai, 1991; Stokes et al, 1997). The identity of the concensus bases, however, is less
critical than the -GTT- recombination site. There is also a conserved triplet, -AAC-,
located at the 5’end of the 59-be, preceded by either -GCCT- or -RYYY- (Stokes et
al, 1997).
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3’-Conserved Structure

5’-Conserved Structure

Pint

CLASS 1 INTEGRON STRUCTURE

Figure 1.10. Class 1 integron structure: model for site-specific gene insertion.
(From Carattoli, 2000.) The diagram represents the process by which a circularised
gene cassette (resistance gene 2) is inserted at the atti site in a class 1 integron
containing a resident gene cassette (resistance gene 1). Genes and open reading
frames (orf) in the 5’- and 3’-CS of a schematic class 1 integron are indicated by
boxes. Vertical black bars represent attC recombination sites. P| and P2 are integronassociated promoters; Pint is the integrase gene {intll) promoter. The qacEAl and sull
genes in the 3’-CS confer resistance to quaternary ammonium compounds and
sulphonamides, respectively.
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1.3.4.4. Characterisation of four classes of integron
Until recently, three distinct classes of integron had been identified, each comprising
all the distinctive features outlined previously (Hall, 1997). Each integron class had a
different integrase, and the integrases themselves had between 43 and 58% sequence
homology, while also being related to the integrases of temperate bacteriophages
(Mazel et al, 1998). All known gene cassettes are recognised by the same integrase
which mediates the acquisition, rearrangement and loss of gene cassettes (Bennett,
1999), despite differences in the precise sequence of their 59-be recombination sites.
Furthermore, the integrases of the first three classes of integrons are capable of
recognising the samiC family of cassettes (Recchia and Hall, 1995).

Class 1 integrons are prevalent among clinical isolates and were the first integrons
characterised. Class 2 include an integron system found on transposon Tn7 and
related elements. The integron on Tn7 possesses three integrated gene cassettes
adjacent to a defective integrase gene, and lacks the 3’-conserved region. Class 3 is
comprised of a single example (Bennett, 1999). Recently however, a fourth class of
integron (Mazel et al., 1998) has been described, arising from studies of the
relationship between integrons and repeat sequences (VCRs) of Vibrio cholerae. The
isolation of a gene for an integron-containing integrase using nucleic acid
hybridisation identified the z>7/14 gene, the product of which has 45 to 50% homology
with the three other known integrases (Mazel et al., 1998). The VCR concensus
sequence is closely related to the concensus sequence of the 59-be, and the gene
cassettes operate in the same manner as those already characterised (Recchia and Hall,
1997). However the VCR integron differs from the previously described integrons in
the following ways: firstly, the VCR is not plasmid-encoded, and is found on the
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chromosome in approximately 80 copies, probably acting as a gene capture system.
Secondly the VCR contains many more genes, often in multiple copies, than have
previously been found on integrons (Clark et al., 1997).

When the completed genome sequence of C. jejuni (Parkhill et al., 2000) was
published, little sequence identity could be found between individual genes being
submitted to GenBank and the chromosome. It is acknowledged that the
Campylobacter genome is dynamic, having a high degree of plasticity. In relation to
the findings in V. cholerae (Mazel et al., 1998), it may not be unreasonable to expect
that integron-like structures in Campylobacter spp. may play a similar role, acting as a
gene capture system (Lucey et al., 2000b).
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Chapter 2
Materials and Experimental Methods^
^Tpublication is pending for most of the following chapter. The original publishing formatting is retained here.

Methods in Public Health Microbiology
Humana Press, Totowa, N.J.
In press 2002

Experimental objectives
Thermophilic Campylobacter spp., mainly C. jejuni and, to a lesser extent, C. coli, are
currently recognised as the most common cause of human bacterial enteritis.
However, most clinical laboratories identify these organisms to genus level only.
Furthermore, antimicrobial susceptibility testing is not routinely performed in most
hospital laboratories and epidemiological typing is uncommon.

The epidemiology of Campylobacter enteritis has been complicated by the ubiquitous
nature of the organism (commonly found as a commensal in the intestines of domestic
animals, in milk and in water).

Acquisition of foreign DNA by microbes, and in particular the contribution of mobile
genetic elements to the spread of antimicrobial resistance has been investigated
extensively among pseudomonads and the Enterobacteriaceae, particularly in relation
to the salmonellae. These investigations have included considerable research on
integron structures. This work has not extended to Campylobacter, however.
Furthermore, the food, water and zoonotic origins of Campylobacter would indicate a
shared reservoir with the Enterobacteriaceae and therefore indicate the possibility of
interspecies transfer of genetic material. This research thesis provided an opportunity
to address the issues outlined above.

Specific experimental objectives were:
•

To identify two separate collections of isolates to species level; the first collection
comprising human, poultry and porcine strains isolated during 1996-1998; the

59

second collection was comprised of strains of human and poultry origin, all of
which were isolated during the year 2000.
To undertake a molecular epidemiological investigation for all isolates using DNA
Amplification Fingerprinting (DAF) analysis, with computational analysis of
trends for isolates from the year 2000.
To perform antimicrobial susceptibility testing on the first collection of isolates
and on a subset of the second collection of isolates, in order to facilitate a
comparison of resistance trends among the isolates over time.
To investigate the molecular basis for emerging resistance to ciprofloxacin and
tetracycline among clinical isolates, and among both domestic and imported
poultiy’ product, within the collection of strains isolated during 2000.
To explore the contribution of mobile genetic elements to the transmission of
antimicrobial resistance. All isolates were investigated for the presence of
integrons (previously undetected among Campylobacter spp.), a number of which
were fully characterised. A subset of strains isolated during 2000 was investigated
for the presence of plasmids, as the transmission of tetracycline resistance genes
has previously been shown to be facilitated by plasmids.
To perform mapping experiments in order to locate tetracycline resistance genes to
either the genome or to plasmids of selected isolates.
To evaluate current methods of speciation for C. jejuni and C. coli, using the
collection of strains isolated during 2000.
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Chapter 2 is divided into two sections. The first section (2.1) details the bacterial
isolates, reagents, chemicals and equipment used in the experiments listed. The
second section (2.2) outlines all methods used.

2.1. Materials
2.1.1. Bacterial cultures
Collection 1: 1996-1998
A total of 89 randomly collected Campylobacter isolates were included in the study.
Thirty-six of the isolates were from patients with clinically confirmed gastroenteritis,
32 isolates were cultured from slaughtered chickens, and a further 16 isolates were
from slaughtered pigs. Five control strains, C. jejuni NCTC 11351, C. coli NCTC
11353, C. lari NCTC 1 1352, C. upsaliensis NCTC 11541 and a Urease Positive
Thermophilic Campylobacter (UPTC) NCTC 11845, were included in the study for
comparative purposes.

Collection 2: 2000
The study collection was comprised of 378 Campylobacter isolates from human and
poultry sources which were submitted to the Molecular Diagnostics Unit (MDU) by
the Irish Equine Centre (241 poultry isolates), Cork University Hospital (61 human
isolates). Northern Ireland Public Health Laboratory Service, Belfast (31 poultry
isolates) and University College Hospital, Galway (45 human isolates). All bacterial
isolates were obtained either on Charcoal Transport Medium Swabs, in Cooked Meat
Medium (CM81) or on Microbank Storage Beads which had been held at -20°C.
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Three control strains, C. jejuni NCTC 11351, C. coli NCTC 11353 and C. lari NCTC
11352 were included in the study.

2.1.2. Phenotypic identification
Carbol Fuchsin staining: Carbol Fuchsin (BDH Chemicals, Poole, Dorset, United
Kingdom), Phenol (BDH Chemicals), Absolute Ethanol. Stock
solution diluted to produce a 10% (v/v) working Carbol
Fuchsin solution (see Note 1).
Catalase (H7O?):

30% (v/v), supplied by BDH.

Oxidase:

Paper strips impregnated with tetramethylparaphenylene
diaminehydrochloride. (Medical, Wire & Equipment Co. Ltd.,
Wiltshire).

Hippurate hydrolysis: Hippurate diagnostic tablets containing Sodium Hippurate
(Rosco Diagnostica, Taastrup, Denmark). Ninhydrin 3.5% (v/v)
solution (Rosco Diagnostica).
API Campy:

BioMerieux, Marcy I’Etoile, France.

2.1.3. Antimicrobial susceptibility testing
All materials marked with an asterisk (*) were autoclaved at 12UC for 15 min prior to
use.
1. IsoSensitest Agar* (Difco, Dublin, Ireland), containing 5% (v/v) lysed horse
blood, prepared according to the manufacturer’s instructions.
2. Distilled water*.
3. Antimicrobial susceptibility discs: ampicillin (Ap, 10 pg/disc), chloramphenicol
(C, 10 pg/disc and 30 pg/disc), ciprofloxacin (Cp, 5 pg/disc), colistin (Ct, 25
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fj,g/disc), erythromycin (E, 5 fig/disc), gentamicin (G, 10 gg/disc), nalidixic acid
(Na, 30 gg/disc), spectinomycin (Sp, 10 pg/disc), streptomycin (S, 25 pg/disc),
sulphafurazole (Su, 100 pg/disc), tetracycline (T, 10 pg/'disc and 30 pg/'disc), and
trimethoprim (Tm, 1.25 pg/disc).
4. E-test strips (AB Biodisc, Solna, Sweden).
5. Camvvlohacter Gas Generating Kit (BR056A) (Oxoid, Hampshire, UK.).

2.1.4. DNA extraction methods
2.I.4.I. DNA extraction (unpurified DNA)
This protocol is a modified version of that published by Mazurier et al. (1992).
1. Preston A^ar* {Campylobacter Agar Base, Oxoid CM689, containing Modified
Campylobacter Selective Supplement SR204E and 5% (v/v) lysed horse blood),
prepared according to the manufacturer’s instructions.
2. Distilled water*.
3. 0.85% (w/v) NaCl*.
4. Formaldehyde solution (37-40% v/v).

2.I.4.2. DNA extraction (purified DNA)
This protocol is a modified version of a purification method for Campylobacter spp.
(Lind et a/., 1996) yielding purified template DNA.
1. Preston Agar* {Campylobacter Agar Base, Oxoid CM689, containing Modified
Campylobacter Selective Supplement SR204E and 5% (v/v) lysed horse blood),
prepared according to the manufacturer’s instructions.
2. Distilled water*.
3. 0.85% (w/v) NaCl*.
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4. Formaldehyde solution (37-40% v/v).
5. 5X TE solution*: (50 mM Tris-HCl [pH 8.0], 50 mM EDTA).
6. Lysozyme: Obtained lyophilised from Sigma (Poole, UK). Reconstituted in 5X
TE solution to a final concentration of 5 mg/mL. Aliquoted and stored at

-20T.
7. 20% (w/y) Sodium Dodecyl Sulphate (SDS): Heated to 35-45°C to dissolye.
8. Proteinase K: Obtained lyophilised from Sigma. Reconstituted in 5X TE solution
to a final concentration of 10 mg/mL. Aliquoted and stored at -20°C.
9. Phenol Chloroform Isoamylalcohol (25:24:1) solution (Sigma), saturated with
lOmM Tris [pH 8.0], 1 mM EDTA.
10. 3M Ammonium Acetate, filter sterilised and stored at room temperature.
11.70 and 100% (v/v) Ethanol stored at -20°C.
12. IX TE solution*: (lOmM Tris-HCl [pH 8.0], ImM EDTA).

2.1.5. PCR amplification methods
1. Sterile water.
2. Deoxyribonucleoside triphosphates (dNTPs) (Promega, Madison, WI). Proyided
at a concentration of 100 mM each dNTP (dATP, dCTP, dGTP, dTTP). Prepare a
working solution of 1.25 mM dNTP by adding 2.5 pL each dNTP to 190 pL sterile
H2O. Stored at -20°C until required.

3. Tag DNA Polymerase (Promega) (5 U/pL). Supplied with 25 mM MgCl2 and
lOX Reaction Buffer (100 mM Tris-HCl [pH 9.0], 500 mM KCl, 1% (w/y) Triton
X-100).
4. Oligonucleotide primers diluted to an optimal working concentration in sterile
H2O. All primers used for Campylobacter speciation, DAF analysis, ciprofloxacin
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resistance-determining PCR, tetO resistance gene PCR and integron analysis were
purchased from Oswel DNA Services (Oswel, Southampton, UK) and were
purified by high performance liquid chromatography (HPLC) prior to use. Primer
sequences along with their relevant characteristics are listed in Table 2.1.
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Table 2.1, Nucleotide sequence and characteristics of oligonucleotide primers used
for PCR.
Cone, per
reaction
25 pmol

%GC

PCR
T-annealing
57°C

CeuE]Q] F

Sequence
5'^3'
CCT GCT ACG GTG AAA GTT TTG C

CeuE\e] R

GAT CTT TTT GTT TTG TGC TGC

25 pmol

38

57°C

CeuEcoW F

ATG AAA AAA TAT TTA GTT TTT GCA

25 pmol

17

57°C

CeuEcoW R

ATT TTA TTA TTT GTA GCA GCG

25 pmol

29

57°C

Hip F

GAA GAG GGT TTG GGT GGT G

25 pmol

58

66°C

Hip R

AGC TAG CTT CGC ATA ATA ACT TG

25 pmol

39

66°C

Therm!

TAT TCC AAT ACC AAC ATT AGT

25 pmol

29

54°C

Coli

TAA ATC CTA ATA CGA AGC G

25 pmol

37

54°C

Lari

ACG GCA TCA GCA ATT CTC

25 pmol

50

54°C

ThermS

TAA AGT AAG TAC CGA AGC TG

25 pmol

40

54°C

Jejl

GTA AAT CCT AAT ACA AAG CT

25 pmol

30

54°C

Jej2

TAA ATC CTA GTA CGA AGC T

25 pmol

37

54°C

HLWL85

ACA ACT GCT C

25 pmol

50

40°C

MAMAgvr/1/ F

TTT TTA GCA AAG ATT CTG AT

20 pmol

25

50°C

GzgyrA4 R

CAG TAT AAC GCA TCG CAG CG

20 pmol

55

50°C

MAMAgvry4J R

CAA AGC ATC ATA AAC TGC AA

20 pmol

37

50°C

GZgyrAS F

ATT TTT AGC AAA GAT TCT GAT

20 pmol

24

50°C

GZgyrA6 R

CCA TAA ATT ATT CCA CCT GT

20 pmol

35

50°C

GZgyrAcoli3 F

TAT GAG CGT TAT TAT CGG TC

10 pmol

40

50°C

CampyMAMAgrr/f^

TAA GGC ATC GTA AAC AGC CA

10 pmol

45

50°C

TetO FW

ACG GAR AGT TTA TTG TAT ACC

100 pmol

33

60°C

TetO RV

TGG CGT ATC TAT AAT GTT GAC

100 pmol

38

60°C

Inti F(5’CS)

GGC ATC CAA GCA GCA AGC

25 pmol

61

55°C

Inti R(3’CS)

AAG CAG ACT TGA CCT GAT

25 pmol

44

55°C

QacEAI F

ATC GCA ATA GTT GGC GAA GT

25 pmol

45

55°C

QacEAI R

CAA GCT TTT GCC CAT GAA GC

25 pmol

50

55°C

Primer
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50

M13 F

GTA AAA CGA CGG CCA G

25 pmol

56

46°C

M13 R

CAG GAA ACA GCT ATG AC

25 pmol

47

46°C

Intll F (integrase)

GCC TTG CTG TTC TTC TAC GG

25 pmol

55

57°C

Intll R (integrase)

GAT GCC TGC TTG TTC TAC GG

25 pmol

55

57°C

Sull F

CTT CGA TGA GAG CCG GCG GC

25 pmol

70

65°C

sull R

GCA AGG CGG AAA CCC GCG CC

25 pmol

75

65°C

Primer annealing temperatures were calculated using Suggs’s formula (Suggs et al.,
1981) as follows:
Melting temperature or Tm = 2 (A+T) + 4 (G+C)
Annealing temperature = Tm - 5°C

2.1.6. Conventional agarose gel electrophoresis
1. Agarose:

Electrophoresis grade from Promega. Gelling
temperature 36-39°C, melting point 87-89°C.

2. Ethidium Bromide:

Obtained from Sigma and used at a concentration of 10
mg/mL in distilled water.

3. lOXTAE:

400 mM Tris-HCl [pH 7.8], 400 mM Glacial Acetic
Acid and 2 mM EDTA. Working concentration IX.

4. Loading dye:

100 pL of 10% (w/v) Bromophenol Blue, 3.3 mL lOX
TAE, 6.6 mL Glycerol

Molecular weight markers:
Three DNA molecular weight marker mixtures were employed to facilitate molecular
weight determination of DNA fragments during PCR:
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DNA marker III:

Generates 13 fragments ranging in size from 0.12 to 21.2 kbp.
Prepared by cleaving lambda DNA with EcoR\ and HindWl.
Supplied by Roche (Roche Diagnostics, East Sussex, UK).

DNA marker V:

Generates 22 DNA fragments from 8 to 587 bp. Prepared by
cleaving pBR322 with HaelW. Supplied by Roche.

100 bp DNA ladder:

Generates 11 fragments ranging in size from 100 to 1,500 bp in
length. Supplied by Promega.

2.1.7. Plasmid isolation from cells
Plasmid purification from cultures grown on Campylobacter (Preston) Agar was
achieved using the Wizard®/’/w.v SV Minipreps DNA purification system (Promega).

Kit contents:
1. Cell suspension solution (50 mM Tris-HCl [pH 7.5], 10 mM EDTA, 100 pg/L
RNase A).
2. Cell Lysis solution (0.2 M NaOH, 1% (w/v) SDS).
3. Neutralisation solution (4.09 M Guanidine Hydrochloride, 0.759 M Potassium
Acetate, 2.12 M Glacial Acetic Acid [pH 4.2]).
4. Column wash solution with 95% (v/v) Ethanol added (final concentration: 60 mM
Potassium Acetate, 10 mM Tris-HCl [pH 7.5], 60% (v/v) Ethanol).
5. Spin columns.
6. Collection tubes.
7. Alkaline Protease solution.
8. Nuclease-free water.
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Not supplied with kit: 0.85% (w/v) NaCl*.

2.1.8. Pulsed-Field Gel Electrophoresis (PFGE)
2.1.8.1. Preparation of agarose plugs and restriction endonuclease digestion
1. Preston Agar {Campylobacter Agar Base, Oxoid CM689, containing Modified
Campylobacter Selective Supplement SR204E and 5% (w/v) Lysed Horse Blood),
prepared according to the manufacturer’s instructions.
2. 0.85% (w/v) NaCl*.
3. Formaldehyde solution (37-40% v/v) (BDH Chemicals).
4. 1 mL sterile plastic syringes with the nozzle removed.
5. Sterile microcentrifuge tubes (1.5 and 2.0 mL).
6. Sterile clear polystyrene capped 17 mm x 120 mm (Sarstedt) tubes (or equivalent).
7. SeaKem® Gold (SKG) Agarose. Obtained from FMC BioProducts (Vallesbaek
Strand, Denmark).
8. 10 mg/mL Ethidium Bromide.
9. 1 M Tris-HCl* [pH 8.0].
10. lOMNaOH*.
11.0.5 M EDTA adjusted to pH 8.0 with IM HCl*.
12. 10 mg/mL Lysozyme stock solution.
13. 20% (w/v) Sodium Dodecvl Sulphate (SDS).
14. 20 mg/mL Proteinase K stock solution.
15. 10% (w/v) Sarcosvl (N-Lauroylsarcosine, Sodium salt).
16. IPX TBE Buffer* [pH 8.0].
17. Tris-EDTA Buffer (TE) [pH 8.0]*.
18. Cell Suspension Buffer*: 100 mM Tris-HCl [pH 8.0], 100 mM EDTA.
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19. Cell Lysis Buffer*: 50 mM Tris-HCl [pH 8.0], 50 mM EDTA, 1% (w/v) Sarcosyl
20 mg/mL Proteinase K (add just before use).
20. Restriction endonuclease Sma\ (10 U/pL) (Promega).

2.I.8.2. Molecular weight markers
1, Low range PFG marker: A mixture of lambda DNA-//z>7dIII fragments and
lambda concatemers embedded in 1% (w/v) Low Melting Point Agarose at a
concentration of 25 pg/mL. Size range: 0.1-200 kbp. Supplied by New England
BioLabs® Inc. (Hertfordshire, UK).
2. Mid range PFG marker: Concatemers of lambda DNA mixed with Xha\ digested
lambda DNA embedded in 1% (w/v) Low Melting Point Agarose at a
concentration of 25 pg/mL (New England BioLabs). Size range: 24-300 kbp.

2.1.9. Southern blotting of gels
2.1.9.1. DNA transfer from agarose gels to nylon membranes
All reagents marked with an asterisk were autoclaved at 121 °C for 15 min.
1. Depurination Buffer*:

0.5 M HCl.

2. Denaturing Buffer*:

0.5M NaOH, 1.5 M NaCl.

3. 20X SSC*:

3 M NaCl, 0.3 M Sodium Citrate [pH

7.0].
4. Neutralising Buffer*:

0.5 M Tris-HCl [pH 7.0], 1.5 M NaCl.

5. Vacu-aid Blot processing pump:

(Hybaid, Middlesex, UK).

6. Positively charged nylon membranes:

(Roche).
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2.1.9.2. Preparation and detection of Digoxigenin-(DIG) labelled probes

Preparation of DIG-labelled probes:
1. Cold 100% Ethanol.
2. Cold 70% (v/v) Ethanol.
3. 4 M Lithium Chloride.
4. DlG-labelled dUTP at a concentration of 1 nmol/p-L (Roche).

Hybridisation and detection:
A DIG-DNA hybridisation and detection kit (Roche) was used in the colour detection
of hybridisation reactions.
Solutions required:
1. Hybridisation Buffer:

5X SSC, 1% (w/y) Blocking solution (from kit),
0.1% (w/y) N-Lauroyl-Sarcosine, 0.02% (w/y)
Sodium Dodecyl Sulphate (SDS).

2. Wash solution A:

2X SSC, 0.1% (w/y) SDS.

3. Wash solution B:

0.1% (w/y) SSC, 0.1% (w/y) SDS.

4. Buffer 1 (Maleic Acid Buffer):

0.1% (w/y) Maleic Acid, 0.15% (w/y) NaCl,
adjust pH with NaOH to pH 7.5.

5. Buffer 2 (Blocking Buffer):

Dilute lOX blocking solution in Buffer 1
(Maleic Acid Buffer) to IX final concentration.

6. Buffer 3 (Detection Buffer):

0.1 M Tris-HCl [pH 9.5], 0.1 M NaCl, 50 mM
MgCb.

Additional reagents required from kit:

71

1. Anti-DiG-AP Conjugate: (750 U/mL). Stock solution diluted 1:5000 in Buffer 2 to
produce a working solution.
2. NBT/BCIP: 50X concentrated stock solution (18.75 mg/mL Nitroblue
Tetrazolium Chloride Phosphate in 67% (v/v) Dimethyl Formamide). Diluted to
1X working solution in Buffer 3 immediately before use.

2.1.10. Cloning
Characterisation of gene cassettes isolated from class 1 integron-like structures in
C. jejuni and C. coli.

2.1.10.1. Extraction and purification of DNA bands from agarose gels
Performed using a QIAquick Gel Extraction Kit (Qiagen, West Sussex, UK).
Kit contents:
1. Buffer QG.
2. Buffer PE (with 100% Ethanol added).
3. Spin columns.
4. Collection tubes.

Required (not supplied in kit):
1. Sterile distilled water.
2. Absolute Ethanol.

2.1.10.2. Cloning of DNA fragments
DNA fragments of interest were cloned with the Invitrogen Original TA Cloning®' Kit
(Invitrogen BV, Groningen, The Netherlands).
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Kit reagents were supplied in two sections:
Section 1: TA Cloning® Reagents stored at -20°C:
1. pCR^2.1 linearised, at a concentration of 25 ng/pL in 10 mM Tris-HCl [pH 8.0], 1
mM EDTA.
2.

1 OX PCR Buffer containing 100 mM Tris-HCl, [pH 8.0], 500 mM KCl, 25 mM
MgCb, 0.01% (w/v) Gelatin.

3.

1 OX Ligation Buffer containing 60 mM Tris-HCl [pH 7.5], 60 mM MgCb, 50 mM
NaCl, 1 mg/mL Bovine Serum Albumin, 70 mM P-Mercaptoethanol, 1 mM ATP,
20 mM Dithiothreitol, 10 mM Spermidine.

4. 50 mM dNTPs containing 1.25 mM each dNTP.
5. T4 DNA ligase at 4.0 Weiss units/pL.
6. Sterile water.
7. Control DNA template at a concentration of 0.1 pg/pl in 10 mM Tris-HCl [pH
8.0], 1 mM EDTA, supplied with amplification Primers 1 and 2 (each at a
concentration of 0.1 pg/pl).

Section 2: One shoC‘^ reagents:
1.

SOC Medium containing 2% (w/v) Tryptone, 0.5% (w/v) Yeast Extract, 10 mM
NaCl, 2.5 mM KCl, 10 mM MgCb, 10 mM MgS04, 20 mM Glucose.

2.

0.5 M B-Mercaptoethanol.

3. INVaF’ cells.

Additional reagents required for cloning:
1. X-Gal stock solution (40 mg/mL). Prepared by dissolving 400 mg 5-bromo-4-
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chloro-3-indolyl-(3-D-Galactopyranoside (X-Gal) (Sigma) in 10 mL
Dimethylformamide (Sigma).
2. Luria-Bertani (LB) agar plates (Life Technologies, Paisley, Scotland). Prepared
according to the manufacturer’s instructions. Cooled after autoclaving to 50°C
prior to addition of ampicillin (50 pg/mL) and X-Gal (40 pL of 40 mg/mL per
plate).
3. Luria-Bertani (LB) Broth (Life Technologies). Prepared according to the
manufacturer’s instructions.

2.1.10.3. Rapid colony plasmid screening procedure
1. Buffer 1:

0.2 M NaOH, 1% (w/v) SDS. Prepared shortly before use.

2. Buffer 2:

3 M Potassium Acetate, 1.8 M Formic Acid. Prepared shortly
before use.

3. Lysis Buffer:

90 pL 0.25% (w/v) Bromophenol Blue, 25% Ficoll type 400
(Sigma).
110 pL sterile distilled water.
400 pL Buffer 1.

2.1.10.4. Plasmid isolation from cells
Plasmid purification was achieved using the Wizard®P/w5 SV Minipreps DNA
purification system (Promega).

Kit contents:
1. Cell Resuspension solution (50 mM Tris-HCl [pH 7.5], 10 mM EDTA, 100 pg/L
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RNase A).
2. Cell Lysis solution (0.2 M NaOH, 1% (w/v) SDS).
3. Alkaline Protease solution.
4. Neutralisation solution (4.09 M Guanidine Hydrochloride, 0.759 M Potassium
Acetate, 2.12 M Glacial Acetic Acid [pH 4.2]).
5. Spin columns.
6. Column wash solution with 95% (v/v) Ethanol added (final concentration: 60 mM
Potassium Acetate, 10 mM Tris-HCl [pH 7.5], 60% (v/v) Ethanol).
7. Nuclease free water.
8. Collection tubes.

2.1.10.5. Confirming the presence of insert in plasmid
1. Restriction Endonuclease digestion of plasmid with EcoR\ (10 U/pL) (Promega),
supplied with Buffer H for maximum activity.
2. M13 PCR using primers M13F and M13R (see Table 2.1).

2.1.11. Purification of PCR products
Performed using a QIAquick Gel Extraction Kit (Qiagen).
Kit contents:
1. Buffer PB.
2. Buffer PE (with 100% Ethanol added).
3. Buffer EB.
4. Spin columns.
5. Collection tubes.
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Required (not supplied in kit):
1. Sterile distilled water.
2. Absolute Ethanol.

2,2. Experimental methods
(for procedures listed in Figure 2.1)
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Isolate or sample received in MDU, CIT

fLogged

i
Culture on
1. Campylobacter (Preston) Agar
2. Columbia Blood Agar

Incubate microaerophilically for 48h at 42°C

i
Perform macroscopic and microscopic evaluation for typical morphology and purity

Biochemical evaluation
tests from Columbia blood
agar:
Oxidase, catalase, hippurate
hydrolysis.
API Campy (BioMerieux)

Duplicate storage on Microbank
storage beads at -80°C________

DNA isolation for genotypic characterisation
1. Species-specific PCR
2. DAF analysis
2. Integron analysis
3. MAMA PCR (ciprofloxacin resistance)
4. TetO gene investigation
5. Development of probe
Pulsed-field gel electrophoresis

Phenotypic antimicrobial
susceptibility testing:
Agar disc diffusion and E-tests
for antibiotic sensitivities

Plasmid isolation

/
Mapping of tetO gene to chromosomal and
plasmid DNA___________________________
Figure 2.1. Procedures used for the isolation, identification and characterisation of
Campylobacter spp.
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2.2 J. Bacterial cultures
Collection!: 1996-1998
Poultry and porcine samples were collected and inoculated into 20 mL volumes of
Oxoid Broth No. 2, to which 5% (v/v) lysed horse blood (LHB) had been added. All
cultures were incubated for 2 h at ambient room temperature, followed by incubation
for a further 48 h at 37®C. Finally, 10 pL of each culture were inoculated in individual
samples onto Preston Agar {Campylobacter Agar Base, Oxoid CM689, containing
Modified Campylobacter Selective Supplement SR204E and 5% (v/v) LHB), and
incubated at 42°C for 48 h. Human (clinical) faecal samples were inoculated in 10 pL
volumes onto Preston Agar and incubated for 48 h at 42°C. Incubation of all cultures
was performed in a microaerophilic environment using an Oxoid BR056A
Campylobacter Gas Generating Kit.

Collection 2: 2000
All isolates were subcultured onto Preston Agar and incubated for 48 h at 42°C.
Incubation of all cultures was performed in a microaerophilic environment using an
Oxoid BR056A Campylobacter Gas Generating Kit. All cultures were maintained on
Microbank Storage Beads (Mast Diagnostics, Merseyside, UK) at -80°C for long-term
storage.

2.2.2. Phenotypic identification
Carbol Fuchsin staining:

Flood a fixed bacterial smear with 10% (v/v) Carbol
Fuchsin. Allow to stain for 2 min. Wash smear with
tap water. Allow to dry in air or blot dry. Examine by
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oil immersion microscopy. Note presence of typical
“seagull-shaped” bacilli characteristic of Campylobacter
spp.
Catalase test:

Pipette 1 mL of 30% (v/v) Hydrogen Peroxide into a
test tube. Using a sterile loop, scrape 2-5 colonies from
a pure culture of Campylobacter and place loop in test
tube. Observe immediate production of bubbles as a
positive result. A negative result is indicated by lack of
bubble formation.

Oxidase reaction:

Using a sterile loop remove 2-4 colonies from agar plate
and transfer onto an oxidase strip. Observe the
development of a purple colour within 20 s as a positive
result. Colour changes after this time should be
disregarded as the reagent changes colour over time due
to auto-oxidation. A negative reaction is indicated
when no colour change occurs.

Hippurate hydrolysis test:

Pipette 0.25 mL of sterile 0.85% (w/v) NaCl into a test
tube. Prepare a dense suspension of the strain to be
tested in the NaCl solution (>McFarland 6 turbidity
standard). Add one Hippurate diagnostic tablet, cap the
tube and incubate at 35-37°C for 4 h. After incubation
add 5 drops of 3.5% (v/v) Ninhydrin solution (Rosco
Diagnostica). Cap the tube and re-incubate tube for 10
min at 35-37°C.

79

Positive reaction: Development of a deep purple
colour.
Negative reaction: Colourless, light yellow, or faint
tinge of purple.
Note: Do not re-incubate for longer than 10 min as
false positives may result.
API Campy:

(BioMerieux, Marcy I’Etoile, France). Prepared and
read according to the manufacturer’s instructions.

2.2.3. Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using the agar diffusion method on
IsoSensitest Agar (Difco) with 5% (v/v) LHB, according to the
method of Reina et al. (1994). Cultures were prepared by inoculating colonies from a
fresh, pure, 24 or 48 h culture into sterile distilled water to give an inoculum turbidity
equivalent to a 0.5 McFarland turbidity standard. The McFarland standard was
prepared by adding 0.5 mL 0.048 mol/L BaCb to 99.5 mL 0.18 mol/L H2SO4, with
constant stirring. Samples were swabbed evenly onto agar plates and allowed to dry.
Agar plates containing the required antibiotic discs were incubated at 37°C under
microaerophilic conditions for 24 h, or where necessary, for 48 h. Inhibition zone
sizes were recorded according to the guidelines of the National Committee for
Clinical Laboratory Standards (1981). A representative selection of isolates from
Collections 1 and 2 were further tested for antimicrobial susceptibility by an E-test
(AB Biodisc).

80

2.2.4. DNA extraction
2.2.4.I. DNA extraction (crude preparation)
This extraction method was a modification of the procedure previously described by
Mazurier et al. (1992). Cultures were treated prior to DNA extraction with
Formaldehyde to inhibit any possible DNAse activity (see Notes 2 and 3), according
to the method of Gibson et al. (1994).

1. A 48 h well-grown plate culture was examined microscopically for purity, by
Carbol Fuchsin staining of a fixed smear.
2. The culture was aseptically removed from the plate and was emulsified in 1 mL
0.85% (w/v) sterile NaCl in a 2 mL microcentrifuge tube.
3. The cell suspension was centrifuged for 5 min at 12,000 rpm.
4.

The supernatant was discarded and cells were re-suspended in 0.9 mL 0.85%
(v/v) sterile NaCl.

5. A 100 pL volume of Formaldehyde (37% v/v) solution was added to the cell
suspension, which was mixed thoroughly and allowed to stand at room
temperature for 1 h.
6. Following this incubation cells were washed three times in 1 mL 0.85% (w/v)
NaCl, then once in 1 mL of 5X TE, centrifuging each time at 12,000 rpm for 5 min
and decanting the supernatant.
7. Cells were re-suspended in 0.5 mL sterile distilled water and were incubated for
10 min in a boiling waterbath.
8. After centrifugation at 12,000 rpm for 5 min at 4°C the supernatant was decanted
to a fresh sterile microcentrifuge tube.
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9.

The DNA concentration was determined for each sample using absorbance
spectrophotometry at 260 nm (under UV light): 1 absorbance unit = 50 ng/pL
DNA

10. DNA suspensions were then diluted to give a stock template DNA concentration
of 100 ng/pL (in sterile distilled water), maintaining the temperature at 4°C.
11. Finally, DNA suspensions were aliquoted for one use only, and were stored at
-20°C until required.

2.2.4.2. DNA extraction (purified DNA)
This extraction method was a modification of the procedure described by Lind et al
(1996). Cultures were treated prior to DNA extraction with Formaldehyde to inhibit
any DNAse activity (see Notes 2 and 3), according to the method of Gibson et al
(1994).
The complete protocol was performed at 4°C except for those steps where an
alternative temperature was indicated.
1. A 48 h plate culture was examined microscopically for purity, using Carbol
Fuchsin staining of a fixed smear.
2. The pure plate culture of Campylobacter was emulsified to a turbidity of >
McFarland 6 standard in a sterile 2 mL microcentrifuge tube containing 1.0 mL
0.85% (w/v) NaCl. (see Note 4).
3. Cells were washed twice in 1 mL 0.85% (w/v) sterile NaCl.
4. After the second wash the NaCl solution was decanted and the cell pellet was re
suspended in 0.9 mL sterile 0.85% (w/v) NaCl.
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5. A 100 |liL volume of 37% (v/v) Formaldehyde solution was added to the cell
suspension, which was mixed thoroughly and incubated for 1 h at room
temperature.
6. Following this incubation cells were washed three times in 1 mL 0.85% (w/v)
NaCl, then once in 1 mL of 5X TE. Cells were centrifuged each time at 10,000
rpm for 5 min and the supernatant was decanted.
7. The cell pellet was re-suspended in 540 pL 5X TE containing Lysozyme (final
concentration of 5 mg/mL).
8. The tube was inverted several times to mix the contents thoroughly and was
incubated at 37°C for 30 min.
9. A 60 pL volume of 20% (w/v) SDS was added after this incubation step, and the
tube was inverted several times. The mixture was then incubated at 37°C for a
further 15 min.
10. Finally, a 150 pL volume of 5X TE containing Proteinase K (10 mg/mL) was
added, the mixture was again inverted several times and incubated at 37°C
overnight.
11. Following overnight incubation the tube was re-incubated at 65°C for 1 h.
12. The tube was then centrifuged at 12,000 rpm for 15 min and the supernatant was
transferred to a sterile 2 mL microcentrifuge tube.
13. An approximately equal volume of Phenol Chloroform was added (see Note 5),
the mixture was shaken vigorously for 5 min and centrifuged for 5 min at 12,000
rpm.
14. The top aqueous phase (containing DNA) was transferred to a new tube (see Note
6).

15. Phenol Chloroform steps 12 and 13 were repeated.
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16. A 1/10 volume of 3 M Ammonium Acetate was added to the final transferred
supernatant, which was mixed by inversion. To this mixture cold Ethanol was
added to the top of each tube (approx. 1 mL). To precipitate the DNA an
incubation step at -20°C overnight was included.
17. Following this overnight incubation the tube was centrifuged at 12,000 rpm for 30
min and the supernatant was decanted.
18. Next the DNA pellet was washed twice with 70% (v/v) Ethanol. The Ethanol was
then fully aspirated, and the tube was allowed to air dry until no moisture traces
remained (5-10 min). A 300 pL volume of IX TE was added to the DNA pellet
which was re-suspended by gently pipetting up and down several times.
19. The chromosomal DNA preparation was examined by conventional agarose gel
electrophoresis (to ensure that the DNA was intact). The DNA concentration in
the sample was determined using absorbance spectrophotometry at 260 nm: 1
absorbance unit = 50 ng/pL DNA.
20. The DNA suspension was diluted to give a stock template DNA concentration of
100 ng/pL. All DNA suspensions were stored at 4°C (see Note 7).

2.2.5. Agarose gel electrophoresis
Agarose gel electrophoresis was performed using a Gibco Horizontal Electrophoresis
Apparatus from Life Technologies. Agarose concentrations varied from 0.8 to 2%
(w/v); the lower concentrations gave greater resolution of the largest products, while
the higher agarose concentrations were more suited to smaller products.
Electrophoresis times and voltages chosen ranged from 1 h combined with 80 V for
small gels (6.5 cm X 8.0 cm), to 1.5-2 h combined with 100 V for large gels (11 cm X
14 cm). Plasmids were separated by electrophoresis on 0.8% (w/v) agarose gels, 1.5%
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(w/v) gels were used for DNA fingerprinting products and 2% (w/v) gels were
selected for single gene amplifications. A concentration of IX TAE Buffer containing
a final concentration of 100 pg/L ethidium bromide was used both to make agarose
gels and as electrophoresis running Buffer. All ethidium bromide products were
examined and photographed using a UV transilluminator (Ultra-Violet products,
Cambridge, UK) using Phoretix software (Phoretix, Newcastle upon Tyne, UK).

2.2.6. PCR amplification methods
PCR amplifications were performed in a MiniCycler™ (MJ Research Inc.,
Watertown, MA). References for all methods are provided in Table 2.2.

2.2.6.1. Campylobacter species identification by ceuE PCR
1. Success of this species-specific PCR is greatly facilitated by the sequence
divergence (of approximately 13%) that exists between the ceuE genes of C. jejuni
and C. coli. All PCR reactions were performed in a final volume of 50 pL.
2. For each reaction a combination of 7 pL 25 mM MgCb, 5 pL lOX Reaction
Buffer, 8 pL working stock dNTPs to give a final concentration of 0.2 mM for
each dNTP, 200 ng purified template DNA and 1 U Taq DNA Polymerase (5
U/pL) were used.
3. Each isolate was analysed by two primer sets, CeuEjej forward and reverse and
CeuEcoli forward and reverse (Table 2.1), in two separate PCR reactions. Each
primer was used at a concentration of 25 pmol.
4. The reaction conditions required for amplification are listed in Table 2.2.
Expected product sizes were as follows; CeuEjej, 793 bp; CeuEcoli, 894 bp.
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2.2.6.2. Campylobacter jejuni identification by hippuricase gene PCR
The hippurate hydrolysis test is frequently the only bioehemical test used to
distinguish C. jejuni from the other thermophilic species of Campylobacter. This test,
however, has some acknowledged technical limitations, is dependent on inoculum
size and results can be difficult to interpret accurately (On and Holmes, 1991).
Furthermore, while all C. jejuni isolates possess the hippuricase gene (Chan et al.,
2000), not all isolates express the gene. For this reason, greater accuracy is shown by
hippuricase gene PCR compared to the more traditional hippurate hydrolysis test.
1. For each reaction a combination of 2.5 pL 25 mM MgCb, 2.5 pL of lOX Reaction
Buffer, 4 pL working stock dNTPs to give a final concentration of 0.2 mM for
each dNTP, 25 ng template DNA and 2.5 U Taq DNA Polymerase (5 U/pL) were
used.
2. Primer pairs Hip F and Hip R were used at a concentration of 25 pmol per reaction
(Table 2.1) in a final reaction volume of 25pL.
3. The reaction conditions for successful amplification are given in Table 2.2 and the
expected product size was 735 bp.

2.2.6.3. Campylobacter species identification by PCR amplification of 23S rRNA
gene fragments
Studies by Eyers et al. (1993) have shown that it is possible to identify thermophilic
Campylobacter isolates to species level by designing primers which amplify
sequences among the most variable regions of their 23 S rRNA genes.
1. All reactions were performed in a final reaction volume of 25 pL. Primer
combinations were as follows:
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C. coli\ Therm 1 F and Coli R
C. jejuni: ThermS F and Jejl R and Jej2 R
C. lari: Therm 1 F and Lari R
See Table 2.1 for primer sequences and annealing temperatures used.
2. For each reaction a combination 2 pL 25 mM MgCb, 2.5 pL lOX Reaction Buffer,
4 pL working stock dNTPs to give a final concentration of 0.2 mM for each
dNTP, 10 ng purified template DNA and 2.5 U Tag DNA Polymerase (5 U/pL)
were used.
3. Primer combinations were used at a concentration of 25 pmol per reaction.
4. The reaction conditions used for amplification are listed in Table 2.2.
5. Expected product sizes were as follows:
C. coli, 390 bp; C. jejuni, 710 or 810 bp, depending on the C. jejuni strain detected, as
there are two known divergent sequences which are specific for C. jejuni', C. lari, 260
bp.

2.2.6.4. DNA amplification fingerprinting (DAF) analysis
A number of primers were tested for their discriminatory ability using DAF analysis
(see Note 8). The primer which optimally fulfilled this criterion was HLWL85, which
was then used to perform DAF analysis on all isolates in Collection 1 and Collection
Each DNA template was analysed in duplicate (or, where necessary, in triplicate)
by DAF to ensure the reproducibility of the DNA profile and to provide reliable data
quality.
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1. Each PCR assay incorporated the 10-mer oligonucleotide primer HLWL85 (see
Table 2.1) for DAF analysis.
2. For each reaction a combination of 5.0 pL 25 mM MgCb, 5.0 pL lOX PCR
Reaction Buffer, 8 pL working stock dNTPs to give a final concentration of 0.2
mM dNTP, 200 ng genomic DNA and 2.5 U Tag DNA Polymerase were used.
3.

The Primer HLWL85 was used at a concentration of 50 pmol per reaction in a
final reaction volume of 50 pL.

4. The reaction conditions used for amplification are listed in Table 2.2. Product
sizes were variable, ranging from 180 to 6,000 bp (Lucey et ai, 2000a).

2.2.6.5. Molecular detection of ciprorofloxacin resistance in Campylobacter
isolates
Ciprofloxacin (and other fluoroquinolones) function as bactericidal agents by
interfering with type II topoisomerase DNA gyrase and topoisomerase IV (Drlica and
Zhao, 1997). The predominant mechanism of resistance to ciprofloxacin in C. jejuni
and C call has been shown to be associated with a mutation in the gyrA gene,
whereby both species demonstrate a Thr-86-Ile substitution in the A-subunit of DNA
gyrase (Zimstein et aL, 1999; Zimstein et al., 2000). In C. jejuni isolates a transition
mutation ACA^ATA occurs, and in C. coli isolates the ACT—>ATT conversion
occurs. A specific PCR assay. Mismatch Amplification Mutation Assay (MAMA
PCR), has been demonstrated to be a useful screening method for ciprofloxacin
resistance among each of these isolates (Zimstein et ai, 1999; Zimstein et aL, 2000).
This method uses a conserved, forward primer and a reverse, diagnostic primer which
together generate a product that is a positive indication of ciprofloxacin resistance.
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1. Primer combinations were as follows:
• MAMAgyr^l F and MAMA^r^tS R for C. jejuni mutation detection assay,
generating a 265 bp product.
• MAMAgyr^ 1 F and GzgyrAA R to generate a positive PCR control product of
368 bp with any C. jejuni gyrA gene.
• GZgyrAS F and GZgyrA6 R to generate a 673 bp product containing the
Quinolone Resistance Determining Region (QRDR) of the gyrA gene of both
susceptible and resistant strains of C. jejuni. This product was used for
sequencing experiments.
• GZ^r^coli3 F and MAMA^ry^ 8 for C coli mutation generation assay,
generating a 192 bp product.
2. Amplifications were performed in 50 pL reaction volumes containing 20 pmol
each of the correct primer pair for C. jejuni PCR reactions and 10 pmol each of the
correct primer pair for C. coli PCR reactions (see Table 2.1 for primer sequences).
An 8 pL volume of working stock dNTPs to give a final concentration of 0.2 mM
dNTP each dNTP and 3.0 pL 25mM MgCl2 were added to this mixture, along with
a 2.5 pL volume of lOX Reaction Buffer and 2.5 U Taq DNA Polymerase.
3. Approximately 33 ng of DNA template, corresponding to 1 pL were added to the
reaction mixture.
4. The reaction conditions used for amplification are listed in Table 2.2.

2.2.6.6. An investigation of the presence of the tetO gene among Campylobacter
spp.
The use of a primer pair designated tetO FW and tetO RV was used by Aminov et al.
(2001), in conjunction with eight other classes of tetracycline resistance genes, in
molecular ecology studies of the rumina of cows, of swine feed and faeces, and in
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swine faecal streptococci. The purpose of the investigation was to estimate the
prevalence of tetracycline resistance genes in the gene pool and the flux of antibiotic
resistance genes in farm animals. TetO primer sequences were derived from C. jejuni
jejuni ATCC 43503. This investigation, using the primer sequences outlined in
the above study, was performed on a subset of Collection 2 isolates.

1. The tetO primer sequences are listed in Table 2.1, and were used at a
concentration of 100 pmol per total reaction volume of 20 pL.
2. For each reaction a combination of 2.0 pL 25 mM MgCb, 2.0 pL 1 OX Reaction
Buffer, 1.6 pL working stock dNTPs to give a final concentration of 0.1 mM for
each dNTP, 200 ng template DNA and 1.0 U Tag DNA Polymerase (5 U/pL) were
used.
3. Reaction conditions are shown in Table 2.2 and the expected product size was
171 bp.

2.2.6.7. Integrons, gene cassettes and sequencing PCR products
PCR reactions were designed to amplify integron-associated gene cassettes located
between the 5’-conserved segment and the 3’-conserved segment of class 1 integrons.

2.2.6.7.1. Integron PCR
1. The integron primer sequences used to identify the presence of integron structures
are listed in Table 2.1.
2. In a final reaction volume of 50 pL the following was added: 5 pL lOX PCR
Reaction Buffer, 5pL 25 mM MgCl2, 8 pL dNTP working stock solution, 40 pmol
each of Inti F and Inti R primer (Table 2.1), 200 ng template DNA and 2.5 U Tag
DNA Polymerase (5 U/pL).
3. The reaction conditions used for amplification are listed in Table 2.2.

2.2.6.7.2. PCR amplification of qacEAL
1. The gacEAl primer primer sequences are listed in Table 2.1, and were used at a
concentration of 25 pmol per total reaction volume of 50 pL.
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2. For each reaction a combination of 5.0 |j.L 25 mM MgCb, 5.0 |aL lOX Reaction
Buffer, 8

working stock dNTPs to give a final concentration of 0.2 mM for

each dNTP, 300 ng template DNA and 2.5 U Tag DNA Polymerase (5 U/pL) were
used.
3. The reaction conditions used for amplification are listed in Table 2.2.

2.2.6.8. M13PCR
1. The Ml3 primer sequences are listed in Table 2.1 and were used at a
concentration of 25 pmol per reaction volume of 50 pL.
2. For each reaction a combination of 5.0 pL 25 mM MgCb, 5.0 pL lOX Reaction
Buffer, 8 pL working stock dNTPs to give a final concentration of 0.2 mM for
each dNTP, 100 ng template DNA and 2.5 U Tag DNA Polymerase (5 U/pL) were
used.
3. The reaction conditions used for amplification are listed in Table 2.2.
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Table 2.2. Thermocycling reaction conditions for PCR programmes used to analyse
Campylobacter isolates.
PCR
programme
CeuEjej and

Step 1
initial
denatu ration

Step 2
Denaturation

Step 3
Annealing

Step 4
Extension

94°C-30 s

57°C-30 s

72°C-lmin

Step 5
Final
extension
72°C-5min

No. of
cycles
30

94°C-lmin

66°C-lmin

72°C-lmin

-

25

Linton et al.,
1997

Gene
23S rRNA

Gonzalez et
al., 1997

CeuEcoli
Hippuricase

Reference

94°C-lmin

54°C-1 min

27

74°C-! min

Eyers et al.,
1993

species
identification
HLWL85

94°C-30 s

40°C-lmin

72°C-lmin

72°C-5min

40

Mazurier et
al., 1992

MAMA PCR

94°C-30 s

50°C-30 s

30

72°C-20 s

Zimstein et
al., 1999;
Zimstein et
al., 2000

TetO

94°C-30 s

60°C-30 s

72°C-30 s

72°C-7 min

25

Aminov et
al., 2001

Inti (CS)

95°C-1 min

55°C-1 min

72°C-2 min

72°C-5 min

30

Collis and
Hall, 1992b

QacEAl

95°C-1 min

55°C-1 min

72°C-2 min

72°C-5 min

30

Stokes and

72°C-5 min

30

Mead et al.,

Hall, 1989
M13

95°C-1 min

46°C-1 min

72°C-1 min

1991
Intll

95°C-1 min

57°C-1 min

72°C-2 min

72°C-5 min

30

al., 1995

(integrase)

Suit

Levesque et

95°C-1 min

65°C-1 min

72°C-2 min

72°C-5 min

30

Sundstrdm
etai, 1988

2.2.7. Plasmid isolation using the Wizard®P/M5 SV Minipreps DNA
centrifugation purification system (Promega)^
^All highlighted reagents were supplied by the manufacturer as part of the kit components.

All steps were performed at room temperature.
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Production of cleared lysate:
1. The plate contents of a pure 48 h Campylobacter culture were emulsified in 1.5
mL 0.85% (w/v) sterile NaCl to correspond to MeFarland 6 turbidity standard. A
2 mL microcentrifuge tube was used (see Note 4). It was not advisable to process
more than 10 cultures at once (see Note 9).
2. Cells were pelleted by centrifugation at 12,000 rpm for 5 min.
3. The pellet was thoroughly re-suspended in 250 pL Cell Resuspension Solution.
4. A 10 pL volume of Alkaline Protease Solution was added to the mixture which
was then inverted 4 times to mix (see Note 10), and incubated for 5 min at room
temperature.
5. A 350 pL volume of Neutralisation Solution was added, inverting 4 times to
mix.
6. The mixture was then centrifuged at 15,000 rpm for 10 min.

Binding of plasmid DNA:
1. A spin column was inserted into a eollection tube.
2. The cleared lysate was deeanted into the spin column.
3. The lysate was then centrifuged at 15,000 rpm for 1 min. The flowthrough was
discarded and the eolumn re-inserted into the colleetion tube.

Washing:
4. A 750 pL volume of Wash Solution was added to the spin column, which was
centrifuged at 15,000 rpm for 1 min. The flowthrough was discarded and the
column re-inserted into the collection tube.
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5. Step 10 was repeated with 250 pL Wash Solution.
6. The spin eolumn was centrifuged at 15,000 rpm for 2 min.

Elution:
7. The spin column was transferred to a sterile 1.5 mL microcentrifuge tube.
8. A 100 pL volume of nuclease-ffee water was added to the spin column, which was
centrifuged at 15,000 rpm for 1 min.
9. The column was discarded and the eluted DNA was stored at -20°C until required.
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Mix with molten
Pellet 48 h pure culture by
centrifugation. Formaldehyde- agarose. Allow to
treat to inactivate endogenous solidify in syringe,
DNases. Wash, re-suspend
and quantify extracted DNA.

Stain gel with ethidium bromide,
and photograph to record results.
Analyse patterns.

Perform lysis of
Restriction
cells in agarose
digestion of
plug. Wash and
DNA/agarose
replace in syringe, slices.

slices of standard and macrorestricted tests into wells.
Select electrophoresis
protocol.

Figure 2.2. An overview of the molecular analysis of Campylobacter spp. by pulsed-field gel
electrophoresis (PFGE).

95

2.2.8. Pulsed-Field Gel Electrophoresis (PFGE)
A one-day standardised laboratory protocol for the molecular subtyping of
Campylobacter spp. by PFGE (adapted for Campylobacter spp. from the tPuiseNet
Method for non-typhoidal Salmonella) was applied in this study. A schematic
representation of the process is shown in Figure 2.2.
t(One-day standardised laboratory protocol for molecular subtyping of non-typhoidal Salmonella by
pulsed-field gel electrophoresis (2000). The National Molecular Subtyping Network.)

2.2.8.I. Preparation of agarose plugs for PFGE
1. Cultures of Campylobacter spp. to be investigated were well-grown (48-72 h) on
Preston medium and checked microscopically for purity before preparation of
agarose plugs.
2. The plate contents of each isolate were emulsified in a 1 mL volume of 0.85%
(w/v) NaCl in sterile 2 mL microcentrifuge tubes, which were then centrifuged at
10,000 rpm for 5 min.
3. The supernatant was decanted and cells were re-suspended in 0.9 mL 0.85% (w/v)
NaCl.
4. A 100 pL volume of Formaldehyde (37-40% v/v) was added to each tube, which
were then mixed and incubated at room temperature for 1 h.
5. Cells were pelleted by centrifugation at 10,000 rpm for 5 min and the supernatant
was decanted. The pellet was washed three times in 1 mL 0.85% (w/v) NaCl.
6. Next the cell pellet was re-suspended in 2 mL of Cell Suspension Buffer.
7. The volume of the Cell Suspension Buffer was adjusted to give an optical density
of between 1.8 and 2.0 at 610 nm.
8. Agarose plugs were prepared as follows: A quantity of 0.25 g SKG was weighed
into a 50 mL screw-capped tube (Sarstedt), to which 23.5 mL TE Buffer was
added and the tube was mixed gently. Next the agarose was dissolved completely
by microwaving.
9. The tubes were placed in a 50°C waterbath for 5 min and then 1.25 mL 20% (w/v)
SDS (pre-heated to 50°C) was added. This was mixed well by gentle inversion of
the capped tube.
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10. For each isolate, 0.4 mL of the pure bacterial culture suspension (at room
temperature) was transferred to a 1.5 mL microcentrifuge tube, to which 20 pL of
Proteinase K (20 mg/mL) was added to each tube and mixed gently by pipetting.
11. A 0.4 mL volume of the SKG/SDS mixture was added to each bacterial culture
and again mixed by pipetting gently up and down several times. Tubes were
placed in a 50°C waterbath.
12. Each sample was aspirated or pipetted into the barrel of a pre-labelled syringe.
The nozzle of each syringe was covered with parafilm and placed on ice for 15
min to allow the plugs to solidify.

2.2.8.2. Cell lysis
1. The appropriate number of 17 mm X 120 mm sterile tubes were labelled with the
isolate numbers.
2. Five millilitres of Cell Lysis Buffer was added to each tube, containing 25 pL of
the stock Proteinase K. The total volume of the Cell Lysis/Proteinase K Buffer
required was calculated and 5 mL of this mixture was aliquoted into the pre
labelled tubes.
3. The agarose plugs were trimmed with a sterile scalpel and either the whole plug or
a plug cut in two segments was added to the lysis Buffer.
4. The agarose plugs were incubated in a 54°C waterbath for 1.5-2 h, with constant
shaking at 175-200 rpm. It was important to ensure that the water level in the bath
was above the level of the Lysis Buffer in the tubes.
5. A sufficient volume of sterile distilled water was heated to 50°C to allow plugs to
be washed twice with 10-15 mL of water.
6. The tubes were removed from the waterbath and the Lysis Buffer was carefully
decanted into an appropriate discard container.
7. A 10-15 mL volume of pre-heated sterile distilled water was added to each tube,
which was shaken vigorously in a 50°C waterbath for 10-15 min.
8. Again the water was decanted from the plugs, repeating this wash step with pre
heated water, ensuring that no Lysis Buffer remained on the rims or caps of tubes.
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9. Next, the water was again decanted and 10-15 mL pre-heated sterile TE Buffer
was added to the tubes, which were then shaken vigorously in a 50°C waterbath
for 10-15 min.
10. The TE Buffer was decanted and this wash step was repeated with pre-heated TE
three more times.
11. The last wash was decanted and 5 mL sterile TE was added to each tube. At this
stage it was possible to continue with the restriction digest or, alternatively, plugs
could be stored at 4°C until ready to proceed.

2.2.8.3, Restriction digest of DNA in agarose plugs with Sma\
An appropriate number of 1.5 mL microcentrifuge tubes were labelled.
The Sma\ digest reactions were prepared (see Note 11) according to the table below
and the mixtures were added into each of the microcentrifuge tubes;

Reagent

pL/sample

Sterile distilled H2O

87.5

lOX Digest Buffer j’

10

Enzyme (10 U/pL)

2.5

Total volume

100

’’Buffer J was the manufacturer’s recommended buffer for maximal enzymatic activity.

Slices 1.5-2 mm wide were cut from each agarose plug with a sterile scalpel blade and
were transferred to the tubes containing the digest mixture (see Note 12).
Tubes were mixed by tapping gently, ensuring that plug slices were fully submerged.
Samples were incubated in a 25-30°C waterbath for a minimum of 2 h (see Note 13).

2.2.8.4. Preparation of agarose gels and sample loading
1. A waterbath was heated to 55-60°C.
2. A 3 L volume of 0.5X TBE Buffer was prepared by mixing 150 mL of the 1 OX
TBE stock Buffer with 2,850 mL distilled water.
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3. To prepare the gel 1.1 g SKG agarose was added to 110 mL of the 0.5X TBE
Buffer in a 250 mL flask and mixed gently (see Note 14).
4. The flask was covered loosely with parafilm and microwaved for 60 s, mixing
gently and repeating for 15 s intervals until the agarose was completely dissolved.
The solution was cooled to approximately 60°C and poured into a pre-casting gel
apparatus. This molten gel mix was allowed to solidify for approximately 30 min
after which time the comb was gently removed.
5. Next the gel was placed into the electrophoresis tank, overlaying it completely
with 0.5X TBE Buffer. The gel was then pre-electrophoresed for 1 h.
6. After the pre-electrophoresis step the gel was removed from the electrophoresis
tank.
7. Digested plug slices were then removed from the 37°C waterbath, and the
Enzyme/Buffer solution was gently decanted, taking care not to score the plug
slices with the pipette tip. A 200 pL volume of 0.5X TBE Buffer was added to
stop the digestion reaction. The tubes were incubated at room temperature for 5
min.
8. A single plug slice was removed from each tube at a time. Each was loaded into
the preformed wells in the agarose gel (see Note 15).
9. A 20 mL volume of a mixture containing 1% (w/v) SKG agarose in 0.5X TBE
was prepared as follows: 0.2 g agarose was added to 20 mL 0.5X TBE and
microwaved until it dissolved. The gel wells were sealed by overlaying them with
this molten agarose solution (see Note 16).
10. Next, the loaded gel was put back into the gel tank, submerging it in 0.5X TBE
Electrophoresis Buffer. An electric current of 200 V was applied to perform the
electrophoresis. DNA fragments were separated using a ramped pulse switching
every 0.5 to 25 s for 20 h, at 10.5°C (Hanninen et al., 1998b).

2.2.8.5. Staining and documentation of PFGE agarose gel
Ethidium bromide solution at a final concentration of 0.5 pg/mL in distilled water was
used to stain the gel. Gels were stained for 20-30 min in a covered container. Destaining could be performed, if required, in distilled water. All ethidium bromide
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products were examined and photographed using a UV Transilluminator (Ultra-Violet
products) using Phoretix software.
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TRANSFER SOLUTION

TRANSFER MEMBRANE

AGAROSE GEL
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RUBBER MASK
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CONNECTION TO PUMP UNITA^ACUUM TRAP

Figure 2.3. IlybaicP'^ vacuum blotting system

2.2.9. Southern blotting of gel
2.2.9.1. DNA transfer from agarose gels to nylon membranes
Transfer of DNA from agarose gel to a nylon membrane was achieved using vacuum
blotting with the Hybaid^"^ Vacu-Aid apparatus (see Figure 2.3).
1. A section of 3 MM filter paper was cut to measure approximately 2-4 cm larger
than the gel to be blotted. The filter paper was submerged in 2X SSC (diluted
from stock solution) for 2-3 min to wet thoroughly.
2. The membrane was cut (without touching its surface) to measure 0.5 cm larger
than the gel. This was also pre-soaked in 2X SSC for 2-3 min.
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3. The Vacu-Aid apparatus was assembled as shown in Figure 2.3 and the gel
overlaid on the rubber mask.
4. Vacuum pressure was applied. The Depurination Solution was added to the gel
and allowed to penetrate for 10 min. The Depurination Solution was then
removed and replaced with Denaturation Solution for 10 min. This solution was
replaced with Neutralisation Solution, again for 10 min. Finally, the
Neutralisation Solution was replaced with 20X SSC to facilitate transfer of DNA
to the membrane. Transfer was allowed to proceed for a minimum of 1 h,
replacing this solution as necessary during that time.
5. Using forceps, the membrane was removed from the Vacu-Aid apparatus and
rinsed in 2X SSC. The membrane was placed on filter paper to air-dry
completely.
6. The transferred DNA was cross-linked to the membrane in a UV Cross-linker, and
was stored in aluminium foil until ready to proceed with hybridisation.
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Figure 2.4. Southern blotting of agarose gels; use of DlG-labelled nucleic acid for
genetic mapping.
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2.2.9.2. Preparation of DIG-DNA gene probes
1. Incorporation of a DIG label was achieved for tetO and qacEAl sequences by
including 1 pL of DIG-Iabelled dUTP (DlG-11-dUTP) (Roche) in the PCR reaction
mixtures outlined in sections 2.2.6.6 and 2.2.6.7.2 (See Note 17).
2. After confirmation that a successful amplification occurred by analysis using
agarose gel electrophoresis, probes were recovered by precipitating 40 pL of each
product in a mixture containing 4 pL 4 M LiCl and 150 pL of cold Absolute
Ethanol, which were mixed well together (see Note 18).
3. The probe was allowed to stand at -20°C, and was then centrifuged at 12,000 rpm
for 15 min.
4. The supernatant was aspirated and the pellet was washed gently (by pipetting)
using 50 pL 70% (v/v) Ethanol. When the 70% Ethanol was aspirated, the
microcentrifuge tube containing the probe was left open to air dry for 10 min.
5. The pellet was re-suspended in 50 pL of TE Buffer, incubating at 37°C for 30 min
to aid in dissolving the labelled probe in the pellet.
6. Finally the probe was transferred to 10 mL of Hybridisation solution and stored at
-20°C until required.

2.2.9.3. Hybridisation of Southern blots of agarose gels with DIG-DNA probes
This process was achieved (represented diagrammatically in Figure 2.4) using a
Hybaid^”^ rotating oven (see Note 19).
1. The Hybridisation Buffer was pre-warmed to 58°C (in a waterbath) prior to
hybridisation. The membrane was placed in a hybridisation bottle with
approximately 50 mL of the pre-warmed Hybridisation solution and incubated in a
hybridisation oven for 1 h.
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2. The probe was denatured by boiling for 10 min and was then cooled rapidly for an
additional 10 min in ice water. The Hybridisation solution was then removed
from the hybridisation bottle containing the membrane and the probe solution was
added. Hybridisation was allowed to occur at 58°C overnight (18-24 h) in the
rotating oven.
3. Following hybridisation, the probe was removed and frozen at -20°C for future use
(see Note 20).
4. The membrane was washed twice with Wash Solution A at room temperature for
5 min per wash, and was subsequently washed twice with Wash Solution B at
68°C for 15 min per wash, with constant rotation.

2.2.9.4. Colour detection of the hybridised DlG-labelied probe
Principle: DIG-labelled probes are detected, after hybridisation to target nucleic acids
by enzyme-linked immunoassay using an antibody conjugate (anti-DlGoxigenin
alkaline phosphatase conjugate, anti-DlG-AP). A subsequent enzyme-catalysed colour
reaction with 5-bromo-4-chloro-3-indolyl phosphate (BCIP) and nitroblue tetrazolium
salt (NBT) produces an insoluble blue precipitate, which visualises hybrid molecules
(Figure 2.4).
1. The membrane was rinsed briefly in 150 mL Buffer 1 (Maleic acid Buffer) and
then incubated for 40 min with 150 mL Buffer 2 (Blocking Buffer) at room
temperature.
2. Anti-DiG-AP conjugate was diluted to 150 mU/mL (1:5000 dilution) in Buffer 2
according to the manufacturer’s instructions (8 pL conjugate in 40 mL Buffer 2)
and the membrane was incubated for a further 30 min with the antibody conjugate.
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3. Unbound conjugate was removed by washing twice with 150 mL of Buffer 1 for
15 min per wash at room temperature.
4. The membrane was then equilibriated in 60 mL of detection Buffer for 2-5 min.
Finally, the membrane was incubated with 30 mL of colour substrate solution (600
pL NBT/BCIP in 30 mL of Buffer 3 Detection Buffer) in a sealed plastic bag. The
bag was placed in the dark, without agitating, until sufficient colour development
had occurred (see Note 21).
5. After colour development the membrane was washed in sterile distilled water for a
few minutes to stop the reaction, and was then allowed to dry before
photographing or photocopying results.

2.2.10. Cloning amplified DNA fragments (after integron PCR)
2.2.10.1. Extraction of DNA bands of interest (after amplification) from agarose
DNA bands were extracted from a 1.5% (w/v) agarose gel using a QIAquick Gel
Extraction Kit^ (Qiagen).
Vll kit reagents are highlighted in the text.

Procedure:
1. Using a sterile scalpel blade, the DNA band of interest was excised under U V
light, minimising the removal of agarose.
2. The agarose slice was weighed and 300 pL of Buffer QG was added for every
100 mg of gel, and the sample was incubated at 50°C for 10 min. The sample was
vortexed every 2-3 min to ensure that the agarose dissolved completely.
3. A volume of 100 pL of Isopropanol was added to the sample tube per 100 mg of
gel, and the tube was mixed thoroughly.
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4. The sample was then added to a QIAquick column (in a 2 mL collection tube)
and centrifuged for 1 min at 10,000 rpm to bind the DNA. Any remaining traces
of agarose were then removed by washing the column with 0.5 mL of Buffer QG,
which was centrifuged at 10,000 rpm for 1 min. All flow-through was discarded.
5.

A washing step was included by adding 0.75 mL Buffer PE to the column, which
was centrifuged for 1 min, and any residual PE was removed by centrifuging the
column for an additional minute.

6. Elution of the DNA was performed by placing the QIAquick column in a sterile
1.5 mL microcentrifuge tube and adding 50 pL of sterile distilled water to the
column, which was centrifuged at 15,000 rpm for 1 min.
7. The eluted DNA was stored at -20°C until required.

2.2.10.2. Re-ampliflcation of excised bands
Following excision and elution, re-amplification of DNA was carried out using the
appropriate primers, and the same reaction conditions as described previously in
section 2.2.6.7.I. The function of this step was twofold:
• To confirm that excision was successful
• To prepare the band of DNA for cloning
A nontemplate-dependent activity of Tag DNA polymerase is the addition of a single
deoxyadenosine (A) onto the 3’ ends of PCR products. These A-overhangs are
complementary to the linearised vector supplied in the TA Cloning*^ Kit, which has
single 3’ deoxythymidine (T) residues, so facilitating the efficient ligation of PCR
inserts with the vector.
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2.2.10.3. DNA ligation

PCR products were ligated into the pCR®2.1 vector using the following reaction
components:

pCR®2

1

vector (25 ng/L)

2 pL

PCR product

1 pL

T4 DNA ligase

1 pL

1 OX ligation Buffer

1 pL

Sterile distilled water

5 pL

Total volume

10 pL

This mixture was incubated at 14°C overnight and stored at -20°C until ready for
transformation.

2.2.10.4. Transformation of ligated constructs into INVaF’ cells

1. The vial containing the ligation reaction above was centrifuged for 5 s and placed
on ice.
2. A vial containing 0.5 M |3-Mercaptoethanol (P-ME) and one 50 pL vial of frozen
OneShot™ competent cells were thawed on ice.
3. A volume of 2 pL 0.5 M P-ME was pipetted into each vial of competent cells,
which was then mixed by stirring gently with a pipette tip.
4. A 2 pL volume of the ligation reaction was pipetted into the competent cells,
which were mixed gently by stirring with a pipette tip. The vial was ineubated on
ice for 30 min. The remainder of the ligation reaction was stored at -20°C.
5. The mixture containing cells and ligation products was heat-shocked for 30 s in a
42°C waterbath, and was then placed on ice for a further 2 min.
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6. A volume of 250 |aL SOC Medium (at room temperature) was added to the cells,
which were incubated at 37°C for 1 h at 225 rpm in a rotary shaking incubator.
7. Cells were then placed on ice until 100 pL was removed from the vial and spread
onto the surface of an LB agar plate containing X-Gal (40 pg/mL) and ampicillin
(50 pg/mL).
8. The agar plate was allowed to dry before being inverted and incubated overnight at
37°C (up to 24 h until sufficient colony size was achieved).
9. Following overnight incubation the plate was then incubated at 4°C for 2-3 h to
allow for colour development of colonies prior to screening.
10. Results, as expected: Blue colonies did not contain the insert in the cloning
vector; white colonies contained the plasmid with the DNA insert.

2.2.10.5. Colony screening of plasmids for inserts
This procedure was undertaken to screen possible recombinant plasmids directly from
the white bacterial colonies for the presence of DNA inserts. Blue colonies were
selected as negative controls.
1. Each colony to be investigated was numbered, and touched onto the side of a
sterile P20 pipette tip. This pipette tip was then used to inoculate the partial
colony onto a fresh LB-X-Gal-ampicillin plate, to preserve it for further analysis.
The partial remaining colony was gently mixed with 16 pL of Lysis solution in a
sterile 1.5 mL microcentrifuge tube, to which 3 pL of Buffer 2 was added. The
tubes were centrifuged at 12,000 rpm for 4 min.
2. A 10 pL volume of supernatant from each tube was loaded into a 0.8% (w/v)
agarose gel. Samples were electrophoresed at 100 V for 1.5 h.
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3. Plasmids containing the insert were recognisable after electrophoresis by an
increase in molecular weight when compared to similar constructs from blue
colonies.

2.2.10.6. Plasmid isolation from INVaF cells
The bacterial culture from which plasmids were to be harvested was inoculated into 5
mL LB broth (containing ampicillin 50 pg/mL) and incubated overnight at 37°C.
Plasmid purification was performed using the Wizard®P/m5 SV Minipreps DNA
purification system (Promega)^ as follows;
^All kit reagents are highlighted in the text.

1. Each bacterial culture was pelleted by centrifugation at 12,000 rpm for 5 min,
discarding the supernatant and blotting the inverted tube to remove exeess
medium.
2. The cell pellet was thoroughly re-suspended in 250 pL of Cell Suspension
Solution.
3. A 250 pL volume of Cell Lysis Solution was added to the tube which was mixed
by inverting 4 times. The tube was incubated at room temperature for 1 -5 min
until partial or complete clearing of the cell suspension had occurred.
4. A 10 pL volume of Alkaline Protease Solution was added to the tube, which was
mixed by inverting 4 times and incubated at room temperature for 5 min.
5. A 350 pL volume of Neutralisation Solution was added to the tube, which was
again mixed by inversion.
6. The bacterial lysate was centrifuged at 15,000 rpm for 10 min, after which the
supernatant was decanted into a Spin Column that had been inserted into a
collection tube, and centrifuged at 15,000 rpm for 1 min.

no

7. After centrifugation the flowthrough was discarded from the collection tube, and
750 |iL Column Wash Solution was added to the Spin Column, after re-insertion
in the collection tube, and centrifuged at 15,000 rpm for 1 min. The flowthrough
was again discarded and the column washed once more using 250 pL of Column
Wash Solution and centrifuging at 15,000 rpm for 1 min.
8. Finally, the Spin Column was inserted into a sterile 1.5 mL microcentrifuge tube,
and the plasmid DNA was eluted by adding 100 pL of nuclease-free water to the
column, which was then centrifuged at 15,000 rpm for 1 min.
9. After elution, the spin column was discarded and the DNA stored in the
microcentrifuge tube at -20°C until required.

2.2.10.7. Confirmation of the presence of the plasmid insert (see Figure 2.5)
It was necessary to confirm the identity of a DNA fragment, cloned into pCR® 2.1 (or
any other suitable vector). This step can be achieved using the following strategies:
(a) Restriction enzyme digest of the purified recombinant plasmid:
The plasmid vector pCR® 2.1 contains restriction sites for EcoK\ flanking the
cloning site. Digestion with this enzyme forms the basis for the restriction digest
method confirming the presence of the insert.
Reaction mix:
Plasmid DNA

5 pL

EcoKX (lOU/pl)

1 pL

Buffer H

2 pL

Sterile water

2 pL

Total volume

10 pL

Ill

The tubes were incubated at 37°C for 1 h after which the samples were
electrophoresed in a 1 % (w/v) agarose gel at 90 V for 1 h. When compared with the
original inserted DNA, authentication can be confirmed.

(b) M13 on isolated plasmid:
The pCR 2.1 plasmid vector contains Ml3 primer (forward and reverse) binding
sites that flank the cloning site. The Ml3 PCR protocol was a method that was
also used to confirm the presence of the insert. A 1 pL volume of plasmid DNA
can be used in the reaction mix outlined previously in section 2.2.6.8.
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Figure 2.5. Flow chart of the experimental process facilitated by the TA® Cloning Kit
for the insertion of a PCR product into a plasmid vector.
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2.2.11. PCR purification protocol (after gyrA gene PCR)
PCR purification was performed using a QIAquick PCR purification kit (Qiagen) after
single band amplifications, for the purpose of DNA sequencing of the amplified
product (see section 2.2.6.5 for PCR protocol).
1. A volume of 40 pL PCR product was added to 200 pL of Buffer PB, which was
mixed and pipetted into a spin column that had been inserted into a 2 mL
collection tube.
2. The sample was centrifuged at 15,000 rpm for 1 min and the flowthrough was
discarded. The spin column was re-inserted into the collection tube.
3. To wash, 750 pL of Buffer PE was added to the column, which was centrifuged
at 15,000 rpm for 1 min and the flowthrough was discarded as before.
4. After replacing the spin column in the collection tube, the tube was spun for an
additional 1 min at 15,000 rpm.
5. The column was then placed in a sterile 1.5 mL microcentrifuge tube, and 50 pL
of Buffer EB was added to the centre of the column membrane. The column was
allowed to stand for 1 min, and was then spun at 15,000 rpm for 1 min, to collect
the eluate.

2.2.12. DNA sequencing
Sequencing of inserts and purified PCR products was performed at MWG Biotech
(Milton Keynes, UK).

Sequence analysis
All sequences were initially analysed using DNA Sequencher'^'^ (version 4.1) software
(Gene Codes, Ann Arbor, MI, USA).
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The BLAST (Basic Local Alignment Search Tool) suite of programmes (Altschul et
al., 1997) was searched for similar sequences and CLUSTALW alignments
(Thompson et al., 1994) were produced to compare amino acid similarities and to
identify any substitutions at the amino acid level. Alignments were carried out online
using the latter programme which is available over the internet at
http://www2/'ebi.ac.uk/clustalw.

DNA sequences were then submitted to the GenBank database, at the internet address
http://www.ncbi.nlm.nih.gov using the“BankIf’ submission facility, and were
assigned accession numbers.
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NOTES
1. Microscopic examination by dilute Carbol Fuchsin staining. Prepared by
dissolving 20g of Carbol Fuchsin (BDH Chemicals) and liquefying lOOg of
Phenol (BDH Chemicals) together in a 3 L conical flask. Add 200 mL of
Absolute Ethanol and 1715 mL of distilled water. Filter the resultant solution and
dilute in sterile distilled water to give a 10% (v/v) working Carbol Fuchsin
solution (see section 2.1.2).
2. A minority of Campylobacter isolates may be non-typeable by DAF or PFGE due
to the production of DNAses. This can be overcome by routinely treating bacterial
suspensions with Formaldehyde before proceeding with the typing method (see
sections 2.2.4.1, 2.2.4.2).
3. Caution: Formaldehyde is toxic; harmful if inhaled or absorbed through skin or
mucosa. This reagent should only be handled in a safety cabinet with extraction
ventilation (see sections 2.2.4.1, 2.2.4.2).
4. Round-bottomed microcentrifuge tubes facilitate emulsification of organisms (see
sections 2.2.4.2, 2.2.7).
5. Caution: Care should be taken when handling Phenol-Chloroform. As Phenol is
an acid it can cause skin bums. This reagent should only be handled in a safety
cabinet with extraction ventilation (see section 2.2.4.2).
6. Ensure that none of the white layer at the interface of the Phenol Chloroform and
DNA solution is disturbed (see section 2.2.4.2).
7. DNA suspensions may be stored at 4°C for up to 3 months or, alternatively, may
be aliquoted and frozen at -20°C and thawed prior to use (see section 2.2.4.2).
8. To ensure reproducibility of DAF patterns the same thermocycler and reagents
should be used. The interpretation of weak bands can be problematic, and typing
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should be duplicated in separate runs to help overcome this problem (see section
2.2.6.4).
9. Incubation of cultures with Alkaline Protease solution for more than 5 min may
result in nicking of the plasmid DNA (see section 2.2.7).
10. Ensure that clearing of the lysate occurs, or false negatives may result (see section
2.2.7).
11. Optimal temperature for Sma\ is 25-30°C (see section 2.2.8.3)
12. Up to 4 gel slices may be cut for digestion in 100 pL total volume of Restriction
solution (see section 2.2.8.3).
13. Alternatively, agarose slices may be allowed to digest overnight (see section
2.2.8.3).
14. Prepare sufficient gel volumes according to the PFGE apparatus used. Quoted
volume applies to the Gene Navigator® System (Pharmacia Biotech, Uppsala,
Sweden), having an actual gel size of 152 mm^ (see section 2.2.8.4).
15. Use blotting paper to blot dry the surface of wells, facilitating the loading to plug
slices into the gel (see section 2.2.8.4).
16. Unused agarose can be allowed to solidify and can be reheated several times as
needed (see section 2.2.8.4).
17. A non-DiG-labelled control was included in each PCR run to allow comparison
with the expected (slight) product size increase which should result from
incorporation of DiG-dUTP (see section 2.2.9.2).
18. Caution: LiCl is toxic; harmful if inhaled or absorbed through skin or mucosa
during preparation. Weigh in a safety cabinet with extraction ventilation (see
section 2.2.9.2).
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19. When the same probe is required for more than one membrane it is possible to
hybridise two membranes simultaneously in the same hybridisation bottle, using
the same hybridisation volumes as for a single membrane (see section 2.2.9.3).
20. Probe solutions may be used up to five times in all, if they are stored at -20°C
when not in use (see section 2.2.9.3).
21. The colour precipitate usually starts to form within a few minutes and the reaction
is usually complete after 16 h. The membrane can be exposed to light for short
time periods to monitor colour development (see section 2.2.9.4).
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3.1. Abstract
Antimicrobial resistance (R) typing and DNA Amplification Fingerprinting (DAF) of
a random eollection of 84 Irish thermophilic Campylobacter isolates is described.
The collection included human, veterinary and poultry isolates cultured between 1996
and 1998 in the Cork region of Ireland. Biochemical and molecular methods were
used to identify Campylobacter jejuni and Camp. coli. Many of these isolates were
simultaneously resistant to several common antimicrobial agents. In partieular,
resistance to spectinomycin, sulphafurazole, tetracycline and ampieillin was common.
A total of 74 DAF profiles were identified among the study collection, showing a high
degree of diversity. Dendrogram analysis of the DNA patterns identified three main
clusters at the 50% similarity level, which included two clusters of Camp, coli and a
third containing a mixture o^ Camp, jejuni and Camp. coli.
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3.2. Introduction

Thermophilic Campylobacter spp., particularly Campylobacter jejuni and
Campylobacter coli are recognised as the most common bacteriological cause of
gastroenteritis in humans (Jackson et al. 1996). The wide spectrum of human
symptoms might suggest the possible existence of different pathovars within the
species (Leach 1997). Intestines of birds and warm-blooded mammals form major
environmental reservoirs of these organisms. Campylobacter appears to colonise the
gut permanently, with few noticeable ill effects (Stem 1992). Tauxe (1992) reported
that chicken is the single most important vehicle for sporadic cases in developed
countries. Furthermore, it has been shown that virtually all swine are contaminated
upon arrival at the slaughterhouse (Weijtens et al. 1993), and that these organisms are
cultured from pork in retail outlets (Fricker 1989).

Campylobacter notifications in the quarterly reports of the Southern Ireland
Communicable Disease Surveillance group (Infoscan), have increased from 226 in
1993 to 550 cases in 1998, and continued to rise during 1999. The objective of this
study was to describe the antimicrobial agent resistance (R) profile and the molecular
epidemiology by DNA amplification fingerprinting (DAF) of human enteritis-causing
Campylobacter isolates in the Cork area, and to compare these data with two noted
animal reservoirs of the organism. DAF profiling was previously reported to be
reproducible when applied to pure cultures of Campylobacter spp. (Mazurier et al.
1992) and was used to assess the genomic relationships among the collection.
Elucidating the molecular epidemiology of these foodbome pathogens has
considerable implications for public health.

121

3.3. Materials and Methods

3.3.1. Bacterial isolates
A total of 89 randomly-collected Campylobacter isolates was included in the study.
Thirty-six of the isolates were from patients with clinically confirmed gastroenteritis,
32 isolates were cultured from slaughtered chickens, and a further 16 isolates were
from slaughtered animals. Human, poultry and veterinary strains were isolated
between 1996 and 1998. Five control strains. Camp, jejuni NCTC 11351, Camp, coli
NCTC 11353, Camp, lari NCTC 11352, Camp, upsaliensis NCTC 11541 and a
Urease Positive Thermophilic Campylobacter (UPTC) NCTC 11845 were included in
the study for comparative purposes. Poultry and veterinary samples were collected
and inoculated into 20 mL volumes of Oxoid Broth No. 2 (Oxoid, Basingstoke,
Hampshire, England), containing 5% lysed horse blood (LHB). All cultures were
incubated for 2 h at ambient room temperature, followed by incubation for a further
48 h at 37°C. Finally, 10 pL of each culture were inoculated individually onto Preston
Agar (Campylobacter Agar Base, Oxoid CM689, containing Campylobacter Selective
Supplement SRI 17E and 5% LHB), and incubated at 42°C for 48 h. Clinical faecal
samples were inoculated in 10 pL volumes onto Preston Agar, and incubated for 48 h
at 42°C. Incubation of all cultures was performed in a microaerophilic environment
using an Oxoid BR056A Campylobacter Gas Generating Kit.

3.3.2. Identification
Bacteria were identified by testing the following parameters: Carbol Fuchsin staining
for typical morphology, growth at 42°C, positive oxidase and catalase tests, and ability
to hydrolyse hippurate Qiip^), determined by using hippurate-containing tablets
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(Rosco Diagnostica, Taastrup, Denmark) according to the manufacturer’s instructions.
Isolates which metabolised hippurate {hip^) were identified as Camp, jejuni^ the
hippuricase gene being specific to Camp, jejuni (Hani and Chan 1995), although hip'

Camp, jejuni isolates are known to occur (Totten et al. 1987). Hip' isolates were
further characterised by amplifying the Camp. co//-specific 23S rRNA gene fragment
according to the method described by Eyers et al. (1993), and by using the API Campy
system (BioMerieux, Marcy I’Etoile, France). All isolates were preserved on cryostat
beads at -70°C for long-term storage.

3,3.3. Antimicrobiai susceptibility testing
Susceptibility testing was performed using the agar diffusion method on IsoSensitest
Agar (Difco, Dublin, Ireland), with 5% horse blood (Reina et al., 1994). Cultures
were prepared by inoculating colonies from a fresh, pure, 24 h culture into sterile
distilled water to give an inoculum turbidity equivalent to a 0.5 McFarland turbidity
standard. The McFarland standard was prepared by adding 0.5 mL 0.048 M BaCE to
99.5 mL 0.18 M H2SO4, with constant stirring. Samples were swabbed evenly onto
agar plates and allowed to dry. Twelve antimicrobial agents were tested on discs.
These agents, together with their abbreviations and concentrations shown in
parentheses, included:

ampicillin (Ap, lOpg/disc), chloramphenicol (C, lOpg/disc),

ciprofloxacin (Cp, 5pg/disc), colistin (Ct, 25pg/disc), erythromycin (E, 5pg/disc),
gentamicin (G, lOpg/disc), nalidixic acid (Na, 30pg/disc), spectinomycin (Sp,
lOpg/disc), streptomycin (S, 25pg/disc), sulphafurazole (Su, lOOpg/disc), tetracycline
(T, lOpg/disc), and trimethoprim (Tm, 1.25 pg/disc).
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Agar plates containing the antibiotic discs above were incubated at 37°C under
microaerophilic conditions for 24 h or, where necessary, for 48 h. Inhibition zone
sizes were recorded according to the guidelines of the National Committee for
Clinical Laboratory Standards (1981). A representative selection of isolates was
further tested for antimicrobial susceptibility by an E-Test (AB Biodisc, Solna,
Sweden).

3.3.4. DNA isolation
Isolates were cultured for 48 h on Columbia Agar (Oxoid CM331) containing 5%
horse blood at 37°C for 48 h. DNA was extracted as described previously (Mazurier
et al. 1992). The integrity of the extracted DNA was assessed by electrophoresis in a
conventional 2% agarose gel, and the DNA concentration measured
spectrophotometrically at A260

3.3.5. DAF fingerprinting
Reaction volumes (25 pL) were prepared, each containing 225 ng genomic DNA, 1.25
mmol/L of each deoxynucleoside triphosphate, 2.5 units Taq DNA Polymerase
(Sigma, Poole, UK), 11.2 pmol primer HLWL85 (5’-ACAACTGCTC-3’) (Mazurier
et al. 1992), 4 mM MgCband 2.5 pL of lOX buffer (100 mM Tris-HCl, [pH 8.3], 500
mM KCl). A negative control containing sterile distilled water in place of template
DNA was also included. Amplification was performed using an initial denaturation
step at 94°C (5 min), followed by 40 cycles consisting of denaturation (94°C for 30 s),
annealing (40°C for 1 min), and extension (72°C for 1 min) steps, with a final
extension step (72°C for 10 min). For detection, 8 pL of PCR product was combined
with 2 pL of loading dye and electrophoresed on a 2% agarose gel in IX Tris-EDTA-
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acetate (TAE) buffer containing 0.1 p,g/mL ethidium bromide at 90 V for 90 min.
Each DNA template was DAF fingerprinted three times, ensuring the reproducibility
of the method and the reliability of the final data.

3.3.6. Quantitative analysis of DNA fingerprint patterns
Quantitative analysis of gel fingerprint patterns was performed for all isolates as
outlined previously. Hierarchical clustering was performed according to the method
of Cotter et al. (1997). A dendrogram was constructed from these data to assess
genetic relationships among the isolates studied.
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3.4. Results

3.4.1. Species distribution
Thirty-six Campylobacter isolates randomly cultured from human cases of
gastroenteritis were identified as Camp, jejuni, as shown in Figure 1. Of the 32
poultry-derived strains isolated, 30 were identified as Camp, jejuni and the remaining
two were Camp. coli. Two hip' Camp, jejuni isolates were also cultured, one from a
clinical sample, the other from poultry. The 16 veterinar>' thermophilic isolates were
all identified as Camp. coli.

3.4.2. Antimicrobial susceptibility
Forty-five antibiogram or resistance (R) patterns were determined. Table 1 shows the
numbers of resistant isolates as a percentage of the total collection (in parentheses)
together with their corresponding R-types in Figure 1. All isolates, with the
exception of C1T-P9 and -VI5 (which were not available), were resistant to
trimethoprim, in accordance with the findings of Karmali et al. (1981). Otherwise,
the highest levels of antimicrobial resistance found were to spectinomycin, 81.7%
(n=67) and to sulphonamide, 65.9% (n=54). As the antimicrobial agents
erythromycin, ciprofloxacin and tetracycline are the agents of choice where
Campylobacter enteritis necessitates treatment, it was interesting to determine levels
of resistance to these agents among the collection. The incidence of resistance among
the test strains to erythromycin was 15.9% (n=13). However, 60% (n^9) of the
veterinary isolates were resistant to this antimicrobial agent compared with only 9.7%
(n=3) of the poultry isolates and 2.8% (n=l) of clinical isolates (see Table 1).
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Resistance to tetracycline was 29.3% (n=24) for the collection. Interestingly, a higher
rate of resistance was recorded among the veterinary isolates, 86.7% (n=13),
compared with 19.4% (n=6) for poultry and 13.9% (n=5) for clinical isolates. Finally,
nalidixic acid resistance was measured at 19.5% (n=16), while ciprofloxacin
resistance accounted for 7.3% (n=6) of the study collection. No resistance to
ciprofloxacin was encountered among human isolates. However, 33.3% (n=5) of the
veterinary isolates and 3.2% (n=l) of poultry isolates were resistant to this
fluoroquinolone. In particular, CIT-H17 was resistant to nine antimicrobial agents
and had the R-type ApCtENaSSpSuTTm. Furthermore, CIT-V6, -V9 and -VI3 were
each resistant to a different combination of eight agents.

Table I. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter
coli

tTotal
Resistance (%)

*Ap

C

Cp

Ct

18
(22.0)

4
(4.9)

6
(7.3)

6
(7.3)

Na
13
(15.9)

2
(2.4)

16
(19.5)

Sp
67
(81.7)

Su
17
(20.7)

54
(65.9)

28

22

Poultry

24

22

Veterinary

15

10

Human

10

*Ap, ampicillin; C, chloramphenicol; Cp, ciprofloxacin; Ct, colistin; E, erythromycin;
G, gentamicin; Na, nalidixic acid; Sp, spectinomycin; S, streptomycin; Su,
sulphafurazole; T, tetracycline.
tPercentages shown in parentheses refer to the % resistance e.g. 22% of isolates were
resistant to ampicillin.
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T
24
(29.3)

13

3.4.3. DAF analysis
Total genomic DNA was successfully purified from all 84 isolates in the collection
together with five unrelated control strains. This genomic DNA template was then
subjected to a single-primed DNA amplification reaction with the previouslycharacterised primer HLWL85 (Mazurier et al. 1992), The resulting DNA fingerprint
arrays were resolved by conventional agai'ose gel (2%) electrophoresis. DAF analysis
of all isolates generated between three and 13 distinct bands, ranging in size from 0.1
to 2.1 kbp, with four exceptions: CIT-Hl 1, -P31, -P32 and -P33, wherein a single
amplicon was produced (Figure 1). A total of 74 DAF types (denoted as DAF-types 1
to 74, Figure 1) were found among the 84 laboratory isolates. (DAF types were
designated on the basis of a single-band difference between isolates). The large
number of bands produced with the HLWL85 primer proved useful in discriminating
between these isolates. With the exception of two Camp, coli isolates (CIT-P3 and VIO, Figure 1), DAF analysis could distinguish Camp, jejuni and Camp. coli.
Careful inspection of these DNA fingerprint profiles showed a high degree of genetic
diversity among the study population. Among the 36 human isolates studied (see
Figure 1) 32 DAF types were identified, while the 31 poultry isolates produced 27
types. Finally, each of the 16 veterinary isolates produced a different DAF pattern.

Quantitative analysis of the DNA banding profiles above facilitated the construction
of a dendrogram, permitting the genetic relationship (if any) among these isolates to
be explored. These data grouped the 84 DAF patterns into three main clusters
(denoted A, B and C) at the 50% similarity level. Cluster A, (containing five Camp,
coli isolates), comprised one poultry isolate and four veterinary isolates. Cluster B
(66 Camp, jejuni isolates and two Camp, coli) comprised 36 human Camp, jejuni
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isolates, 31 poultry isolates (30 Camp, jejuni and one Camp, coli) and one veterinary
Camp, coli isolate. Included in this cluster are the four indistinguishable Camp, jejuni
isolates (CIT-Hl 1, -P31, -P32 and -P33), which only produced a single amplified
DNA band (Figure 1). Three of these isolates originated from the same flock of
chickens, and the fourth was cultured from a human case. All isolates in Cluster C
(11 Camp, coli) were cultured from infected animals. Clusters A and C produced
fragments which fell into two molecular weight groupings, the first containing
fragments ranging from approximately 0.2-0.6 kbp and the second containing DNA
fragments of between 1.2 and 2.1 kbp in size. In contrast, cluster B produced DAFamplified fragments, the majority of which ranged in size from 0.1 to 0.85 kbp.
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Isolate No.

Year

CIT-V7 Cct
CIT-V8
CIT-V9
CIT-P2
CIT-V6
CIT-P8 Cj
C1T-H27
C1T-H17
C1T-H15
CIT-H33
CIT-P18
CIT-P19
CIT-P20
CIT-H34
CIT-H35
CIT-P9
CIT-P21
CIT-Pl
C1T-P22
CIT-H36
CIT-H23
CfT-H19
CIT-H9
CIT-H8
CIT-HIO
CIT-H25
C1T-H24
C1T-P5
CIT-P4
CIT-Hl
C1T-H18
C1T-H32
C1T-H22
CIT-H21
CIT-H28
CIT-H16
CIT-H7
CIT-H12
CIT-P15
CIT-P14
CIT-P23
C1T-H14
C1T-P24
CIT-H4
CIT-H26
CIT-H29
CIT-P16
CIT-H2
CIT-H20
CIT-P25
C1T-P26
CIT-Pl 1
CIT-H31
CIT-P13
CIT-P12
CIT-P7
CIT-VIO Cc

1998
1998
1998
1997
1998
1997
1997
1996
1996
1997
1997
1997
1997
1996
1996
1997
1997
1997
1996
1997
1996
1997
1997
1997
1997
1997
1997
1997
1997
1996
1997
1997
1996
1997
1997
1997
1996
1997
1996
1996
1997
1997
1996
1996
1997
1997
1996
1996
1996
1997
1997
1996
1996
1996
1996
1997
1998

*R-type
ESpSuTTm
CtESSpSuTTm
CpENaSSpSuTTm
SpSuTm
CCpENaSSpTTm
SpSuTm
NaSSpSuTm
ApCtENaSSpSuTTm
SpTm
ApCtSpSuTm
SpTm
SpTm
SpTm
SpSuTTm
SSuTm
IN/A
SuTm
SpSuTm
ESpSuTm
NaSuTTm
SpSuTm
SpSuTm
SpTm
ApSpTm
Tm
SSpTm
ApNaTm
SpSuTm
TTm
SpSuTm
ApCtSSpSuTm
SSpSuTm
SpSuTm
SpSuTm
CtTm
SpTTm
SpTm
NaSpTm
SpSuTTm
SuTTm
ApTm
SpTm
ApSpSuTTm
SpSuTm
ApSpTm
SuTm
ApSpSuTTm
SpSuTm
ApSpTm
Tm
CpNaTm
NaSpTm
SpSuTm
NaTm
CtNaSpSuTTm
NaSuTm
SpTTm

DAF type

Similarity (%)

DAF fingerprint array

100 90 80 70 60 50

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
16
17
18
19
20
21
22
22
22
23
23
24
25
26
27
28
29
29
30
31
32
33
34
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
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1
1
1
1
1
1

1

1
1
1
1
1
1
1
1
1
1
1
1
1

1

1
1
1
1 1
1
1
1 1
1 1

1
1
i
1
1

1
1
1

1 1 II 1 1 1
1 1 II III I
1 1 1 II 1 M
II
III
II 1 II
1 1 1 M 11 INI
1 1 1 M 1 1 INI
MIN 1 1 1 II
1
1 Ml 1 II III
1 1 1 1 II 1 1 1
III 1 II II II
II 1 II II II
II 1 II II II
1 III INI II
1 II 1 1 nil 1 1
II III III
M Ml III
1 1 1 1 1 1
II 1 II 1 1 1
1 1 II II 1
1
II III III
1 1 II 1 1 II
1 1 1 1 1 1
1 1 1 1 1 1
1 1 1 1 1 1
1 II 1 1 II II
Ml 1 1 II II
Mill
1
1 1 1 1 1
1
1 1 1 II Mill
III II 111 II
M11 II 1 II II
Mil 1 Ml II
Mill 1 II II
11 1 1 1 III
1 Mill 1
1 11 11
1
11 11
1
1 1 M
1
1 1 11
1
11 Mil 1
1 Ml 1
Mill
1 11 11 II 1
1
MM 11 Ml 1
11 11 11 Ml 1
Ml 1111 1 1
Mini
1
11 Mill II
11 1 11 II
11 MMMI
11 11 Mill
11 11 Mill
MM 11 1 1
Mill 11 1 1
11 Ml 11 1
1 1 M 1

I

1 1 1 1 !
1
1 i
1
1 1
1 1 1
1 II 1

A

1

bn

th

H

B
A

CIT-H6Cj
C1T-H5
C1T-P27
Cir-P28
C1T-P29
C1T-P30
Crr-H3
CIT-Hll
C1T-P31
C1T-P32
Crr-P33
C1T-P6
C1T-H13
CTr-H37
Crr-P34
C1T-P3 Cc
CIT-Vll
Crr-V12
CIT-V13
C1T-V14
Crr-V15
CIT-Vl
Crr-V16
C1T-V2
C1T-V5
Crr-V4
C1T-V3

1997
1997
1998
1997
1997
1998
1997
1997
1998
1998
1998
1997
1997
1997
1997
1996
1998
1998
1998
1998
1998
1998
1998
1998
1998
1998
1998

SpSuTm
SuTm
ApSSpSuTm
SpSuTm
SpSuTm
CSpSuTm
SuTTm
ApSpSuTm
ApCSpSuTm
EspSuTm
ApSpSuTm
SpSuTm
ApCSpTm
ApNaSpSuTm
ApSpSuTm
EGSSpSuTm
CpGNaSpSuTTm
ESSpSuTTm
ApCpENaSpSuTTm
CpNaSSpTTm
N/A
SpSuTm
SSpSuTm
ESSpSuTTm
ESSuTTm
SSpTTm
ESpTTm

NCTC 11351
NCTC 1 1353
NCTC 11352

C. jejuni
C. coli
C. lari

NCTC 11541
NCTC 1 1 845

UPTC

52
53
54
55
56
56
57
58
58
58
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74

B

A

1 I

I
1 I
I I

I
I
II
III

C. upsaliensis

2.1 kb

II
III
I

I II I I I
II II II I I
I I I I
I I I I I

II

0.1 kbp

* Antimicrobial agents: Ap, ampicillin; C, chloramphenicol, Cp, ciprofloxacin; Ct, colistin, E,
erythromycin; G, gentamicin; Na, nalidixic acid; S, streptomycin, Sp, spectinomycin; Su, sulphafurazole;
T, tetracycline; Tm, trimethoprim.

Trimethoprim was included in the susceptibility testing as a check on identity; all Campylobacter strains
are intrinsically resistant.
t H, hospital isolate; P, poultry isolate; V, veterinary isolate.
1 /, not available or not determined.

Figure 1. A list of all isolates in the collection together with the corresponding year
of isolation, R-, DAF types and DAF fingerprint array. A dendrogram was
constructed to show the genetic relationships. Included is an approximate molecular
weight scale at the foot of the figure.
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3.5. Discussion
Campylobacter spp. and Salmonella spp. are the most commonly isolated causes of
bacterial enteritis. Campylobacter differs from Salmonella by not multiplying on
food. In addition, the organism is rarely spread from person to person and is
uncommonly associated with outbreaks (Pebody et al. 1997). It is probably for these
reasons that the epidemiology of clinical Campylobacter infection remains poorly
elucidated.

In this study, 84 randomly-collected thermophilic Campylobacter isolates were
acquired by the Molecular Diagnostics Unit. All isolates were cultured between 1996
and 1998 and were taken from clinical and food sources. Biochemical analysis and
the amplification of the Camp. co//-specific 23 S rRNA gene fragment from
thermophilic Campylobacter isolates identified 36 human isolates as Camp, jejuni,
together with 30 (of the 32) poultry isolates. The remaining two isolates were
identified as Camp. coli. The 16 veterinary isolates were all identified as Camp. coli.
The absence of clinical Camp, coli enteritis in this small study may indicate that pork
does not represent a major reservoir for human Campylobacter-?iSsoc\eA.Q(i disease in
this region of Ireland.

A comparison of the R-types between the three sources of thermophilic
Campylobacter spp. shows that for many of the antibiotics, significantly higher levels
of resistance, particularly to erythromycin, ciprofloxacin and tetracycline, were
encountered among the veterinary {Camp, coli) isolates compared with either the
human or poultry isolates. Tetracyclines, erythromycin (or related macrolides), and
quinolones are commonly used in veterinary medicine to treat swine, poultry and
132

cattle. In a recent Danish survey focusing on resistance to antimicrobial agents used
for animal therapy, acquired resistance to all antimicrobials was identified, with
resistance occurring more frequently among isolates from pigs than for cattle and
poultry (Aarestrup et al. 1998). Similar trends were also evident in this study.

Interestingly, quinolone resistance in this study collection showed that 19.5% (n==16)
of isolates were resistant to nalidixic acid, while a smaller 7.3% (n=6) were resistant
to ciprofloxacin. Importantly, resistance to ciprofloxacin was not encountered among
the human isolates, and only infrequently among poultry isolates. However,
resistance was identified in one third of all veterinary isolates. Sensitivity to nalidixic
acid has been one of the common phenotypic characteristics used in the identification
of thermophilic Campylobacters. Emerging quinolone resistance, therefore, has
significance for the future reliable identification of Campylobacter isolates in the
routine clinical laboratory. Finally, when the level of ciprofloxacin resistance was
compared to other collections, higher rates of resistance were identified among other
populations of Camp, jejuni, from 10% during 1997 in England and Wales (Thwaites
and Frost 1999), to 49% in Spain by 1993 (Reina et al. 1994). Ciprofloxacin is
frequently used as prophylaxis for travellers (Gibreel et al. 1998).

Campylobacter spp. have a natural ability for transformation, facilitating the uptake of
naked DNA (e.g. heterologous plasmids), which may become chromosomally
integrated by illegitimate recombination (Wang and Taylor 1990; Richardson and
Park 1997). The presence of integron-like structures among Campylobacter spp.
(Lucey et al. 2000) suggests another means by which antimicrobial resistance may be
transmitted. This adaptability, and the potential for interspecies transfer of genetic
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material in reservoirs of mixed bacterial flora, such as the intestines, together with
emerging antimicrobial resistance among Campylobacter spp., suggests that there is a
continuous need for surveillance of resistance rates and an elucidation of the
mechanisms by which this resistance is transferred within and between different
species.

When the DNA fingerprinting profiles were considered, they were remarkably diverse,
suggesting considerable genetic heterogeneity among isolates in this collection.
Dendrogram analysis at the 50% similarity level identified three clusters. Cluster B
accounted for the largest grouping, consisting of 68 isolates and accounting for 58 of
the 74 DAF patterns. Significant genome polymorphism, as determined by DAF
profiling, exists among isolates from clinical, poultry and veterinary sources, which
complicates the definition of the organisms’ molecular epidemiology. Furthermore,
the present observations support those of Mazurier et al. (1992), who previously
reported genome heterogeneity among Campylobacter strains (even within the same
serotype) following DNA fingerprint analysis. Nevertheless, the HLWL85 primer
could distinguish between Camp, jejuni and Camp. coli.

For the 36 human isolates, each from a different patient, 32 DAF types were
identified. Two independent isolates cultured on the same day were indistinguishable
by DAF type, suggesting a possible link. A further three isolates, each cultured from a
different patient within a one-week period, were indistinguishable by DNA
fingerprinting. Finally, two isolates which were isolated within a four-week period
could not be distinguished. In none of these cases was an outbreak suspected,
contrary to the molecular data obtained. Poultry has been identified as the most
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common source of human Campylobacter enteritis, both through consumption of
inadequately-cooked chicken, and cross-contamination of kitchen utensils and other
foods (Lior 1992). Of the 30 poultry isolates of Camp, jejuni only two isolates were
indistinguishable. No DAF banding pattern observed for any poultry isolates matched
those of any human-derived isolates, with the exception of the three poultry and one
human isolate for which only a single band of DNA was amplified. The genomic
diversity of 36 human isolates appeared to demonstrate at least 32 different potential
sources of infection. Previously, Pebody et al. (1997) suggested that while
Campylobacter represents the commonest enteric pathogen cultured from humans in
England and Wales since 1981, few cases are linked to outbreaks. The latter view,
when taken together with data from this study, may support the hypothesis that
Campylobacter spp. from food animals and humans may not be represented by
discrete populations, but rather form part of a common population shared by food
animals and humans. Furthermore, this study shows that the potential sources of the
majority of clinical Campylobacter enteric infections are difficult to identify. The
latter contrasts with findings from similar studies on Salm. enterica serotype
Typhimurium DTI04, wherein DAF profiles are indistinguishable in most cases,
suggesting a clonal origin for this organism (Daly et al. 2000). Flowever, molecular
typing techniques may be useful in defining localised outbreaks, provided that
sufficient technical consideration is given to the genomic diversity existing in this
organism.
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4.1. Abstract
Resistance to antimicrobial agents used to treat severe Campylobacter spp.
gastroenteritis is increasing worldwide. We assessed the antimicrobial resistance
patterns of Campylobacter spp. isolates of human and animal origin. More than half
(n = 32) were resistant to sulphonamide, a feature known to be associated with the
presence of integrons. Analysis of these integrons will further our understanding of
Campylobacter spp. epidemiology.
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4.2. Introduction/Materials and Methods/Results/Discussion
Campylobacter spp. are isolated from a wide range of animals and birds, and also
from the environment, particularly from surface water. Poultry have been implicated
as a significant source of sporadic infection (1). Themophilic Campylobacter spp.,
particularly C. jejuni and C coli are recognised as one of the aetiological agents of
acute diarrhoeal disease in humans worldwide (2, 3). Antimicrobial chemotherapy is
usually reserved for patients with advanced infection or patients prone to relapses.
Erythromycin, fluoroquinolones and tetracycline are the antimicrobial drugs of choice.

Bacterial resistance to antimicrobial agents which is increasing worldwide, is
frequently caused by the acquisition of new genes, rather than by mutation (4, 5). An
efficient means of acquiring new genes is by mobile genetic elements such as
resistance (R)-plasmids and transposons. Recently, a novel class of naturallyoccurring mobile genetic element, integrons, have been described as vehicles for the
acquisition of antimicrobial resistance genes (5). Horizontal and vertical transfer can
occur readily as shown by the widespread acquisition of these gene cassettes among
the Enterobacteriaceae and Pseudomonas spp. Integrons comprise two conserved
structural regions (5’CS and the 3’CS) flanking an internal variable region containing
one or more site-specific recombined gene cassettes. While most known cassetteassociated genes located distal to the 5’CS region encode resistance to antimicrobial
drugs, some cassettes may include one or more open reading frames (ORE) whose
product(s) and corresponding function(s) remain to be defined (5). In the 3’CS
downstream of the gene cassette are two genes, one of which encodes resistance to
quaternary ammonia compounds {qacEd^X) while the other is the sulphonamide
resistance determinant {sull). Antimicrobial resistance among Campylobacter spp. to
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drugs used in the treatment of human infection is increasing (6-8). This article reports
the results of an investigation of a collection of Irish thermophilic Campylobacter spp.
cultured from clinical cases of gastroenteritis, and from porcine and poultry sources.
We studied a representative sample of 55 isolates (47 C. jejuni and 8 C. coli isolated
between 1996 and 1998), cultured from intestinal tissue of animals at slaughter, and
from human faecal samples.

Antimicrobial agent susceptibility tests were performed using the agar diffusion
method on IsoSensitest agar (Difco, Dublin, Ireland) with 5% horse blood (9).
Cultures were prepared by inoculating colonies from a fresh, pure 24-hour culture into
sterile distilled water to give an inoculum turbidity equivalent to a 0.5 McFarland
turbidity standard. The McFarland standard was prepared by adding 0.5 mL 0.048 M
BaCb to 99.5 mL 0.18 M H2SO4 with constant stirring. Samples were swabbed
evenly onto agar plates and allowed to dry. Twelve antimicrobial agents were tested
on discs. Antimicrobials tested together with their abbreviation and corresponding
concentrations in parentheses included: ampicillin (Ap, 10 pg/disc), chloramphenicol
(C, 10 pg/disc), ciprofloxacin (Cp, 5 pg/disc), colistin (Ct, 25 pg/disc), erythromycin
(E, 5 pg/disc), gentamicin (G, 10 pg/disc), nalidixic acid (Na, 30 pg/disc),
spectinomycin (Sp, 10 pg/disc), streptomycin (S, 25 pg/disc), sulphafurazole (Su, 100
pg/disc), tetracycline (T, 10 pg/disc) and trimethoprim (Tm, 1.25 pg/disc). The plates
containing the antibiotic discs were incubated at 37°C under microaerophilic
conditions for 24 hours. Inhibition zone sizes were recorded according to the
guidelines of the National Committee for Clinical Laboratory Standards (10).
Resistance profiles were further confirmed by E-Test (AB Biodisc, Solna, Sweden).
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Table 1. Isolates of Campylobacter coli and Campylobacter jejuni from which
gene cassette-like structures were amplified: year of isolation, R-type and gene
cassette IP-profile
Isolate No.
C. jejuni
C1T-H7
C1T-H8
CIT-H9
CIT-HIO
CIT-H12
CIT-HI4
CIT-H15
C1T-HI6
CIT-H22
CIT-H25
CIT-H26

crr-P4
C1T-P5
CIT-H30
crr-H31
CIT-PIO
CIT-P13
CIT-PI4
C1T-P15
C1T-P16
CIT-H29
C1T-P7
CIT-P8
C1T-P9
CIT-P6
CIT-Pll
CIT-P17
CIT-HII
CIT-H13
CIT-P12
CIT-H24
CIT-H27
CIT-H1
CIT-Pl
CIT-H2
CIT-H3
CIT-H4
CIT-H5
C. coli CIT-P3
CIT-V3
CIT-V6
CIT-Vl
CIT-V4
CIT-V5
CIT-V2
C. jejuniCM-1123
CIT-H28
C. coli CIT-P2
Cjejuni CM-H\9
CIT-H 17
C1T-H21
CIT-H32
C1T-H18
CIT-H20

Year of isolation
1997
1996
1997
1997
1997
1997
1997
1996
1997
1996
1997
1997
1997
1997
1Q97
1996
1997
1996
1996
1996
1996
1997
1997
1997
1997
1997
1996
1997
1997
1997
1996
1997
1997
1996
1997
1996
1997
1996
1997
1996
1998
1998
1998
1998
1998
1998
1996
1997
1997
1997
1996
1997
1996
1997
1996

R-type
SpSuTm
SpTm
ApSpTm
SpTm
Tm
NaSpTm
SpTm
SpTm
SpTIm
SpSu'fm
SSpTm
ApSpfm
TTm
SpSuTm
SiiTTm
SpSuTm
SpTm
NaTm
SuTTm
SpSuIfm
ApSpSuTTm
SuTm
NaSufm
SpSu Im
/
SpSuTm
NaSpTm
HSpSuIm
ApSpSuTm
ApCSpfm
CtNaSpSuTTm
ApNaTm
NaSSpSuTm
SpSuTm
SpSuTm
SpSu'fm
SuTTm
SpSu'fm
SuTm
EGSSpSufm
ESpTTm
CCpENaSSp ITm
SpSuTm
SSpTTm
ESSuTTm
ESSpSu'ITm
SpSuTm
Cffm
SpSuTm
SpSuTm
ApCtENaSSpSuTTm
SpSu'fm
SSpSuTm
ApCtSSpSuTm
ApSpTm
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IP-profile
I
I
I
I
I
I
I
I
I
1
I
I
I
1
I
I
I
1
I
I
I
II
II
II
II
III
III
III
IV
IV
V
VI
VII
VIII
IX
X
XI
XII
XIII
XIV
XIV
XIV
XV
XVI
XVI
XVI
XVll
XVlIl
XIX
XX
XXI
XXI
XXI
XXII
XXII

Control strainst
E. coh [R 100.1]
E. co//[R751]
S. Typhimurium

/

/

/

/

1998

ACSSuT

CIT-F 100

Notes:
H = hospital isolate; P = poultry isolate; V = veterinary isolate;
/ = not available or not determined.
Antimicrobial agents: Ap=ampicillin; C=chloramphenicol; Cp=Ciprofloxacin;
Ct=colistin; E=erythromycin; G=gentamicin; Na=nalidixic acid; S=streptomycin;
Sp=spectinomycin; Su=sulphafurazole; T=tetracycline and Tm=trimethoprim.
t E. coli and Salmonella enterica serotype Typhimurium control strains. The former
carried plasmids R 100.1 and R752 respectively these were kindly provided by Dr. D.
Sandvang (13). Salmonella Typhimurium DTI 04 [CIT-F 100] was previously
characterised by Daly M., et al. (14).

Briefly, 17% of all isolates were resistant to ampicillin, 3.8% to chloramphenicol,
1.9% to ciprofloxacin, 7.5% to colistin, 11.3% to erythromycin, 1.9% to gentamicin,
17% to nalidixic acid, 77.4% to spectinomycin, 20.8% to streptomycin, 62.3% to
sulphonamide and 24.5% to tetracycline. Many of the isolates tested (n = 42, 77%)
were resistant to three or more antimicrobial agents and part of the R-type included
SSpTm, among others. Two strains, C. jejuni CIT-H17 (R-type:
ApCtENaSSpSuTTm) and C. coli CIT-V6 (R-type: CCpENaSSpTTm), were
particularly resistant (Table 1); both were resistant to nalidixic acid and the latter was
also resistant to ciprofloxacin. In reviewing the R-types among the collection, the
presence of sulphonamide resistance (in 62.3% of the collection) suggested that
integron-like structures may exist in Campylobacter spp.

To test the latter hypothesis genomic DNA was purified from all isolates (11). Using
the oligonucleotide primers Int 1 F 5’-GGC ATC CAA GCA GCA AG-3’ and Int 1 R
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5’-AAG CAG ACT TGA CCT GA-3’ designed to anneal to the 5’CS and 3’CS
flanking regions (12) of integrons, we tested the Campylobacter spp. genome by
polymerase chain reaction (PCR) for the presence of putative gene cassettes.
Escherichia coli containing the characterised plasmids RlOO.l and R751 (13) together
with CIT-F 100, a Salmonella enterica serotpye Typhimurium DTI04 strain cultured
from a contaminated food source (14), were included as controls. Gene cassettes of
1.0-kb and 800 bp respectively from E. coli (data not shown) and 1.0- and 1.1-kb
(Figure la, lane 2), from S. Typhimurium were detected post-amplification. These
amplicon profiles were designated as integron pattern (IP)-groups A, B and C
respectively (Table 1). After amplification and conventional agarose gel analysis of
all Campylobacter spp. isolates in the study population, DNA amplicons of 230 bp to
1.47 kb were detected. A total of 22 gene cassette structures were identified (Figure
2). The most commonly occurring amplified gene cassette pattern was designated IPgroup I, consisting of four DNA fragments ranging from 350 to 700 bp (Figure 2,
lane 1 and Figure la, lane 1). This gene cassette pattern was present in both poultry
and clinically-derived C. jejuni, accounting for 38% of strains. IP-group II (Figure 2,
lane 2) accounted for 7% of all C. jejuni isolates only. The IP-groups III (Figure 2,
lane 3), XIV (Figure 2, lane 14), XVI (Figure 2, lane 16) and XXI (Figure 2, lane
21) each accounted for 6% of the collection, with IP-groups XIV and XVI being
unique to C. coli. All other IP-groups (Table 1, Figure 2) were represented by single
isolates. A 350 bp amplified DNA fragment was common to all isolates, with the
exception of the poultry-derived C coli CIT-P2 and a clinical isolate C. jejuni CITH3. Amplicons of 230 and 250 bp were conserved among C coli isolates only.
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la

lb

Ic

I 175 bp.

Figure 1.
a. Agarose (1.5%) gel electrophoresis in lx TAE but'fer containing 0.5 pg/mL
ethidium bromide. Purified genomic DNA was used as the template in a PCR
reaction with the primers Int 1 F 5’-CjGC AIC CAA GCA CGA AG-3 and Int 1
R 5'-AAG CAG ACT I GA CCl GA-3' (12). Lane M contains an equal mixture
of molecular weight markers grades 111 and V (Boehringer Mannheim, Germany).
Fane N is the negative containing all reaction components with the exception of
template DNA, Fane 1, Campylobacter coli CIT-H 6 (lP-1); Fane 2, Salmonella
ryphimurium DTI04 CTT-F 100 (IP-C).
b. As in a above except that the primers used were qacEls.\ F 5'-Al'C GCA A l A
GTT GGC GAA G1-3' and qacEA\ B 5'-CAA GCT TFT GCC CAT GAA GC-3’
(13).
c. As in a above using primers sull F 5’-C FT CGA FGA GAG CCG GCG GC-3
and sull B 5'-GCA AGG CGG AAA CCC GCG CC-3’ (13).

Three putative gene cassettes of 243, 388 and 466 bp were cloned after amplification
by using the Int 1 F and Int 1 R primers (4, 12) as described above. All were
sequenced by automated methods. Sequencing data showed a short imperfect inverted
repeat element at the 3’ end of the cloned fragments which represented the 59 base
element [5’-GTTRR-3’]. This is the target for site-specific recombination involved in
the insertion and excision of gene cassettes (4, 5, 15). Isolates were also tested for the
5’ CS encoded integrase (int), and the 3’ CS encoded qacEAX and sull genes by PCR.
A DNA fragment of 225 bp was detected after amplification and agarose gel analysis
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(Figure lb, lane 1) using primers qacFAX F 5’-ATC GCA ATA GTT GGC GAA GT3’ and qacE^\ B 5’-CAA GCT TTT GCC CAT GAA GC-3’ (13). The latter
fragment corresponded with a similar sized amplicon in S. Typhimurium (Figure lb,
lane 2). The 3’-CS region of integrons, known to contain a sul\ gene was similarly
tested with the primers sull F 5’-CTT CGA TGA GAG CCG GCG GC-3’ and sull B
5’-GCA AGG CGG AAA CCC GCG CC-3’ (13). When compared with a S.
Typhimurium DTI04 amplicon of 436 bp (Figure Ic, lane 2) (13), the Campylobacter
spp. sull primer-derived DNA fragment (Figure Ic, lane 1) appears smaller at
approximately 360 bp. Nevertheless, the latter amplicon was consistently amplified
from all Campylobacter spp. Smaller 5w/7 primer-generated DNA fragments were
also detected in S. Typhimurium after PCR and gel analysis (14). These may derive
from the partial sull genes recently located in a 14-kb gene cluster on the
chromosome of S. Typhimurium (16). On probing the Campylobacter spp. sull
primer-derived amplicon (Figure Ic, lane 1) with the digoxigenin-labelled 436 bp S.
Typhimurium sull DNA amplicon (Figure Ic, lane 2) no hybridising signal was
detected (data not shown). This result suggests that the Campylobacter spp. sull gene
is different when compared to S. Typhimurium. To investigate the 5’-CS region,
primers (inti F [Tn27]: 5'-GAA GAC GGC TGC ACT GAA CG-3' and inti R
[Tn27]: 5'-AAA ACC GCC ACT GCG CCG TTA-3’) were designed to amplify a 1.2kb DNA fragment from the integrase gene of Tn27 and were tested against
Campylobacter spp. and S. Typhimurium (Table 1). The predicted amplicon was
detected in the latter together with two smaller amplimers of 270bp and 450 bp.
These latter PCR products (270bp and 450 bp) were also identified in Campylobacter
spp. (data not shown), consistent with a deleted form of a class 1 integrase gene in
these isolates.
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Figure 2. Schematic representation of all amplified gene cassettes from
Campylobacter spp. in the study population. Roman numerals refer to the designated
integron pattern (IP)-type assigned to each pattern.

The DNA sequences from the amplified cassettes (of 243 bp, 388 bp and 463 bp)
above were also searched using the BLAST search tool (17). GenBank accession
numbers were assigned as follows; ATI 55357 (243 bp gene cassette); AFl 55356
(388 bp gene cassette), and AT 152561 (463 bp gene cassette). The former amplicon
contains two ORFs. No corresponding sequences were identified in the database. The
388 bp amplicon also contained two ORFs and did not match any sequences when
subjected to a BLAST search of the current databases. Finally, the larger 463 bp
amplicon contained two incomplete ORFs. Interestingly BLAST searches using the
latter sequence identified glycyl-tRNA synthetase from the genome of Helicobacter
pylori matching 102 (85%) of 119 nucleotides. Further characterisation of other gene
cassettes is in progress, focusing on amplicons of 700 bp and greater.

Drug selection may promote recombinational events between Campylobacter spp.,
Enterobacteriaceae and other Gram-negative organisms (15). A common habitat for
these organisms is the human and animal gastrointestinal tract. Modem animal
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husbandry promotes the use of large animal housing facilities, thereby ensuring
genetic interconnection between large populations of bacteria. Campylobacter spp.
have a natural ability for transformation (18), and in shared animal reservoirs,
interspecies transfer of DNA, including antimicrobial resistance encoding genes and
other unrelated genes, may occur by strategies analagous to site-specific
recombination (19,20). Our findings may indicate a novel mechanism by which
unrelated DNA becomes incorporated into cells (21). Detailed characterisation of
integron-like structures in these organisms is an essential step in understanding the
role(s) of these novel genetic elements. The existence of these structures may have
interesting implications regarding the diversity of the Campylobacter spp. genome and
the evolution of this species. Together with the corresponding DNA fingerprint
profile (Lucey B., Fanning S., manuscript in preparation) the variation in genetic
content and structure of these determinants may be used as a potential tool in
elucidating the epidemiology of Campylobacter spp. (22, 23).
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4.5. Assessment for class 1 integrons of a large collection of Campylobacter
strains isolated during the year 2000
A collection of 378 isolates was screened for the presence of integron-like structures.
This collection was comprised of 272 poultry and 106 human isolates, of which 319
were identified as C. jejuni, a further 54 as C. coli and the remaining 5 isolates were
identified as Campylobacter spp. only. Total genomic DNA was isolated as
previously outlined in Section 2.2.4.2. Integron analysis was performed by PCR,
using the oligonucleotide primers Inti F 5’-GGC ATC CAA GCA GCA AG-3’ and
Inti R 5’-AAG CAG ACT TGA CCT GA-3’ designed to anneal to the 5’- and 3’-CS
flanking regions of class 1 integrons, containing the recombined gene cassette, as
described in Section 4.2. This primer set was selected to amplify any integrated gene
cassettes present. PCR reactions were performed as outlined previously in Section
2.2.6.7.I.

Table 2 summarises the prevalence of integron-like structures among the collection.
No amplicons were detected in 15.9% of the isolates, which included human and
poultry isolates, and both C. jejuni and C. coli. A total of 67.5% of isolates contained
amplicons of not more than 700 bp long (data not shown). A fragment of 1,000 bp in
size (with additional smaller fragments) was detected among 15.8% of C. jejuni and
C. coli isolates, both from human and poultry sources. Amplicons greater than 1,000
bp in size were detected in two strains only (0.5%); both of which were poultryderived C. coli isolates. In all, several combinations of amplicons were observed, as
shown in Figures 3a and 3b. These ranged in size from approximately 150 to 1,100
bp. A total of 62 isolates were shown to have a cassette structure of approximately
1,000 bp in size, of which 54 were identified as C. jejuni', the remaining eight isolates
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were identified as C coli. Fifty-five of these isolates were from poultry and the
remaining seven were of human origin. This amplicon was of particular interest due
both to its larger size, and the frequency with which it was detected among the
collection. Furthermore, amplicons of <500 bp had previously been characterised (see
Sections 4.1 to 4.4) and were previously found to contain incomplete ORFs.
Amplified DNA fragments of this size were not considered further on this occasion.
[A 700 bp fragment was sequenced, and contained a partial ORF. A BLAST search of
this sequence identified glycyl-tRNA synthetase from the genome of Helicobacter
pylori (data not shown), similar to the sequence described in the GenBank Accession
number AFl52561 (463 bp amplicon) detailed earlier in Section 4.2].

Table 2. Detection of integron-like structures (gene cassettes) among Campylobacter
spp. isolated during the year 2000 using the primers Inti F and Inti R.
INTEGRON PATTERN

No of isolates (%)

Number of integrons identified

60(15.9)

DNA fragments 700 to 1,000^

60 (15.8)

DNA fragments >1,000 bp

2 (0.5)

UNote: It is estimated that the average size of a bacterial ORF is approximately 800
bp. Therefore, it would seem prudent to sequence any cassette that was within an 800
to 1,000 bp size range (Lucey et al, 2000).

Sequence analysis of the 1,000 bp sized amplicons was essential to establish the
identity of the integrated gene cassette(s). A greater proportion of the integron
structure was generated (see Figure 4 for a schematic diagram of a class 1 integron)
by amplifying a sequence extending to regions flanking the gene of interest. This was
achieved using the primer combination intll F (5’-GGC ATC CAA GCA GCA AGC-
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3’) and sull R (5’-GCA AGO CGG AAA CCC GCG CC-3’), in a PCR reaction
protocol detailed in Section 2.2.6.7.1, (and incorporating an annealing temperature of
57°C). Four representative isolates were investigated, namely CIT-134, -186,-195
and -325. All four isolates were of poultry origin; and were identified as C. jejuni (3)
M12

3
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789 10 11 12 M

1,375 b
947 bp
587 bp

•

--1

267 bp
124 bp
3a

M1234

56789

1,375 bp
947 bp
587 bp
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Figures 3a and 3b. Multiple amplicons among Campylobacter spp. ranging in size
from approximately 150 to 1,100 after Inti PCR. Figure 3a. Lane M, Grade III and
V molecular weight markers; Lane 1, fragments <587 bp; Lane 2, fragments <700 bp;
Lane 11, fragments <1,000 bp. Figure 3b. Lane M, Grade 111 and V molecular
weight markers; Lane 6, fragments include >1,100 bp.

and C. coli (1). PCR products were purified as outlined in Section 2.2.11, and
sequencing was performed by MWG Biotech (Milton Keynes, UK), which generated
sequences that did not extend (read) to the sull gene. These sequences were initially
compared against the current databases by analysis using the BLAST (Altchul et al,
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1997) suite of programmes, (http://www.ncbi.nlm.nib.gov/BLAST/) and a class 1
integron structure was identified that contained a single ORF corresponding to 264
amino acids. A 1,392 bp sequence from the isolate CIT-134 is shown as an example
in Figure 5. The ORF was identified as encoding an aminoglycoside
adenyltransferase (aadAl), which confers resistance to streptomycin and
spectinomycin. This ORF extends from an ATG codon at nucleotide position 139 bp
to a TGA (stop) codon at nucleotide position 928 bp. Amino acid sequence alignment
of these sequences to existing a^/J-encoding polypeptides was performed over the
internet using the CLUSTALW (Thompson et ai, 1994) alignment programme
(http://www2.ebi.ac.uk/clustalw) and this demonstrated very close similarities to these
proteins (Figure 6), differing only by a few amino acid substitutions from the
published sequences for a number of enteric pathogens including Salmonella
serovars.. Shigella flexneri., Aeromonas salmonicida and Vibrio cholerae. A 1,392 bp
sequence shown for CIT-134, includes a partial intll gene, the complete aadA2 gene
and a partial qacEAl gene. Following BLAST analysis, this sequence aappears to
have diverged from a published Salmonella enterica Typhimurium class 1 integron
sequence by only four nucleotide bases, three of which were located within the aadA2
gene. These point mutations corresponded to Gln-12-Arg [CTA^CGA] - a transition
mutation, Val-38-Glu [G/G-^GTG] and Phe-249-Leu [/TT^( TT] - both
transversion mutations. The fourth point mutation was located in the qacEAl gene.
To date no published sequences have linked the aadA gene with Campylobacter spp.
We believe that this is the first report of such an intact gene cassette within this
organism. The high degree of sequence identity observed among these enteric
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pathogens suggests that class 1 integrons permit not only interspecies transfer of
genetic material via gene cassettes, but also allow transfer between separate genera.

There are a number of additional features associated with the aadA2 gene, which are
shown in Figure 5. Firstly, the gene features a string of seven bases (-AGACATC-)
between the GTT insertion {attl) site and the ATG start codon at its 5’ end (Stokes
and Hall, 1989). This GTT triplet is found at the end of both conserved segments, but
it is the only obvious feature that attl shares with the 59-be. The 59-be recombination
site for aadA2 is 60 bases in length (Recchia and Hall, 1997), and extends in this
sequence from nucleotides 932 to 961. As for other gene cassettes, this recombination
site is flanked at the 5’ end by the inverse core sequence RYYYAAC (here,
GTCTAAC ) from bases 932 to 938, and at the 3’ end by the forward core sequence
GTTRRRY (Francia et al., 1997), which in this case has the combination GTTAGAT.

^ kb amplified gene cassege

GTTAG AT

int

GTTRRRY

Figure 4. Schematic representation of a class 1 integron containing gene cassette inserted
at the attl insertion point. Also shown are the relative locations of the intll, qacEAl and
sull genes. Pi is an integron-associated promoter, and Pint is the intll promoter. Included
(in the box) is the 59-base element (59-be) recombination site for the aadA2 gene, shown
with the concensus sequence (lower).
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1

GAA TTGAA TTTAG CGGCC GCGAA TTCGC CCTTG GCATC CAAGC AGCAA

49 GCGCG TTACG CCGTG GGTCG ATGTT TGATG TTATG GAGCA GCAAC GAT
97 GT TACGC AGCAG GGCAG TCGCC CTAAA ACAAA G I TAG ACATC ATC AGG
Met Arg
145 GTA GCG GTG ACC ATC GAA ATT TCG AAC CGA CTA TCA GAG GTG CTA AGC
Val Ala Val Thr He Glu He Ser Asn Arg Leu Ser Glu Val Leu Ser
193 GTC ATT GAG CGC CAT CTG GAA TCA ACG TTG CTG GCC GTG CAT TTG TAC
Val He Glu Arg His Leu Glu Ser Thr Leu Leu Ala Val His Leu Tyr
241 GGC TCC GCA GAG GAT GGC GGC CTG AAG CCA TAC AGC GAT ATT GAT TTG
Gly Ser Ala Glu Asp Gly Gly Leu Lys Pro Tyr Ser Asp He Asp Leu
289 TTG GTT ACT GTG GCC GTA AAG CTT GAT GAA ACG ACG CGG CGA GCA TTG
Leu Val Thr Val Ala Val Lys Leu Asp Glu Thr Thr Arg Arg Ala Leu
337 CTC AAT GAC CTT ATG GAG GCT TCG GCT TTC CCT GGC GAG AGC GAG ACG
Leu Asn Asp Leu Met Glu Ala Ser Ala Phe Pro Gly Glu Ser Glu Thr
385 CTC CGC GCT ATA GAA GTC ACC CTT GTC GTG CAT GAC GAC ATC ATC CCG
Leu Arg Ala He Glu Val Thr Leu Val Val His Asp Asp He He Pro
433 TGG CGT TAT CCG GCT AAG CGC GAG CTG CAA TTT GGA GAA TGG CAG CGC
Trp Arg Tyr Pro Ala Lys Arg Glu Leu Gin Phe Gly Glu Trp Gin Arg
481 AAT GAC ATT CTT GCG GGT ATC TTC GAG CCA GCC ATG ATC GAC ATT GAT
Asn Asp He Leu Ala Gly He Phe Glu Pro Ala Met He Asp He Asp
529 CTA GCT ATC CTG CTT ACA AAA GCA AGA GAA CAT AGC GTT GCC TTG GTA
Leu Ala He Leu Leu Thr Lys Ala Arg Glu His Ser Val Ala Leu Val
577 GGT CCG GCA GCG GAG GAA TTC TTT GAC CCG GTT CCT GAA CAG GAT CTA
Gly Pro Ala Ala Glu Glu Phe Phe Asp Pro Val Pro Glu Gin Asp Leu
625 TTC GAG GCG CTG AGG GAA ACC TTG AAG CTA TGG AAC TCG CAG CCC GAC
Phe Glu Ala Leu Arg Glu Thr Leu Lys Leu Trp Asn Ser Gin Pro Asp
673 TGG GCC GGC GAT GAG CGA AAT GTA GTG CTT ACG TTG TCC CGC ATT TGG
Trp Ala Gly Asp Glu Arg Asn Val Val Leu Thr Leu Ser Arg He Trp
721 TAC AGC GCA ATA ACC GGC AAA ATC GCG CCG AAG GAT GTC GCT GCC GAC
Tyr Ser Ala He Thr Gly Lys He Ala Pro Lys Asp Val Ala Ala Asp
769 TGG GCA ATA A AA CGC CTA CCT GCC CAG TAT CAG CCC GTC TTA CTT GAA
Trp Ala He Lys Arg Leu Pro Ala Gin Tyr Gin Pro Val Leu Leu Glu
817 GCT AAG CAA GCT TAT CTG GGA CAA AAA GAA GAT CAC TTG GCC TCA CGC
Ala Lys Gin Ala Tyr Leu Gly Gin Lys Glu Asp His Leu Ala Ser Arg
865 GCA GAT CAC TTG GAA GAA CTT ATT CGC TTT GTG AAA GGC GAG ATC ATC
Ala Asp His Leu Glu Glu Leu He Arg Phe Val Lys Glu Glu He He
913 AAG TCA GTT GGT AAA TGA TGTCT AACAA TTCGT TCAAG CCG AC CGCGC
Lys Ser Val Gly Lys
961 TACGC GCGGC GGCTT AACTC CGGCG TTAGA TGCAC TAAGC ACATA ATT
1009 GC TCACA GCCAA ACTAT CAGGT CAAGT CTGCT TTTAT TATTT TTAAG C
1057 GTGC ATAAT AAGCC CTACA CAAAT TGGGA GATAT ATC AT GAAAG GCTG
1105 G CTTTT TCTTG TTATC GCAAT AGTTG GCGAA GTAAT CGCAA CATCC GC
1153 ATT AAAAT CTAGC GAGGG CTTTA CTAAA CTTGC CCCTT CCGCC GTTGT
1201 CATAA TCGGT TATGG CATCG CATTT TATTT TCTTT CTCTG GTTCT GAA
1249 AT CCATC CCTGT CGGTG TTGCT TATGC AGTCT GGTCG GGACT CGGCG T
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1297 CGTC ATAAT TAG AG CCATT GCCTG GTTGC TTCAT GGGCA AAAGC TTGA
1345 A GGGCG AATTC GTTTA AACCT GCAGG ACTAG TCCCT TTAGT GAGGG

Figure 5. DNA sequence of an amplified 1,390 bp DNA fragment from a class 1
integron contained within Campylobacter jejuni CIT-134 (poultry origin). This sequence
contains the complete coding sequence for an aadA2 gene. The ORF (blue) extends from
the ATG codon (green) at position 139 bp, extending to a TGA stop codon (red) at
position 928 bp. Further sequences are involved in site-specific recombination (purple),
and also shown is the incomplete qacEAl gene (turquoise).

Features:
..1..131 - 5’ conserved segment of class ) integron (showing partial gene sequence for
inti I gene)
129.. 131 - GTT insertion site
132.. 138 - Seven bases (-AGACATC-) between GTT insertion site and the start codon at
the 5’ end characteristic of the aadA gene.
139.. 141 - ATG - start codon
139.. 931 - aadA2 gene
928.. 930 - TGA - stop codon denoted by
932.. 991 - 59-base element
936.. 938 - AAC inverted repeat of GTT
985.. 987 - GTT recombination site
1094.. >1390 - qacEAl gene
1094.. 1096 - ATG - start codon

162

60
CIT-134
AF261825
AF327728
AF221903
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MRVAVTIEISNRLSEVLSVIERHLtSTLLAVHI.YGSAEDGGI.KPYSDlDTLVTVAVKLDE
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MRVAVTIEISNOLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
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CIT-134
AF261825
AF327728
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TTRRAEENDl.Ml ASAFPGESETLRAJEVTLVVUDDIIPWRYPAKRELQFGEWQRNDIEAG
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
TTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKREI.QFGEWQRNDILAG
TTRRALLNDLMI ASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAG
TTRRAELNDEMKASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWORNDILAG

CIT-134
AF261825
AF327728
AF22I903
AF71555

IFEPAMIDIDI.AILLTKAREHSVALVGPAAEEFFDPVPEQDEFEALRETLKI.WNSQPDWA
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
IFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWA
IFEPAMIDIDLAILL'FKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSOPDWA

CIT-134
AF261825
AF327728
AF221903
AF71555

GDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKOAYLGOKEDHLA
GDERNVVLTESRIWYSAITGKIAPKDVAADWAIKREPAOYQPVLLEAKQAYLGOKEDIIEA
GDERN V VLTLSRIW YSAn GKIAPKDVAADWAIKRLPAQYQP VLl.EAKQAYLGQKEDHLA
GDERNVVI.TLSRIWYSA1TGKIAPK(jVAADWAIKREPAQYQPVEEEAKOAYLGQKEDIILA
GDERNVVLTLSRIWYSAUGKIAPKDVAADWAIKRLPAQYQPVLLEAKOAYLGOKEDHLA

CIT-134
AF261825
AF327728
AF221903
AF7I555

SRADHLEEl IRFVKGEIIKSVGK
SRADIIEEEIIRFVKGEIIKSVGK
SRADHLEEFIRFVKGEIIKSVGK
SRADI lEEEFIRFVKGElIKSVGK
SRADHLEEFIRFVKGEIIKSVGK

80

240

263

:(c:4e ^

Figure 6. Alignment of deduced amino acid sequences of the CIT-134 Campylobacter
jejuni aadA2 gene, along with other closely related aadA2 genes from the current version
of GenBank®. Amino acid substitutions identified in CIT-134 after sequencing are
shown in blue (and arrowed above the alignment), and these correspond to Gln-12-Arg
[C^A^CGA], Val-38-Glu [GTG^G/IG] and Phe-249-Leu [7TT->CTT]. The
sequences differ from one other at three other locations and are shown in green (arrowed
above the alignment). Details of the accession numbers are as follows: AF261825,
Salmonella Enteritidis; AF327728, Aeromonas salmonicida; AF221903, Vibrio cholerae
and AF71555, Salmonella Typhimurium.
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5.1. Abstract
Antimicrobial susceptibility of Campylobacter isolates to six commonly-prescribed
antibiotics, including erythromycin, tetracycline and ciprofloxacin was determined. The
collection was comprised of 130 Campylobacter jejuni isolates and 15 Campylobacter
coli isolates cultured from human and poultry sources during 2000. These data were
compared to a previous collection of strains isolated between 1996 and 1998. Changes in
antimicrobial susceptibility patterns were noted. Erythromycin remains an effective
antimicrobial agent with low levels of resistance being encountered (2% and 4.4% for
human and poultry isolates, respectively). Resistance to tetracycline was moderately
increased (31% and 24.4% versus 13.9% and 18.8% during the earlier period, for human
and poultry isolates, respectively). However, the most marked change occurred for
ciprofloxacin, where resistance rates for strains isolated during 2000 increased to 30%, in
contrast to previous data from 1996-1998 which showed no resistance to this agent
among human isolates, and only 3.1% resistance among poultry isolates. The underlying
molecular basis for this resistance was previously shown to be the result of a single amino
acid substitution, Thr-86-Ile, in the gyrA subunit of DNA gyrase in Campylobacter jejuni.
A subset of 59 isolates was tested by molecular methods and, of 25 phenotypically
resistance isolates, all possessed the latter substitution. None of the human isolates had
been treated with ciprofloxacin prior to laboratory isolation. Since Campylobacter is
primarily a zoonotic organism whose main source in human infection has been shown to
be poultry, it is likely that ciprofloxacin resistance had a foodbome basis that was either
domestic or imported in origin.
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5.2. Introduction
Campylobacter is currently the most commonly-reported bacterial cause of human
enteritis in developed countries (Pebody et al. 1997). Compared to other foodbome
pathogens, most infections appear to be sporadic and person-to-person transmission is
rare. Furthermore, clinical symptoms of Campylobacter spp. infection are difficult to
distinguish from those of other enteric pathogens, necessitating laboratory confirmation.
Data available from Infoscan (Communicable Disease Reports for the area covered by the
Southern and South-Eastern Health Board Regions of Ireland with a population of 1.5
million people) between 1995 and 2000 has shown an increase in the number of
isolations over each yearly period. Notifications of infection in Ireland reached
57.5/100,000 in 1999 (data from the National Disease Surveillance Centre, 1999.
Website: ww^.ndsc.ie). There has, however been a corresponding decrease in the
number of salmonella notifications during the same period.

Campylobacter enteritis is primarily a zoonosis, and chicken has been shown to be the
most common cause of infection in both sporadic infections and outbreaks (Lior 1996).
We previously reported Campylobacter susceptibility rates for a number of antimicrobial
agents during 1996-1998 (Lucey et al. 2000). While most human enteric Campylobacter
infections are self-limiting, it is important to be able to treat severe or recurrent infection.
In this paper we report changing trends in resistanee rates for Campylobacter jejuni (C.
jejuni) and Campylobacter coli (C. coli) isolates from human and poultry sources during
2000.
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5.3. Materials and Methods
5.3.1. Bacterial isolates
A total of 145 isolates were included in the study. The collection was comprised of 100
strains cultured from patients with clinically confirmed enteritis and 45 poultry isolates.
All isolates were obtained during the year 2000. Clinical faecal samples were inoculated
onto Preston Agar (Campylobacter Agar Base, Oxoid CM689, containing Campylobacter
Selective Supplement SRI 17E and 5% (v/v) lysed horse blood), and incubated
microaerophilically (using an Oxoid BR056A Campylobacter Gas Generating Kit) for 48
h at 42°C. Poultry isolates were obtained from the Food Safety Authority of Ireland
culture bank, representing both domestic and imported sources.

5.3.2. Bacterial identification
Bacteria were initially identified using the following parameters: typical microscopic and
colonial morphology, positive oxidase and catalase tests, and hippurate hydrolysis (the
hippuricase gene being unique to C. jejuni among the Campylobacter species).
Biochemical tests were carried out on isolates grown on Columbia Blood Agar (Columbia
Agar Base CM331 with 5% (v/v) defibrinated horse blood). Further confirmatory tests
included species-specific Polymerase Chain Reaction (PCR) (Fyers et al. 1993) for all
isolates and API Campy (bioMerieux, Marcy I’Ftoile, France).

5.3.3. Antimicrobial susceptibility testing
Susceptibility testing was performed using the agar diffusion method on IsoSensitest
Agar (Difco, Dublin, Ireland) with 5% (v/v) horse blood (Reina et al. 1994). Sensitivity

168

determinations by disc diffusion were conducted in accordance with the guidelines
recommended by the National Committee for Clinical Laboratory Standards (NCCLS).
Cultures were prepared by inoculating colonies from a fresh, pure 24 or 48 h culture into
sterile distilled water to give an inoculum turbidity equivalent to a 0.5 McFarland
turbidity standard. Samples were swabbed evenly onto agar plates and allowed to dry.
The following discs were then applied to each agar plate: ampicillin (Amp, 10 pg disc),
augmentin (Aug, 30 pg disc, consisting of amoxycillin 20 pg and clavulanate 10 pg),
chloramphenicol (C, 10 pg disc), ciprofloxacin (Cp, 5 pg disc), erythromycin (E, 5 pg
disc), and tetracycline (T, 10 pg disc). Agar plates were incubated at 37°C under
microaerophilic conditions for 24 h or, if necessary, for 48 h. Inhibition zone sizes were
recorded according to the guidelines of the NCCLS for bacteria that grow aerobically.
Resistance was later confirmed by E-test (AB Biodisc, Solna, Sweden).

5.3.4. Genomic template DNA purification

Isolates were cultured for 48 h microaerophilically as outlined previously. Cultures were
re-suspended in 900 pL of 0.85% (w/v) NaCl and were initially treated with a 100 pL
volume of 37% (v/v) Formaldehyde prior to DNA extraction to inhibit any DNAse
activity according to the method of Gibson et al. (1994). DNA extraction was performed
as previously described (Lind et al. 1996). Integrity of the purified template was assessed
by testing a 10 pL aliquot in a conventional 1.5% (w/v) agarose gel. DNA concentrations
were measured at 260 and 280 nm.
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5.3.5. Mismatch amplification mutation assav-PCR
Mismatch Amplification Mutation Assay-PCR (MAMA-PCR) was perfoimed as
described previously (Zimstein et al. 1999). This method was designed specifically to
detect the Thr-86-Ile point mutation [ACA^ATA] in the corresponding quinolone
resistance determining region (QRDR) of the gyrA gene of C. jejuni. A 265-bp DNA
fragment was amplified only when the latter mutation was present. The following
primers were used: MAMAg^yr^t / (5’-TTT TTA GCA AAG ATT CTG AT-3’) in the
forward direction, and MAMAgj^ryl5 (5’-CAA AGC ATC ATA AAC TGC AA-3’) in the
reverse direction, purchased from Oswel (Southampton, UK). PCR am.plification was
performed in 25 pL reaction volumes containing 33 ng of purified template DNA, 2.5 pL
of lOX buffer (100 mmol/L Tris-HCl, pH 8.3, 500 mmol/L KCl), a 200 pM concentration
of each deoxyribonucleoside triphosphate, 1.5 mM MgCb, 2.5 Units Taq DNA
polymerase and 20 pmol of each primer (above). Thermal cycling conditions were as
follows: 94°C for 3 min, 30 cycles of 94°C for 30s, 50°C for 30s and 72°C for 20s.
Similarly, amplification of a 673 bp product from the QRDR of C. coli isolates was
performed, according to the method of Zimstein et al. (1999). The following primers
were used: GZgyrA5 (5'-ATT TTT AGC AAA GAT TCT GAT-3’) in the forward
direction and GZgyrA6 (5'-CCA TAA ATT ATT CCA CCT GT-3') in the reverse
direction. Reaction mixtures were identical to those above for MAMA-PCR. Thermal
cycling conditions were as follows: 94°C for 3 min, 30 cycles of 94°C for 1 min, 50°C
for 1 min and 72°C for 1 min, with a final step of 72°C for 5 min. For detection in each
case, 10 pL of PCR product were combined with 2 pL of loading dye and electrophoresed
in a 2% (w/v) agarose gel in IX Tris-EDTA-acetate (TAE) buffer containing 0.1 pg/mL
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ethidium bromide at 90 V for 90 min. Gel images were captured on a UV
transilluminator using Grabit’’’^ software (Phoretix, UK).

5.3.6. DNA sequencing
Amplified PCR products were directly ligated to pCR2.1 (Invitrogen BV, Amsterdam,
The Netherlands) and cloned according to the manufacturer’s instructions. The
corresponding constructs were screened for the correct insert prior to purification using
the Wizard® Plus SV Minipreps DNA Purification system (Promega). Inserts were
sequenced using dye terminator chemistry protocols with cycle sequencing (Beckman
Coulter, CA).

All sequences were initially analysed using DNA Sequencher^'^ (version 4.1) software
(Gene Codes Corp., Ann Arbor, MI). The BLAST suite of programmes (Altschul et al.
1997) was searched for similar sequences.

5.3.7. Nucleotide sequence accession numbers
The nucleotide sequence data reported in this paper was submitted to GenBank and
assigned the following Accession Nos: AY043271, AY043272, AY043273 and
AY043274.
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5.4. Results
5.4.1. Species identification
Human isolates in this study were identified as C. jejuni (96%), and C. coli (4%), based
on biochemical tests and species-specific amplification methods outlined previously
(Eyers et al. 1993). Forty-five isolates randomly cultured from poultry were all similarly
identified as C. jejuni (76%) and C. coli (24%).

5.4.2. Antimicrobial susceptibility testing
The susceptibility to a panel of antimicrobials was determined by disc diffusion methods,
following NCCLS recommendations where possible, although the NCCLS has yet to
approve a testing method for Campylobacter spp. However, published information
(Gaudreau and Gilbert 1997) showed good correlation between the results obtained using
an agar dilution and disc diffusion method. All isolates tested from both collections were
interpreted in an identical manner. Figure 1 shows the percentage resistance encountered
among human- and poultry-derived Campylobacter isolates for the year 2000 and
compared with the figures for the previous period 1996-1998. Resistance to
erythromycin was measured at 2 and 4.4% during 2000 for human and poultry isolates
respectively. These data, when compared with a two-year period 1996-1998, showed
similar erythromycin resistance rates of 2.8% for human- and 9.4% for poultry-derived
isolates (Lucey et al. 2000). Human isolates and those cultured from poultry during 2000
accounted for 31% and 24.4% resistance to tetracycline, respectively. This shows a
moderate increase when compared to earlier data (Lucey et al. 2000) reporting resistance
rates of 13.9% for human, and 18.8% for poultry isolates.
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Figure 1. Antimicrobial resistance rates of Campylobacter spp. to ampicillin,
chloramphenicol, ciprofloxacin, erythromycin and tetracycline for the period 1996-1998
and the year 2000.

Chloramphenicol resistance was not encountered among any isolates cultured during
2000. In contrast, a low level of resistance to this agent was detected during 1996-1998
(2.8% for human and 6.3% for poultry isolates). Finally, ampicillin resistance rates for
2000 were determined to be 24 and 22.2% for human and poultry strains, respectively;
during 1996-1998, values of 28 and 21.9% resistance among human and poultry isolates,
respectively, were measured. Sensitivity testing was also performed for augmentin
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(amoxycillin 20 }ig/clavulanate 10 |ig) (data not shown). No resistance to this agent was
detected at the present time or previously.

However, the most significant shift in resistance patterns occurred for ciprofloxacin. In
this case resistance was noted to have increased to 28.9% for poultry and 34% for humanderived isolates, during 2000. In the previous two-year period, from 1996-1998, no
resistance to ciprofloxacin was demonstrated among human isolates and only 3.1%
resistance was encountered among poultry isolates. Table 1 shows a breakdown of the
percentage ciprofloxacin resistance encountered among C. jejuni and C. coli isolates from
human and poultry sources for each period. It can be seen that the percentage resistance
encountered among both species during 2000 was similar, ranging from 25 to 36%
resistance. This increased resistance to ciprofloxacin prompted an investigation to
determine first of all the origin of the poultry meat, and secondly the corresponding
mechanism of resistance among isolates cultured from these samples.

Table 2 shows the incidence of ciprofloxacin resistance among domestic and imported
poultry. These data showed an increased level of resistant isolates recovered from
imported product.
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Table 1. Number (%) of Campylobacter jejuni (C. jejuni) and Campylobacter coli (C.
coll) isolates from human and poultry sources showing resistance to ciprofloxacin during
the periods 1996-1998 and 2000.

C. jejuni

HUMAN

C. coli
POULTRY

1996-1998

Species

Origin

2000
33/96 (34.4)

0/36 (0)
^O(O)

1/4 (25)

C. jejuni

1/30(3.3)

C. coli

0/2 (0)

~ 9/34 (26.5)
4/11 (36.4)

Table 2. Origins of poultry samples from which ciprofloxacin-resistant isolates were
cultured during 2000.
Origin of Poultry

No. tested

No. (Vo)^ resistant to Ciprofloxacin

Domestic

37

7(18.9%)

Imported

8

6 (75%)

^ Refers to the % within each category only.

5.4.3. MAMA-PCR
Several authors (Wang et al 1993, Gaunt and Piddock 1996, Zimstein et al. 1999) have
previously shown that the Thr-86-Ile amino acid substitution in the gyrA subunit
encoding gene was sufficient to generate resistance to ciprofloxacin. As no molecular
analysis of isolates cultured in Ireland had previously been reported, we tested a subset of
59 (of 130) C. jejuni for the Thr-86-Ile amino acid substitution by MAMA-PCR
(Zimstein et al. 1999). Twenty-five isolates showing phenotypic resistance to
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ciprofloxacin possessed this mutation. Figure 2 shows the 265 bp DNA amplicon
obtained after MAMA-PCR consistent with the Thr-86-ile substitution in the gyrA
subunit. All remaining isolates (34/59) were phenotypically sensitive to ciprofloxacin;
however, MAMA-PCR detected the latter substitution in two of these remaining isolates.
This substitution was further confirmed in the latter isolates by automated sequence
analysis of the QRDR of the gyrA gene (data not shown).

The QRDR of four C. co/i isolates was also investigated by DNA sequencing. Three
were phenotypically resistant to ciprofloxacin, showing the characteristic Thr-86-Ile
substitution corresponding to the ACT'^ATT transition mutation (Zimstein ef al. 2000).
The remaining C. coli which was sensitive to the antimicrobial possessed the wild-type
sequence.

DNA amplification fingerprinting (DAF) analysis using a single primed reaction similar
to that described previously (Lucey et al. 2000) suggested that the majority of these
isolates were not clonal, as diverse DNA fingerprint patterns were obtained among
isolates resistant to ciprofloxaein (data not shown).
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Figure 2. MAMA-PCR of C. jejuni isolates for the deteetion of the Thr-86-Ile
substitution eonferring resistanee to eiprotloxaein. Amplified DNA produets were loaded
onto a 2% (w/v) agarose gel and eleetrophoresed at 100 V for 60 min. Lanes designated
M eontain 100 bp DNA ladder (Boehringer-Mannheim, Germany). Lane 1 MAMA-PCR
positive eontrol C. jejuni. Lanes 2, 3 and 5 MAMA-PCR positive isolates. Lanes 4, 6 and
7 MAMA-PCR negative isolates. Lane 8 MAMA-PCR negative eontrol C. jejuni.
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5.5. Discussion
Campylobacteriosis is a zoonosis and there is strong evidence that fresh meat, especially
poultry, is a major source of infection (Tauxe 1992). Erythromycin and, less commonly,
ciprofloxacin are the agents of choice for the treatment of severe or recurrent
Campylobacter enteritis in humans. Studying the transmission of antimicrobial resistance
is difficult in Campylobacter due to the acknowledged diversity of genotypes commonly
found (Hanninen et al. 1998, Wassenaar and Newell 2000, Manning et al. 2001).

Data obtained in this study shows that erythromycin remains an effective agent in the
treatment of Campylobacter enteritis in humans. Our data also showed that the incidence
of tetracycline resistance was 29% for strains isolated during 2000, a moderate increase
from 16.2% during 1996-1998 for human and poultry strains combined. The figure for
the year 2000 corresponds with data for 1997 in the UK (Thwaites and Frost 1999).
Ampicillin resistance was less prevalent among Irish isolates during the year 2000 (23.4%
for all isolates combined) than in the UK during 1997 (34%). Similarly, the lack of
chloramphenicol resistance encountered in Ireland during 2000 contrasts with the 1997
UK data (Thwaites and Frost 1999) wherein 5.4% resistance was recorded, being similar
to the 1996-1998 Irish incidence of resistance. Some investigators have suggested that
resistance in C. jejuni and C. coli can be accounted for, at least in part, by use of
antimicrobials to treat human infection. In this study, neither ciprofloxacin nor
tetracycline were cited as having been used to treat any patient prior to the isolation of
Campylobacter (54% of patients were under 16, and therefore should not be treated with
these agents in any case). Foreign travel has also been suggested as a possible risk factor
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for infection, and in this case was cited for 3% of patients in this study. However, it is
interesting to note the increase in resistance to ciprofloxacin among human and poultry
isolates. Based on our observations, the efficacy of ciprofloxacin in the management of
Campylobacter enteritis is now less certain. When trends of resistance were closely
examined during 2000, a majority of the isolates in this collection (from both human and
poultry sources) showed greater resistance to ciprofloxacin during the first half of the
year. The significance of this observation remains to be determined. Similarly, an
increased rate of ciprofloxacin resistance has been reported in the UK (Thwaites and
Frost 1999), where it has been shown that there was a temporal association between the
appearance of resistance to ciprofloxacin and the licensing of fluoroquinolone
antimicrobials for use in food-producing animals (Threlfall et al. 2000). The licensing of
enrofloxacin (a fluoroquinolone similar to ciprofloxacin) in Ireland for use in poultry
occurred prior to 1987 however, and the apparently late development of resistance by
Campylobacter spp. to this agent is surprising. Fluoroquinolones are used for mass
medication of birds and for the treatment and control of other bacterial diseases in poultry
production (e.g. in-water medication of chickens with enrofloxacin for treatment or
control of salmonellosis). Since 1998 Ireland has been importing a significant proportion
of its poultry from a number of countries, mostly outside the European Union, where
increased resistance rates to ciprofloxacin have been reported (Hoge and Gambel 1998;
Engberg et al. 2001). In this study the late detection of resistance to ciprofloxacin
appears to be related in part to the importation of foreign product. Campylobacter spp.
isolates of domestic origin showed only 18.9% (7 of 37 isolates tested) resistance to
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ciprofloxacin, while 75% resistance (6 out of 8 isolates tested) was demonstrated among
isolates obtained from imported birds.

The association between the use of fluoroquinolones in veterinary medicine and the
emergence of resistance in human isolates requires investigation. Systematic reporting of
antimicrobial resistance trends should be a high priority in any infection control protocol.
Antimicrobial resistance has global dimensions due to increasing international trade and
travel. Targeted strategies should be implemented to circumvent the development of
resistance and to protect public health.
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6.1. Abstract

The speciation of a collection of 372 Campylobacter strains isolated from human and
poultry sources during the year 2000 was undertaken, using four unrelated identification
protocols. The tube hippurate hydrolysis test correctly identified 364 (97.8%) isolates
after hippurate hydrolysis tests had been performed in duplicate, whilst a 23S rRNA
strategy correctly identified 358 (96.2%) isolates. A subset of 55 of these isolates was
determined by two additional polymerase chain reaction (PCR)-based strategies. In one
of these the hippuricase-encoding {hip) gene was amplified, correctly identifying 54
(98.2%) of these isolates, whilst a second method, involving the amplification of part of
the ceuE gene, correctly identified 52 (94.5%) isolates in this subset. These data suggest
that no single method is likely to correctly identify all C. jejuni and C. coli isolates, and
that a combination of traditional methods along with PCR-based protocols may be
necessary.

Keywords: Campylobacter, human, poultry, speciation, hippurate, PCR
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6.2. Introduction
Thermophilic Campylobacter spp., mainly Campylobacter jejuni {Camp, jejuni) and, to a
lesser extent, Campylobacter coli {Camp, coli) are the most frequently reported bacterial
cause of human enteritis in developed countries. A third species, Campylobacter lari
{Camp, lari) is sometimes reported as an unusual cause of human enteritis (Jackson et al.
1996). All of these species occur in food animals and household pets and may also be
isolated from environmental sources (Skirrow, 1994). A large proportion of the world’s
poultry flocks are known to harbour Campylobacter, and poultry has been implicated as
the most common source of infection in humans (Giesendorf et al, 1992; Jacobs-Reitsma,
2000).

The reliable identification of Campylobacters to species level is complicated by the
asaccharolytic nature of this organism, making many conventional biochemical tests
unsuitable as part of a routine identification screen. For many diagnostic laboratories, the
identification of these isolates depends on macroscopic and microscopic morphology, and
the use of a few conventional tests including catalase, oxidase, susceptibility to
cephalothin and nalidixic acid, the ability to grow at 42°C, but not at 25°C, along with the
hippurate hydrolysis test.

The emergence of resistance to antimicrobial agents makes reliable identification on the
basis of susceptibility uncertain. The hippurate hydrolysis test is widely regarded as the
standard test for the differentiation of Camp, jejuni from the other thermophilic species.
However, not all Camp, jejuni isolates are hippurate-positive by this method (Totten et al.
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1987), and this can lead to false identifications. Certain commercial systems, such as the
API Campy (BioMerieux, Marcy I’Etoile, France) are convenient to use, but have been
found to offer no advantage over conventional methods (Huysmans et al, 1995).

In contrast to these phenotypic-based approaches, several PCR-based methods have been
developed to facilitate the speciation of Campylobacter. One such method involves the
amplification of 23S rRNA gene targets for the differentiation of Camp, jejuni subsp.
jejuni, Camp, coli. Camp, lari, and Campylobacter upsaliensis {Camp, upsaliensis)
(Eyers et al, 1993). Another method utilises a nucleotide sequence divergence in the
ceuE genes (which encode a protein involved in siderophore transport) to identify Camp,
jejuni subsp./e/'w/?/ and Camp, jejuni subsp. doylei, and Camp, coli (Gonzalez et al,
1997). Linton et al. (1997) developed a hippuricase-gene based strategy for the
identification of Camp, jejuni, following cloning studies by Hani and Chan (1995). This
test has an advantage over the hippurate hydrolysis test, as Camp, jejuni isolates almost
universally possess the hippuricase gene, which may or may not be expressed.

This paper describes the application of some of these unrelated methods to speciate a
large collection of human- and poultry- derived isolates, in order to form a basis for
investigating the epidemiology of these pathogens in an Irish context. Based on our
observations, useful suggestions were formulated to facilitate similar large studies in the
future.
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6.3. Materials and Methods
6.3.1. Bacterial isolates and culture conditions
A collection of 372 thermophilic Campylobacter isolates consisting of 106 clinical
isolates and 266 poultry isolates, all of which had been isolated during the year 2000, was
tested. Three reference strains including Camp, jejuni NCTC 11322, Camp, coli NCTC
11353 and Camp, lari NCTC 11352 were also included for each method. All isolates
were maintained at -80°C on cryostat beads, and were subcultured onto Preston Agar
(Campylobacter Agar Base, Oxoid CM689 (Oxoid, Basingstoke, UK), containing Oxoid
Campylobacter Modified Selective Supplement SR204E and 5% (v/v) lysed horse blood).
Subcultures were incubated at 42°C for 48 h in a microaerophilic environment generated
using a BioMerieux GENbox gas generating kit. [Note that Camp, jejuni subsp. doylei
does not grow at 42°C (On et al, 1996), and therefore Camp, jejuni refers only to Camp,

jejuni subsp. /e/w«/ in this study].

6.3.2. Identification with biochemical tests
Bacteria were initially identified by examining for typical microscopic and colonial
morphology, and were then subcultured onto Columbia Blood Agar (Columbia Agar Base
CM331 (Oxoid) with 5% (v/v) defibrinated horse blood) for biochemical testing. Having
been assessed for purity, all cultures were tested for positive oxidase and catalase
reactions and for their ability to hydrolyse hippurate (Hippurate Diagnostic Tablets,
Rosco Diagnostica, Taastrup, Denmark). Hippurate hydrolysis tests were performed
according to the manufacturer’s instructions. The detection of glycine (as a by-product of
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hippurate hydrolysis) was achieved by the addition of a 3.5% (v/v) ninhydrin solution
(Rosco Diagnostica).

6»3,3. DNA isolation and DNA amplification by PCR
Isolates were cultured on Preston Agar at 42°C for 48 h under mieroaerophilic conditions
as outlined previously. Cultures were suspended in 1 mL 0.85% (w/v) NaCl (attaining a
turbidity of McFarland 6 turbidity standard) and washed once before re-suspending in 900
pL of the same NaCl solution. A 100 pL volume of 37% (v/v) Formaldehyde was added
to each culture prior to DNA extraction to inhibit any DNAse activity according to the
method of Gibson et al. (1994). DNA extraetion was performed as described previously
by Lind et al. (1996). DNA concentrations were measured at 260 and 280 nm, and the
integrity of the purified template was assessed by testing a 10 pL aliquot in a
conventional 1.5% (w/v) agarose gel. DNA was stored at 4°C. The following PCR
identifieation methods were used (see Table 1 for primer sequences), and three NCTC
control isolates previously outlined were ineluded for each method. Each PCR run
contained a negative control in which template DNA was replaced with sterile distilled
water.

6.3.4. Amplification of 23S rRNA targets
Camp, jejuni subsp. jejuni- and Camp, coli- speeific PCR reaetions were performed for
all isolates, and Camp, lari- specific PCR reactions were performed for a subset of
isolates, aeeording to the method of Eyers et al. (1993). Primer sequences are shown in
Table 1. For Camp, jejuni isolates, the forward primer THERM3 and the reverse primers
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JEJ1 and JEJ2 produced DNA amplicons of approximately 700 and 800 bp, respeetively.
For Camp, coli isolates, the forward primer THERM 1 and the reverse primer COLI had a
predieted produet size of approximately 400 bp, and for Camp, lari isolates, a 260 bp
species-speeific fragment was obtained using the primer combination THERM 1 and
LARI.

6.3.5. Amplification of the ceuE gene for the differentiation of Camp, jejuni and
Camp, coli.
A subset of 55 isolates was tested according to the method of Gonzalez et al. (1997).
Primer sequences are shown in Table 1. The predicted product sizes were 793 bp for
Camp, jejuni, with the primer pair JEJ 1 and JEJ2, and 894 bp for Camp, coli, using the
primer pair COLI and COL2.

6.3.6. Amplification of the hippuricase gene for the specific identification of Camp.
ieiunL
The same subset of 55 isolates was tested aecording to the method of Linton et al. (1997).
A product size of 735 bp was detected for Camp, jejuni isolates after agarose gel analysis
using the primer pair Hip F and Hip R. See Table 1 for primer sequences.
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6.4. Results
All isolates showed typical colonial and microscopic morphology, and had positive
oxidase and catalase tests.

6.4.1. Identification method for Camp, jejuni subsp. ieiunL Camp. coU and Camp.
lari by 23S rRNA PCR
In addition to the predicted product sizes of 700 and 800 bp for Camp, jejuni isolates
(Eyers et al, 1993), a PCR product of approximately 630 bp was also commonly
generated (see Figure 1). The latter amplicon was also found (in this study) to be
specific for Camp, jejuni. In a small minority of isolates, more than one of these bands
was generated for the same isolate (see Figure 2). In contrast, the primer pair THERM 1
(forward primer) and the reverse primer COLI generated only the expected product of
approximately 400 bp when applied to Camp, coli isolates (see Figure 3). (No amplicons
were generated among the test isolates using the Camp, /arz-specific primers (see Figure
4 for C. /ar/-specific amplicon using NCTC 1 1352). This method correctly identified 358
of the 372 isolates (96.2%), as shown in Table 2. Of the remaining 14 isolates, no
product was generated for 12 isolates otherwise identified as Camp, jejuni (10) and
Camp, coli (2) respectively. An additional isolate generated both Camp. jejuni-s^QC\f\c
and Camp. co//-specific products. However, using other strategies, this isolate was
identified as Camp, jejuni. Finally, one isolate was identified as Camp, coli using this
method, in contrast to the other three methods used, which gave an identification of
Camp, jejuni.
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6.4.2. Identification of Camp, ieiuni by tube hippurate hydrolysis test
The hippurate hydrolysis test method along with the 23S rRNA PCR method gave
clearly-defined concordant results for 317 of the 372 isolates tested as shown in Table 2.
The remaining 55 isolates were further tested using a repeat hippurate hydrolysis test, the
23S rRNA-PCR strategy (Linton et al, 1997), and by species-specific ceuE PCR
(Gonzalez et al, 1997). Within the subset of 55 isolates, 27 isolates were identified as
Camp, jejuni by 23S rRNA-PCR and these were hippurate-negative {hip'). Upon repeat
analysis 26 isolates were hippurate-positive {hip"). Fifteen isolates identified as Camp,
coli by 23S rRNA PCR were inteipreted as hip". On repeat testing, eight isolates were
hip', while seven isolates remained hip^. The percentage error for the hippurate
hydrolysis test after repeat testing of conflicting results was 2.1%.

6.4.3. Identification of Camp, ieiuni by hippuricase gene PCR
The same subset of 55 isolates were identified using all methods outlined previously and
of this group, 38 were identified as Camp, jejuni and 17 as Camp, coli isolates (see
Figure 5 for representative results). Hippuricase gene PCR produced the expected DNA
product for 37 of the 38 Camp, jejuni isolates and no amplcions were detected for any of
the 17 Camp, coli strains. The remaining Camp, jejuni isolate, CIT030, despite repeated
hippurate hydrolysis tests and hippuricase gene PCR, remained negative for both, but
generated the expected products for Camp, jejuni using 23 S rRNA and ceuE PCR
methods (see Figures 1, 2, 3, 5, 6 and 7). The percentage error for this method was
calculated at 1.8%, as shown in Table 2.
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6.4.4. Identification of Camp, ieiuni and Camp, coli by ceuE PCR
The subset of isolates outlined in section 3.3 above was also tested by ceuE PCR (see
Figures 6 and 7 for representative results). Discrepant results were encountered for three
of the isolates previously identified as Camp, jejuni. Two of the three isolates failed to
generate a PCR product, and the remaining isolate generated products indicative of both
Camp, jejuni and Camp. coli. The percentage error calculated for this method was 5.5%
as shown in Table 2.
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6.5. Discussion
The identification of thermophilic Campylobacter to species level in the diagnostic
laboratory depends largely on the hippurate hydrolysis test to distinguish between Camp,
jejuni and Camp, coli or, rarely, Camp. lari. The species most commonly isolated is
Camp, jejuni, so a positive hippurate test is most likely to be recorded since the
hippuricase gene is specific to Camp, jejuni among Campylobacter spp. This test is
inoculum-dependent, and hippurate tests are more often positive when cultured on Blood
Agar than on blood-free medium (On and Holmes, 1991). Furthennore, the detection of
glycine as a by-product (Harvey, 1980) after the addition of ninhydrin is strictly timedependent. Interpretation of a positive result depends on the production of a purple
colour some 10 min after the addition of ninhydrin reagent, and analysis is subjective as
varying degrees of colour development can occur for both negative and positive analyses.
In this study of 372 isolates (317 Camp, jejuni and 55 Camp, coli), a total of 42 isolates
(27 Camp, jejuni and 15 Camp, coli) produced hippurate results other than expected.
Upon repeat analysis, eight isolates continued to show anomalous results when compared
to data obtained by the three molecular-based identification protocols. One Camp, jejuni
strain, previously determined to be negative after the tube hippurate and hippuricase gene
PCR strategies, appeared to lack the hippuricase gene, which, although an unusual
finding, has been noted previously (Nicholson and Patton, 1995). A particular cause for
concern however was the misidentification identification of seven Camp, coli isolates
which were repeatedly interpreted as tube hippurate-positive. None of these generated an
amplicon by hippuricase gene PCR. Interpreting hippurate hydrolysis tests is known to
be difficult and inconsistent (Nicholson and Patton, 1995), and therefore reliance on this
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single phenotypic test alone to differentiate Camp, jejuni from the other thermophilic
Campylobacter species cannot be recommended. Conversely, the hippuncase gene PCR
method produced clear results. For the 23S rRNA PCR protocol, the generation of an
amplicon other than those predicted, based on previously published observations for
Camp, jejuni with this assay (Eyers et al, 1993) nonetheless reliably identified Camp,
jejuni isolates, and this method had a calculated error rate of 3.8%. Similarly, the ceuE
PCR method carried an error rate of 3.4%

It may be noted from this study that the identification of wild-type strains of
Campylobacter to species level prior to an epidemiological investigation remains
complicated by several factors. Phenotypic identification can be subjective and
inoculum-dependent and the characteristic being tested may not be consistently
expressed. The molecular methods used here also failed to identify all isolates correctly.
Reasons for this included an atypical isolate that did not contain the gene on which the
assay was based. Campylobacter spp. have also been shown to be genomically unstable
(Harrington et al, 1997; Wassenaar et ah 1998). This may explain why the 23S rRNA
and ceuE methods did not reliably identify all isolates tested, or did not always generate
amplicons of the expected size. In conclusion, this study has shown that a collection of
Campylobacter isolates is likely to contain atypical strains that cannot be identified
correctly by a single method, and therefore it is advisable to use a combination of two or
more methods.
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6.7. Tables and figures
Table 1. Nucleotide sequence and characteristics of oligonucleotide primers used for
PCR
PCR
T-annealing
57°C

Cone.

%GC

CeuE]t] F

Sequence
5'^3’
CCT GCT ACG GTG AAA GTT TTG C

25 pmol

50

CeuE]Q] R

GAT CTT TTT GTT TTG TGC TGC

25 pmol

38

57°C

CeuEcoW F

ATG AAA AAA TAT TTA GTT TTT GCA

25 pmol

17

57°C

CeuEcoW R

ATT TTA TTA TTT GTA GCA GCG

25 pmol

29

57°C

Hip F

GAA GAG GGT TTG GGT GGT G

25 pmol

58

66°C

Hip R

AGC TAG CTT CGC ATA ATA ACT TG

25 pmol

39

66°C

THERMl

TAT TCC AAT ACC AAC ATT AGT

25 pmol

29

54°C

COLI

TAA ATC CTA ATA CGA AGC G

25 pmol

37

54°C

LARI

ACG GCA TCA GCA ATT CTC

25 pmol

50

54°C

THERMS

TAA AGT AAG TAC CGA AGC TG

25 pmol

40

54°C

JEJl

GTA AAT CCT AAT ACA AAG CT

25 pmol

30

54°C

JEJ2

TAA ATC CTA GTA CGA AGC T

25 pmol

37

54°C

Primer
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Table 2. The percentage error associated with four methods used to identify Camp,
jejuni and Camp. coli.
No. of isolates tested

% Error

{Camp. jejuni/Camp, coli)

(No. of isolates)

Hippurate hydrolysis test

372 (317/55)

2.1% (8)*

23S rRNA PCR

372 (317/55)

3.8% (14)

CeuE PCR

55 (38/17)

5.4% (3)

Hippuricase PCR

55 (38/17)

1.8% (1)

Identification Method

* Results after repeat hippurate hydrolysis testing. A total of 11.3% (42) of isolates
initially showed discrepant results.
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M
1000 bp.
^

V

500 bp

Figure 1. Gel showing Camp. jejimi-s^QC\T\c 23S rRNA PCR, which identifies
eight of the above nine samples as Catnp. jejuni (with products of approximately
600 bp, 700 bp and 800 bp in size). An exception is a sample for which a result is
shown in lane 4. Lane M contains lOObp DNA ladder (Promega). Note: Lane 1,
CIT-030; I.ane 2, ClT-044; Lane 3, CIT-074; Lane 4, CIT-093; Lane 5, CIT-117.

M

1

1000 bp
500 bp

Figure 2. Camp, jejimi-spec'ii'ic 23S rRNA PCR. Lane 1 contains C1T064 for
which three amplicons were generated simultaneously, of approximately 600,
700 and 800 bp respectively. This isolate was identified as Camp, jejuni by
the other identification methods used. Lane M contains 100 bp DNA ladder.
M

434 bp267 bp-

Figure 3. Gel showing Camp. cY;//-specific 23S rRNA PCR, which detects
presence of this species in lane 4 only, showing the predicted product of
approximately 400 bp in size. Lane M contains DNA molecular weight marker
Grade V (Roche Diagnostics). Note: Lane 1, CIT-030; Lane 2, CIT-044; Lane
3, CIT-074; Lane 4, CIT-093; Lane 5, CIT-117.
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M
500 bp --

100 bp

Figure 4. Gel showing Camp, /(^n-specific 23S rRNA PCR, for which the
predicted product of approximately 250 bp appears in Lane 5 only. Lane M
contains 100 bp DNA ladder. Lanes 1-4 are negative for Camp, lari; Lane 5
contains NCTC 11352 Camp. lari.

1000 bp

500 bp —I

Figure 5. Hippuricase gene PCR, showing the predicted product of 735 bp in
Lanes 2, 4, 5, 6, 7 and 8, thereby identifying isolates as Camp. Jejuni. Lane M
contains 100 bp DNA ladder. Lanes 1 and 3 are negative for the hippuricase
gene. Note: Lane 1 contains CIT030, identified by 23S rRNA and CeuE PCR
methods as Camp, jejuni.
2

3

4

5

6

7

Figure 6. CeuEjejuni-s^ec\j\c PCR, showing the predicted 793 bp product
in Lane 7 only, and no product in Lanes 1-6. Lane M contains 100 bp DNA
ladder. Note: Lane 7 contains CIT030.
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M

1

2

3

4

5

6

7

1000 bp.

500 bp

Figure 7. CeuE 6Y;//-specific PCR showing the predicted 894 bp product in
lanes 1-6, and no product in Lane 7. Note: Lane 7 contains CIT030.
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7.1. Abstract
A detailed epidemiological investigation of a collection of 378 human and poultry
Campylobacter isolates is described. All isolates were collected during the year 2000 at
four centres throughout the island of Ireland. Human (enteritis-causing) isolates which
numbered 106 were identified as C. jejuni (99%) and C. coli (1%), while the poultryderived collection consisted of 272 isolates and these were identified as C. jejuni (79%),
C. coli (19%), with the remaining 2% identified as Campylobacter spp. only, and could
not be further identified at this time. Genomic analysis by DNA amplification
fingerprinting (DAF) was used to investigate the possible genetic relationships among the
isolates in this unique collection. Following data analysis, 145 designated fingerprints at
80% similarity were identified, including 39 indistinguishable clusters consisting of two
or more isolates. The majority of these clusters were comprised of human or poultry
isolates alone. Based on a detailed epidemiological evaluation of these clusters, the
majority of the human infections studied did not represent significant recognisable
outbreaks. Strain diversity observed among human and poultry isolates suggests the
ubiquitous nature of Campylobacter and the scarcity of common types.
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7.2. Introduction
Thermophilic Campylobacter spp., particularly Campylobacter jejuni {C. jejuni) and
Campylobacter coli (C. coli) are currently the most common bacterial cause of acute
clinical bacterial diarrhoea worldwide (Linton et al., 1997). Although deaths associated
with Campylobacter infection are uncommon, morbidity associated with the disease is
high, which also results in significant economic costs (Skirrow and Blaser, 1992). While
Campylobacter spp. are widespread in the environment, clinical Campylobacter
infections are considered to be mainly zoonotic in origin, and most human infections are
sporadic. Foods of animal origin are the source of the majority of infections, the greatest
risk factor being the handling and eating of poultry and poultry products (Giesendorf et
al., 1992; Jacobs-Reitsma, 2000), particularly for sporadic infections. Campylobacter has
been isolated from a large proportion of poultry samples examined. A study in Northern
Ireland reported that 65% of chicken wings at retail sources were contaminated with
Campylobacter spp. (Flynn et al., 1994). A more recent Irish study reported isolation
rates of between 20 and 90%, depending on the type of poultry meat sampled (Food
Safety Authority of Ireland, 2001). The crude incidence of laboratory-confirmed
Campylobacter enteritis recorded during the year 1999 was 57.5 cases/100,000, making it
the single largest cause of bacterial food poisoning in Ireland, as has been reported for
other countries (Whyte and Igoe, 2000). As these rates are based on laboratory-confirmed
cases, the true rate of infection is estimated to be 10 to 100 times higher (McDowell and
McElvaine, 1997; Alios, 1998). The objective of this study was to investigate the genetic
relationships (if any) among a collection of thermophilic Campylobacter spp. of human
and poultry origin, which had been isolated during the year 2000 in Ireland. DNA
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amplification fingerprinting (DAF) was the molecular typing method selected. This
method has previously been found to be reproducible (Mazurier et al., 1992; Lucey et ai,
2000), and highly discriminatory when applied to a collection of previously-evaluated
outbreak- and non outbreak- related strains of C. jejuni, from a variety of sources (Moller
Nielsen et al., 2000).
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7.3. Materials and Methods
7.3.1. Bacterial isolates
The study collection was comprised of 378 Campylobacter isolates from human and
poultry sources, which were submitted to the Molecular Diagnostics Unit [MDU] by the
Irish Equine Centre [lEC] (241 poultry isolates), Cork University Hospital [CUH] (61
human isolates). Northern Ireland Public Health Laboratory Service [NI-PHLS], Belfast
(31 poultry isolates) and University College Hospital, Galway [UCH, G] (45 human
isolates). All bacterial isolates were obtained either on Charcoal Transport Medium
Swabs, in Cooked Meat Medium (CM81) or on Microbank Storage Beads which had
been held at -80°C. Three control strains, C. jejuni NCTC 11351, C. coli NCTC 11353
and C lari NCTC 11352 were included in the study for comparative purposes. All
isolates were preserved on cryostat beads at -80°C for long-term storage purposes.

7.3.2. Identification
Bacteria were initially identified as Campylobacter spp. according to the following
parameters: growth at 42°C and Carbol Fuchsin staining for typical morphology.
Biochemical tests were performed on cultures grown on Columbia Blood Agar (Columbia
Agar Base CM331 (Oxoid) with 5% (v/v) defibrinated horse blood). Cultures were
incubated at 42°C for 48 h in a microaerophilic environment generated using a
BioMerieux GENbox gas generating kit. Isolates were tested for (positive) catalase and
oxidase reactions, and for their ability to hydrolyse hippurate {hip^), the hippuricase gene
being specific to C. jejuni among Campylobacter species (Hani and Chan, 1995).
Hippurate hydrolysis tests were performed using hippurate hydrolysis tablets according to
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the manufacturer’s instructions (Rosco Diagnostica, Taastrup, Denmark). All isolates
were further characterised by polymerase chain reaction (PCR)-based amplification of
23S rRNA C. jejuni- and C. co//-specific gene fragments, according to the method of
Eyers et al. (1993). A subset of isolates was tested with C. /r/n-specific primers
according to Eyers’s method. PCR amplification of the ceuE gene for the specific
identification of C. jejuni and C. coli was performed for a subset of isolates, according to
the method of Gonzalez et al. (1997). This subset of isolates was also assessed by
hippuricase gene PCR, according to the method of Linton et al. (1997).

7.3,3. DNA isolation

Isolates were cultured on Preston Agar (Campylobacter Agar Base, Oxoid CM689
(Oxoid, Basingstoke, UK), containing Oxoid Campylobacter Modified Selective
Supplement SR204E and 5% (v/v) lysed horse blood), and were incubated
microaerophilically as previously described. Cultures were suspended in 1 mL 0.85%
(w/v) NaCl (attaining a turbidity of McFarland 6 turbidity standard) and were washed
once before re-suspending in 900 pL NaCl. A 100 pL volume of 37% (v/v)
Formaldehyde was added to each culture prior to DNA extraction to inhibit any DNAse
activity according to the method of Gibson et al. (1994). Total genomic DNA was
purified according to the method previously described by Lind et al. (1996). DNA
concentrations were measured at 260 and 280 nm, and the integrity of the purified
template was assessed by testing a 10 pL aliquot in a conventional 1.5% (w/v) agarose
gel. All DNA samples were stored at 4°C.
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7.3.4. DAF fingerprinting
For each reaction (in a total volume of 50 |j,L) a combination of 5.0 )iL 25 mM MgCli,
5.0 |liL lOX PCR Reaction Buffer, 8 |liL working stock dNTPs (to give a final
concentration of 0.2 mM dNTP), 200 ng genomic DNA, 2.5 U Taq DNA Polymerase and
50 pmol primer HLWL85 (5’-ACA ACT GCT C-3’) (Mazurier et al., 1992) were used.
A negative control containing sterile distilled water in place of template DNA was
included in each set of PCR reactions. Amplification was performed using an initial
denaturation step at 94°C (5 min), followed by 40 cycles consisting of denaturation (94°C
for 30 s), annealing (40'^C for 1 min) and extension (72°C for 1 min) steps, and followed
by a final extension step (72°C for 5 min). All amplifications were performed in a
MiniCycler™ (MJ Research Inc., Watertown, MA).

For detection, an aliquot of 10 pL from each reaction mix was combined with 2pL of
loading dye and electrophoresed on a 1.5% (w/v) conventional agarose gel for 1.5 h at
100 V. A IX TAE buffer containing a final concentration of 100 pg/L ethidium bromide
was used for the agarose gels and as the electrophoresis running buffer. All ethidium
bromide products were examined and photographed using a UV transilluminator (UltraViolet products, Cambridge, UK) using Phoretix software (Phoretix, Newcastle upon
Tyne, UK). Each DNA template was fingerprinted twice using separate runs, or, where
more frequently advisable, to confirm the reproducibility and quality of the final data.

7.3.5. Quantitative analysis of DAF fingerprint patterns
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Quantitative analysis of gel fingerprint patterns was performed for all isolates. Tenover’s
rules were applied to isolates eontaining single band differences (Tenover et al., 1995).
Faint and non-reproducible DNA bands were not included in the analysis. All DAF
images were digitised using a Gel Doc 1000 System (Bio-Rad Laboratories, Herules,
Calif) and stored as uncompressed TIFF files for each gel lane. Each image was later
converted, normalised and analysed using GelCompar software, version 4.0 (Applied
Maths BVBA, Kortrijk, Belgium). The similarity matrix and clustering dendrogram was
constructed from these data, using the Jeffrey’s X coefficient and CJPGMA algorithm,
respectively.

212

7.4. Results
7.4.1. Species distribution
One hundred and six isolates from patients with Campylobacter enteritis were
incorporated in the study. As shown in Table 1, together with their origins, 105 isolates
were identified as C. jejuni and the remaining isolate was identified as C. coli. The
poultry isolates numbered 272 (shown in Table 1), of which 214 were identified as C.

jejuni and a further 53 isolates were identified as C. coli. The remaining five isolates in
the collection were identified only as Campylobacter spp. Despite several attempts, these
isolates could not be identified further (Lucey et al, 2002, in press),

7.4.2. DAF analysis
Total genomic purified DNA was extracted from all isolates, and DAF analysis was
performed using the primer HLWL85 (Mazurier et al., 1992). The resultant fingerprints
were resolved by conventional agarose gel electrophoresis. All isolates produced
between 4 and 14 amplicons, ranging in size from 0.1 to 3.0 kbp, with the exception of
two isolates, namely CIT-113, which generated only a single amplicon, and CIT-067,
which generated two amplicons. DAF analysis, using HLWL85, was suitable as a typing
method, and provided 100% typeability for this large collection of isolates.

The genetic relationships between all isolates in this collection, based on their DAF
fingerprint patterns, is shown in Figure 1. Jeffrey’s band-based similarity coefficient was
used to build the comparison (defining DAF types on the basis of single-band
differences), using a position tolerance of 1% and enabling fuzzy logic. Figure 1 also
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includes additional information on each isolate, including species type, its geographical
origins and the designated DAF type assigned during this study.

Using primer HLWL85 a total of 145 individual DAF patterns were deseribed for the
isolates in this eolleetion on the basis of 80% similarity, demonstrating a high degree of
genomie diversity. The largest cluster identified at this level of similarity eomprised 77
C. jejuni isolates from all four geographical locations (and included both human and
poultry isolates). There were 39 elusters within the grouping that produeed
indistinguishable DNA fingerprint patterns. Of these clusters, eontaining between two
and seven isolates, 18 were from the lEC collection, a further six clusters were from
UCU,G, four were from CUH and single cluster was from the NI-PHLS collection of
isolates. The remaining 10 elusters were comprised of isolates from different
geographical regions, with eight of these clusters containing both poultry and human
isolates.
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7.5. Discussion
Use of DAF fingerprinting protocols for Campylobacter is well recognised as a valuable
epidemiological tool, to identify the source of infection. This approach provides useful
data when applied to a well-characterised population of isolates. These combined
approaches can facilitate the screening of a complete genome and the identification of
potentially useful genetic markers. Following the speciation of all 378 Campylobacter
isolates from poultry and human sources C. jejimi accounted for 99% of the human cases
of enteritis investigated and, in contrast, accounted for 81% of the poultry isolates
submitted to the MDU for analysis. This predominance of C. jejuni over C. coH among
poultry is widespread (other species are rarely encountered), whilst the proportions of C.
jejuni isolates relative to C. coli have been shown to vary somewhat between
geographical locations. Studies in Denmark, the United Kingdom and The Netherlands,
described the proportion of C. jejuni to be 85, 95 and 65%, respectively (Newell and
Wagenaar, 2000). The lower incidence of C. coli infection among humans may be
partially accounted for by the greater ability of C. jejuni to survive both at 4 and at 20°C
in moist conditions (Korhonen and Martikainen, 1991). Interestingly, within this Irish
collection, five isolates could not be identified to species level, despite using a
combination of biochemical tests and a number of molecular identification strategies
(including C. /on-specific PCR). All isolates were of poultry origin, including four from
NI-PHLS and one from the lEC. It is not unreasonable to suggest that these are
inseparably mixed cultures.
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The elucidation of the epidemiology of Campylobacter infection is dependent on the
stability of the entire genome, or of certain “housekeeping” genes, depending on the
typing method being applied. A study by Hanninen et al. (1999), which examined the
stability of 12 human and chick C. jejuni genotypes following passage through chick
intestine, found that two isolates (one human and one chick isolate) changed their
genotypes, as demonstrated by Pulsed-Field Gel Electrophoresis (PFGE) and ribotyping.
In addition, the isolate of human origin underwent a change of serotype. In a similar
study by Wassenaar et al. (1998) PFGE variations among a collection of C. jejuni isolates
that were indistinguishable by Penner serotyping and //« typing were identified. It was
concluded that these isolates were clonal in origin and that the diversity in the PFGE
banding patterns was most likely the result of genomic rearrangements. Some authors
suggest that certain clones of C. jejuni remain genetically stable in completely different
environments over long periods of time and throughout a variety of geographical
locations (Manning et al., 2001). It has been suggested, however, that DAF, due to the
generation of multiple small bands, is one of the most suitable typing methods, being
least affected by genomic instability (Wassenaar and Newell, 2000). In this study, DAF
allowed a comparison of the polymorphisms of the entire bacterial genome among the
isolates in this collection, in an unselected manner.

The investigation of poultry and human isolates in this study provided data on Irish
Campylobacter strains for the first time. The rather complex dendrogram generated
following the DNA fingerprinting of the collection demonstrated a high degree of
genomic diversity, consistent with the findings of several authors (Lucey et al., 2000;
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Wassenaar and Newell, 2000) and with a greater degree of diversity occurring among C.
coli isolates than had been previously reported. In all, there were 145 designated DAF
types at the 80% similarity level. Thirty-nine clustered isolates among the collection
were identified, of which 27 consisted of two isolates only. In one case, a cluster of five
indistinguishable C. jejuni strains was identified at CUH over a six-week period. This
cluster also included two poultry isolates obtained from lEC, and showed 95% similarity
with two human UCH, G isolates. Two further clusters, each consisting of four
indistinguishable C. jejuni strains, were isolated within (separate) periods of one week.

Whilst these findings may represent small outbreaks, they may also suggest a
predominance of certain strains (or genomic types) in the food chain during that period,
which are replaced by new strains over time. The largest designated DAF type XVI was
comprised of 77 C. jejuni isolates from the four geographical locations that shared at least
80% homology at the DNA fingerprint level, and that encompassed 16 clusters of
indistinguishable isolates. This large cluster was comprised of 61 human isolates and
only 16 poultry isolates. DAF type XVI alone accounted for 20% of the entire collection,
with 80% of its isolate content being of human origin. As the greater part of the humanderived isolates in the entire collection shared at least 80% homology, these data may
suggest that certain strains are more likely to cause human disease than others.
Variability in the clinical expression and in the phenotypic traits may be related to the
genetic diversity of Campylobacter strains (Carvalho et al, 2001). Fingerprinting
strategies may be a useful method of discriminating between isolates based on other
independent characteristics. For example, in an unrelated study conducted during the
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period 1996-1998 human and poultry isolates were investigated, and these data noted an
absence of ciprofloxacin resistance among human isolates and a resistance rate of only
1% among poultry isolates (Lucey et al., 2000). Concurrent with DAF analysis in the
present study was a re-examination of the rates of ciprofloxacin resistance among
Campylobacter spp. (data not shown). It was interesting to note that ciprofloxacin
resistance had risen to approximately 30% among the subset of isolates tested (Lucey et
al., 2002), a figure confirmed by the subsequent testing of the entire collection
(unpublished data). Within certain clusters of indistinguishable C. jejuni isolates (after
DAF analysis) a mixed population of ciprofloxacin-resistant and ciprofloxacin-sensitive
strains exists, suggesting an even greater diversity than DAF analysis had demonstrated.
Nevertheless, the rate of ciprofloxacin resistance among the clusters of indistinguishable
isolates was 64%, more than double the expected rate when compared to figures for the
entire collection. This may suggest that these isolates had a greater infectivity, or a
selective advantage when compared to susceptible strains. Similar observations have
been made in relation to virulence potential (Carvalho et al, 2001).

Use of DAF as a molecular typing method is effective and provided discriminatory
assessment of the collection along with complete typeability. Construction of the detailed
dendrogram in this study clearly showed that the poultry-derived isolates were more
heterogeneous based on their DNA fingerprints when compared to the human-derived
isolates, and the degree of similarity shown among the greater part of the human
collection of isolates suggests that certain types may have a more significant pathogenic
impact on humans. The basis for this requires further investigation among the current
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collection as a first attempt in establishing a relationship between the genetic diversity of
the population, as deseribed in this study, and an isolate’s ability to adhere and invade
epithelial cells, thereby causing disease.
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7.7. Table and Figures
Table 1. Speciation and origins of the 378 Campylobacter isolates included in the study.
Location

Origin

C. jejuni (%)

C. coli (%)

Campylobacter spp. (%)

Total

tlEC

Poultry

194

46

1

241

{NI-PHLS

Poultry

20

7

4

31

^CUH

Human

60

1

-

61

*UCH,G

Human

45

-

-

45

Combined
locations

Human
and
poultry

319(84.4)

54(14.3)

5(1.3)

378

tirish Equine Centre; ^Northern Ireland Public Health Laboratory Service; ^jCork University Hospital;
*University College Hospital, Galway.

Figure 1. (overleaf) A listing of the 378 isolates in the collection together with the
corresponding DAF pattern, species name, host, origin and designated DAF type at 80%
similarity. A dendrogram was constructed to show the genetic relationships. The four
locations from which the isolates originated are abbreviated (to minimise the use of
space) as follows: CUH, Cork University Hospital; lEC, Irish Equine Centre; GUH,
University College Hospital, Galway; UHB, Northern Ireland Public Health Laboratory
Service.
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DAF
t>pe

AF pattern

Species

Host

CIT
no.

Origin

li Nil II
III II 1
MM
HUM 1
mil 11II
mill 1
mm 1
III II 1
III II 1
iiiiiiii 1
iiiiiiiiii 1
III 1
III! 1
III 1111
II Nil
INI 1 1
11 1 1 1
1 mil 11
1 HIM
1 llilll
llfllll
mill
mil II
III Nil 1
I milII
llilll
mill
mill
iiiiiii
1 llilll
1 llilll

Campylobacter cc!i

Poultry

088

lEC

1

Campylobacter coli

Poultry

089

lEC

II

Campylobacter jejuni

Poultry

170

lEC

III

Campylobacter jejuni

Poultry

154

lEC

IV

Campylobacter jejuni

Poultry

153

lEC

V

Campylobacter jejuni

Poultry

150

lEC

VI

Campylobacter jejuni

Poultry

149

lEC

via

Campylobacter jejuni

Poultry

152

lEC

VIb

Campylobacter jejuni

Poultry

151

lEC

VIb

Campylobacter jejuni

Poultry

148

lEC

VII

Campytobacter jejuni

Poultry

147

lEC

VII

Campylobacter coli

Poultry

001

lEC

VIII

Campylobacter coli

Poultry

090

lEC

IX

Campylobacter coli

Poultry

093

lEC

X

Campylobacter coli

Poultry

183

lEC

Xa

Campylobacter coli

Poultry

094

lEC

XI

Campylobacter coli

Poultry

095

lEC

XII

Campylobacter jejuni

Human

246

CUH

XIII

1 nil 1
llilll
II mill
11 llilll
11 llilll
II mill
II llilll
11 llilll
II III 11
1 llilll
IIIIIII 11
11II ii 11
II mill
II mill
II mill
11 mill
II llilll
II null
II IIIIIII
II llilll
li IIIIIII
IIIIIIIIII
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Campylobacter jejuni

Human

288

CUH

Xllla

Campylobacter jejuni

Poultry

133

lEC

XIV

Campylobacter jejuni

Human

268

CUH

XlVa

Campylobacter jejuni

Poultry

203

lEC

XV

Campylobacter jejuni

Poultry

202

lEC

XV

Campylobacter jejuni

Poultry

212

lEC

XVa

Campylobacter jejuni

Poultry

117

lEC

XVb

Campylobacter jejuni

Human

248

CUH

XVc

Campylobacter jejuni

Poultry

333

UHB

XVc

Campylobacter jejuni

Human

270

CUH

XVd

Campytobacter jejuni

Human

253

CUH

XVe

Campylobacter jejuni

Human

296

CUH

xvt

Campylobacter jejuni

Poultry

318

UHB

XVI

Campylobacter jejuni

Human

295

CUH

XVg

Campytobacter jejuni

Human

294

CUH

XVh

Campylobacter jejuni

Human

293

CUH

XVi

Campylobacter jejunt

Human

299

CUH

XVI

Campylobacter jejuni

Poultry

311

UHB

XVI

Campylobacter jejuni

Poultry

313

UHB

XVI

Campytobacter jejuni

Poultry

314

UHB

XVI

Campylobacter jejuni

Poultry

317

UHB

XVI

Campylobacter jejuni

Poultry

322

UHB

XVla

Campytobacter j^uni

Human

336

CUH

XVIb

Campytobacter jejuni

Human

342

GUH XVIc

Campytobacter jejuni

Human

343

GUH XVIc

Campylobacter jejuni

Poultry

125

lEC

XVId

Campylobacter jejuni

Poultry

123

lEC

XVld

Campylobacter jejuni

Human

246

CUH

XVId

Campylobacter jejuni

Human

252

CUH

XVId

Campylobacter jejuni

Human

254

CUH

XVId

Campylobacter jejuni

Human

251

CUH

XVId

Campylobacter jejuni

Human

255

CUH

XVId

Campylobacter jejuni

Human

286

CUH

XVIe

Campylobacter jejuni

Human

285

CUH

XVIe

Campylobacter jejuni

Human

290

CUH

XVIe

Campylobacter jejuni

Human

289

CUH

XVIe

Campylobacter jejuni

Human

291

CUH

XVIf

Campylobacter jejuni

Human

244

CUH

XVlg

VF pattern

Species

Host

CIT

Origin

no.

II IHIIII

Hill II
IHIIII
mil II
HIM II
IHIIII
llllll
IHIIII
HUM
llllll
llilll
IHIIII
Hill 1
HUM
HUM
HUM
HUM
illll 1
IHIIII
llllll 11
Hli 11
HI 11
lllilM
IHIIII 1
IHIIII 1
I HUM
I HIIIM
1 mill
HUM
llllll
I HUM
I HUM
HUM
IIHIII
HI II
IIHIIH
HUM
I HIIIM
1 llllll
1 INI 11
1 HIM 1
IHIIII
HUM
1 Hll 1
1 HUM
I IHIIII 1
I HI HIM
i llllll 1
I IIII Hll
1 mill
I Hill HI 1
1 llllll
1 HI HI
1 III Hll
1 Hll 111
1 Hll 111
III HIM II
I HIMI
1 nil
1 II 11
1 IIHIII 1
Hlllliiil 1
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DAF
type

Campytobacier jejuni

Human

244

CUH

Campylobacter jejuni

Human

362

GUH XVlh

XVIg

Campylobacter jejuni

Human

366

GUH XVIh

Campylobacter jejuni

Human

292

CUH

XVIi

Campylobacter jejuni

Human

364

GUH

XVIi

Campylobacter jejuni

Human

361

GUH

XVIi

Campylobacter jejuni

Human

274

CUH

XVIj

Campylobacter jejuni

Human

280

CUH

XVIk

Campylobacter jejuni

Human

256

CUH

XVII

Campylobacter jejuni

Human

338

GUH XVII

Campylobacter jejuni

Poultry

320

UHB

XVII

Campylobacter jejuni

Poultry

024

lEC

XVtm

Campylobacter jejuni

Poultry

023

lEC

XVIm

Campylobacter jejuni

Human

258

CUH

XVIm

Campylobacter jejuni

Human

257

CUH

XVIm

Campylobacter jejuni

Human

350

GUH

XVIm

Campylobacter jejuni

Human

349

GUH

XVIm

Campylobacter jejuni

Human

337

GUH

XVIn

Campylobacter jejuni

Human

367

GUH

XVio

Campylobacter jejuni

Human

371

GUH XVIo

Campylobacter jejuni

Human

372

GUH XVIp

Campylobacter jejuni

Human

344

GUH

XVIq

Campylobacter jejuni

Human

335

CUH

XVIr

Campylobacter jejuni

Human

378

GUH

XVIr

Campylobacter jejuni

Human

345

GUH

XVIs

Campylobacter jejuni

Human

356

GUH

XVII

Camnpylobacter jejuni

Human

358

GUH

XVIt

Campylobacter jejuni

Human

360

GUH

XVII

Campylobacter jejuni

Human

357

GUH

XVIu

Campylobacter jejuni

Human

326

GUH

XVIv

Campylobacter jejuni

Human

353

GUH

XVIv

Campylobacter jejuni

Human

355

GUH

XVIv

Campylobacter jejuni

Poultry

319

UHB

XVIw

Campylobacter jejuni

Poultry

325

UHB

XVIw

Campylobacter jejuni

Human

283

CUH

XVIx

Campylobacter jejuni

Poultry

158

lEC

XVIy

Campylobacter jejuni

Human

369

GUH

XVIzI

Campylobacter jejuni

Human

249

CUH

XVIz2

Campylobacter jejuni

Human

282

CUH

XVIZ2

Campylobacter jejuni

Human

377

GUH

XVIz3

Campylobacter jejuni

Human

241

CUH

XVI24

Campylobacter jejuni

Human

250

CUH

XVlzS

Campylobacter jejuni

Poultry

302

UHB

XVIz6
XVIz7

Campylobacter jejuni

Poultry

156

lEC

Campylobacter jejuni

Human

365

GUH

XVIz8

Campylobacter jejuni

Human

260

CUH

XVIz9

Campylobacter jejuni

Human

264

CUH

XVIz9

Campylobacter jejuni

Human

263

CUH

XVIz9

Campylobacter jejuni

Human

261

CUH

XVIz9

Campylobacter jejuni

Poultry

047

lEC

XVIzI 0

Campylobacter jejuni

Human

265

CUH

XVIzIl

Campylobacter jejuni

Human

339

GUH

XVIzI 2

Campylobacter jejuni

Human

341

GUH XVtz12
GUH XVIzI 3

Campylobacter jejuni

Human

340

Campylobacter jejuni

Human

259

CUH

Campylobacter jejuni

Human

347

GUH XVIzI 5

Campylobacter jejuni

Poultry

116

lEC

Campylobacter jejuni

Poultry

195

lEC

XVIIa

Campylobacter jejuni

Poultry

025

lEC

XVIII

Campylobacter jejuni

Human

277

CUH

XVIIIa

Campylobacter jejuni

Poultry

227

lEC

XVIIIb

Campylobacter jejuni

Poultry

036

lEC

XIX

XVIzI 4
XVII

^

s

^

^

1

f.

DAF pattern
II

II II III

Species

C'lT
no.

Origin

DAF
type

I

II 1
n1
III 1
II 1
III II
II 1
II 1
lllli I II
III 1
II 1
II 1
I III II 1
II 1
II 1
II 1
1
1
1
1 1
II 1
II 1
1
1
1
II 1
1
I 1
1
I II
II 1
II II
1
II 1
II 1
1
II 1
II 1
II 1
1
II 1
1
1
1
1
1
1
I 1
1
1 1
1
1
1
1
1 1
1
I 1
1 1
I
1
1
1
1
1

227

Host

Campylobacter jejuni

Poultry

036

lEC

Campylobacter jejuni

Poultry

034

lEC

XIX
XiXa

Campylobacter jejuni

Poultry

032

lEC

XlXb

Campylobacter jejuni

Poultry

046

lEC

XIXc

Caunpytobacter jejuni

Poultry

033

lEC

XlXd

Campylobacter jejuni

Poultry

178

lEC

XIXe

Campylobacter jejuni

Human

352

GUH

XIXt

Campylobacter jejuni

Poultry

002

lEC

XX

Campylobacter jejuni

Poultry

031

lEC

XXa

Campylobacter jejuni

Poultry

166

lEC

XXI

Campylobacter jejuni

Poultry

169

lEC

XXI

Campylobacter jejuni

Human

351

GUH

XXIa

Campylobacter jejuni

Poultry

167

lEC

XXIb

Campylobacter jejuni

Poultry

177

lEC

XXIb

Campylobacter jejuni

Poultry

176

lEC

XXIb

Campylobacter jejuni

Poultry

163

lEC

XXIc

Campylobacter jejuni

Human

374

GUH

XXIc

Campylobacter jejuni

Human

370

GUH

XXId

Campylobacter jejuni

Poultry

161

lEC

XXIe

Campylobacter jejuni

Poultry

182

lEC

XXIe

Campylobacter jejuni

Poultry

042

lEC

XXIf

Campylobacter jejuni

Poultry

038

lEC

XXII

Campylobacter jejuni

Poultry

045

lEC

XXIIa

Campylobacter jejuni

Poultry

157

lEC

XXIII

Caonpylobacter jejuni

Human

334

GUH

XXIIIa

Campylobacter jejuni

Poultry

026

lEC

XXIIIb

Campylobacter jejuni

Human

267

CUH

XXIIIc

Campylobacter jejuni

Poultry

110

lEC

XXIIId

Campylobacter jejuni

Human

266

CUH

XXIV

Campylobacter jejuni

Human

275

CUH

XXIVa

Campylobacter jejuni

Poultry

187

lEC

XXIVb

Campylobacter jejuni

Poultry

028

lEC

XXV

Campylobacter jejuni

Poultry

181

lEC

XXVa

Campylobacter jejuni

Poultry

018

lEC

XXVI

Campylobacter jejuni

Poultry

017

lEC

XXVI

Campylobacter jejuni

Poultry

224

lEC

XXVIa

Campylobacter jejuni

Human

271

CUH

XXVIta

Campylobacter jejuni

Human

272

CUH

XXVIb

Campylobacter jejuni

Poultry

039

lEC

XXVII

Campylobacter jejuni

Poultry

175

lEC

XXVIla

Campylobacter jejuni

Poultry

112

lEC

XXVlIb

Campylobacter jejuni

Poultry

119

lEC

XXVlIb

Campylobacter jejuni

Poultry

118

lEC

XXVlIb

Campylobacter jejuni

Poultry

115

lEC

XXVIlc

Campylobacter jejuni

Poultry

105

lEC

XXVIII

Campylobacter jejuni

Poultry

107

lEC

XXVIII

Campylobacter jejuni

Human

348

GUH

XXVIlla

Campylobacter jejuni

Human

281

CUH

XXIX

Campylobacter jejuni

Human

375

GUH

XXIXa

Campylobacter jejuni

Poultry

171

lEC

XXIXIb
XXIXc

Campylobacter jejuni

Poultry

155

lEC

Campylobacter jejuni

Poultry

324

UHB

XXIXd

Campylobacter jejuni

Human

243

CUH

XXIXe

Campylobacter jejuni

Human

284

CUH

XXIXI

Campylobacter jejuni

Poultry

072

lEC

XXX

Campylobacter jejuni

Human

346

GUH

XXXI

Campylobacter jejuni

Human

368

GUH

XXXIa

Campylobacter jejuni

Poultry

193

lEC

XXXII

Campylobacter jejuni

Human

312

GUH

XXXIIa

Campylobacter jejuni

Poultry

160

lEC

XXXIll

Campylobacter jejuni

Poultry

162

lEC

XXXIII

Campylobacter jejuni

Poultry

048

lEC

XXXIIIa

Campylobacter j^uni

Human

354

GUH

XXXIIlb

DAF pattern

Host

Species

CIT

DAF

Origin

type

no.
1

III ill II
II II II
lllllll
mil III
lllllll
1 Mil
1 mill
1 nil
II Hill
1 III 11 1
1 Hill
1 mill
1 mil
mill
1 mil II
1 IIIIHIII
II liMI II
II mm
II III 1
11 1 Hi II
Hill 1
nil
'i

ill'
Hill

i
1 iiii
i mill
nil 1 II
1 mil
1 mill 11
iiiiii
11 III
II11
iiiiiiii

1 Mill
1 III! 1
1 Mil
Hllili
Hll
Hill 1
1 Mil 1
HI
Ml
IIII
IIIIIIII
i IIIIII
1 IIHIIi
IIII
1 1 Mil
1 lliil
1 HIHIII
1 Hllil
1 mil
IIIIIIII
millill
III lliil
1
1 II
lliil
Mill

1 II IIIIII

228

1
1

Campylobacter jejuni

Human

354

GUH XXXIIIb

oampyiobacter jejunt

Human

<L<\I

UUH

XXAIIIC

Campylobacter jejuni

Poultry

316

UHB

XXXIIId

Campylobacter jejuni

Poultry

165

lEC

XXXIIIe

Campylobacter jejuni

Poultry

179

lEC

XXXIIIf

Campylobacter jejuni

Poultry

041

lEC

XXXIV

Campylobacter jejuni

Poultry

114

lEC

XXXIVa

Campylobacter jejuni

Poultry

120

lEC

XXXV

Campylobacter jejuni

Human

278

CUH XXXVa

Campylobacter jejuni

Poultry

306

UHB

Campylobacter jejuni

Human

359

GUH XXXVI

Campylobacter jejuni

Poultry

205

lEC

XXXVII

Campylobacter jejuni

Poultry

206

lEC

XXXVII

Campylobacter jejuni

Human

373

GUH XXXVIla

Campylobacter jejuni

Poultry

172

lEC

XXXVIII

Campylobacter jejuni

Poultry

174

lEC

XXXVII

Campylobacter jejuni

Poultry

226

lEC

XXXIX

Campylobacter jejuni

Poultry

228

lEC

XXXIXa

Campylobacter jejuni

Human

376

GUH XXXIXb

Campylobacter jejuni

Poultry

229

lEC

Campylobacter jejuni

Poultry

330

UHB

IXL

Campylobacter jejuni

Poultry

103

lEC

XLII

Campylobacter jejuni

Poultry

230

lEC

XUIa

Campylobacter jejuni

Poultry

225

lEC

XUII

Campylobacter jejuni

Poultry

200

lEC

XLIV

Campylobacter jejuni

Poultry

208

lEC

XLIVa

Campylobacter

XXXVI

XL

Poultry

310

UHB

XLV

Campylobacter jejuni

Poultry

173

lEC

XLVI

Campylobacter jejuni

Poultry

185

lEC

XLVIa

Campylobacter jejuni

Poultry

044

lEC

XLVIl

Campylobacter jejuni

Poultry

237

lEC

XLVIla

Campylobacter jejuni

Poultry

040

lEC

XLVIll

Campylobacter jejuni

Poultry

168

lEC

XLVIlla

Campylobacter jejuni

Poultry

240

lEC

XLVIlIb

Campylobacter jejuni

Poultry

052

lEC

XUX

Campylobacter jejuni

Poultry

054

lEC

L

Campylobacter jejuni

Poultry

111

lEC

LI

Campylobacter jejuni

Poultry

214

lEC

Ua

Campylobacter jejuni

Human

269

CUH

Ub

Campylobacter jejuni

Poultry

030

lEC

Lll

Campylobacter jejuni

Poultry

223

lEC

Lila

Campylobacter j^uni

Poultry

100

lEC

Llll

Campylobacter jejuni

Poultry

211

lEC

LIV

Campylobacter jejuni

Poultry

096

lEC

LV

spp

Campylobacter jejuni

Poultry

159

lEC

LVa

Campylobacter jejuni

Poultry

029

lEC

LVI

Campylobacter jejuni

Poultry

043

lEC

LVIl

Campylobacter jejuni

Poultry

215

lEC

LVIla

Campylobacter jejuni

Human

298

CUH

LVIll

Campylobacter jejuni

Human

300

CUH

LVlIla

Campylobacter jejuni

Poultry

124

lEC

LIX

Campylobacter jejuni

Poultry

127

lEC

LIXa

Campylobacter jejuni

Poultry

132

lEC

LIXb

Campylobacter jejuni

Poultry

129

lEC

UXc

Campylobacter jejuni

Poultry

134

lEC

UXd

Campylobacter jejuni

Poultry

131

lEC

LX

Campylobacter jejuni

Poultry

130

lEC

l_Xa

Campylobacter jejuni

Poultry

067

lEC

LXI

Campylobacter jejuni

Poultry

301

UHB

LXII

Campylobacter coil

Poultry

113

lEC

LXIII

Campylobacter jejuni

Poultry

106

lEC

LXIV

Campylobacter jejuni

Poultry

191

lEC

LXIVa

Campylobacter jejuni

Poultry

079

lEC

LXV

DAF pattern

Species

Host

CIT

Origin

no.

1 li I I III
1 III Hill
III III!
Ill III! 11
Ill lill
III II 1 II
1 1 III 1
mill
III INI 11
III nil
II mil
II 111
III III 11
III mil 11 II
1II II
II1
1 III 1
Mil 1 11
1 II III 1
1 HIM
1 III III
III mill II
III III III II
II III
Hill
nil
mill
miiiii
nil 1
II Hill 11
Hill 1
1 mill III
1 Hill
III HIM
Ml 11 III
MIHIIIHI
II INI
II mil
1 Mini
1 HUM
1 HUM
11 mill
II III!Hill
1 HIM
HI III!
HI nil
HHIHI
Hllll
Hill
Mini
1 Hill
Hllll
MIIIII
III HI
III Ml
Ml Ml
1 mill
III!
MIHIII
11 Hill 11 1
1 III
1 1 III 1
1 HIM

229

DAF
type

Campytobacter jejuni

Poultry

079

lEC

LXV

Campylobacter jejuni

Poultry

108

lEC

LXVa

Campylobacter jejuni

Poultry

075

lEC

LXVI

Campylobacter j^uni

Poultry

078

lEC

LXVI

Campylobacter jejuni

Poultry

076

lEC

LXVI

Campylobacter jejuni

Poultry

077

lEC

LXVIa

Campylobacter jejuni

Poultry

102

lEC

LXVIl

Campylobacter jejuni

Human

276

CUH

LXVIla

Campylobacter jejuni

Poultry

073

lEC

LXVIll

Campylobacter jejuni

Poultry

101

lEC

LXVIlla

Campylobacter jejuni

Poultry

064

lEC

LXIX

Campylobacter jejuni

Poultry

066

lEC

LXIXa

Campylobactet jejuni

Poultry

059

lEC

LXX

Campylobacter jejuni

Poultry

062

lEC

LXXI

Campylobacter jejuni

Poultry

074

lEC

LXXII

Campylobacter jejuni

Poultry

065

lEC

LXXIII

Carrtpylobacter jejuni

Human

279

CUH

LXXIIIa

Campylobacter jejuni

Poultry

145

lEC

LXXIV

Campylobacter jejuni

Poultry

109

lEC

LXXV

Campylobacter jejuni

Poultry

135

lEC

LXXVa

Campylobacter jejuni

Poultry

104

lEC

LXXVI

Campylobacter jejuni

Poultry

137

lEC

LXXVIl

Campylobacter j^uni

Poultry

136

lEC

LXXVll

Campylobacter jejuni

Poultry

207

lEC

LXXVIll

Campylobacter )ejuni

Poultry

122

lEC

LXXIX

Campylobacter jejuni

Human

297

CUH

LXXIXa

Campylobacter jejuni

Poultry

232

lEC

LXXX

Campylobacier jejuni

Poultry

235

lEC

LXXXa

Campylobacter jejuni

Poultry

007

lEC

LXXXI

Campylobacter jejuni

Poultry

236

lEC

LXXXII

Campylobacter jejuni

Poultry

239

lEC

LXXXIIa

Campylobacter jejuni

Poultry

012

lEC

LXXXIII

Campylobacter jejuni

Poultry

199

lEC

LXXXIIIa

Campylobacter jejuni

Poultry

196

lEC

LXXXIV

Campylobacter jejuni

Poultry

197

lEC

Lxxxrv

Campylobacter jejuni

Poultry

013

lEC

LXXXIVa

Campylobacter jejuni

Poultry

213

lEC

LXXXV

Campylobacter jejuni

Human

267

CUH

LXXXVa

Campylobacter j^uni

Poultry

006

lEC

LXXXVI

Campylobacter jejuni

Poultry

216

lEC

LXXXVIl

Campylobacter jejuni

Poultry

218

lEC

LXXXVIl

Campylobacter jejuni

Poultry

126

lEC

LXXXVIla

Campylobacter jejuni

Human

242

CUH

LXXXVIlb

Campylobacter jejuni

Human

273

CUH

LXXXVIlc

Campylobacter jejuni

Poultry

220

lEC

LXXXVIll

Campylobacter jejuni

Poultry

219

lEC

LXXXVIlla

Campylobacter jejuni

Poultry

221

lEC

LXXXVIlIb

Campylobacter jejuni

Poultry

222

lEC

LCCCVIIIc

Campylobacter jejuni

Poultry

128

lEC

LXXXVIlId

Campylobacter jejuni

Poultry

217

lEC

LXXXVIlle

Campylobacter jejuni

Poultry

008

lEC

LXXXIX
LXXXIXa

Campylobacter jejuni

Poultry

010

lEC

Campylobacter jejuni

Poultry

Oil

lEC

LXXXIXb

Campylobacter jejuni

Poultry

060

lEC

LXL

Campylobacter jejuni

Poultry

081

lEC

LXLa

Campylobacter jejuni

Poultry

003

lEC

ULI

Campylobacter jejuni

Poultry

143

lEC

LXUI

Campylobacter jejuni

Poultry

142

lEC

LXUll

Campylobacter jejuni

Poultry

144

lEC

LXLIV

Campylobacter jejuni

Human

363

GUH

LXLIVa

Campylobacter jejuni

Poultry

139

lEC

LXLV

Campylobacter jejuni

Poultry

138

lEC

LXLVa

Campylobacter jejuni

Poultry

140

lEC

LXLVI

DAF pattern

Species

Host

CIT

Origi n

DAF

no.

1 1 ill 1 1
1 mil 1
1 III II 1
1 Mill
ill liiii
I 1 II 1
iiiiiiiiii
II Ml
1 Hill 1
1 Mil 1
III II
III II1
1 llll IIIII
1 INI II
1 llllll 1
1 llll
1 HIM 1
I mill 1
II iiiiiii 1
Hill 1
II1 II
Ml nil
IIII Mil 1
IIM II II
llll 1 1 1
II nil
II 111
II Mil
II1 Mil
III nil
1 mill
III IIUIIII
III III 1
III III
llll 111
II1 II1
IN nil
II nil
III nil
III nil
II Mini
111 III 11
llll llll I
II mil
U 1 1 1
II 1 III
1 I III
II llllll I
1II iiiiiii

iiiiiniiii

iniiiinii
1 nnini
llllll 1
11 nil 1
11 III II1
ill llllll
III mil
nil nil
III Hill
III Hill
ill Mill
III llllll
1 llllll
ill nil 1

230

type

Campylobacter jejuni

Poultry

138

lEC

LXLVa

Campylobacter jejuni

Poultry

140

lEC

LXLVI
LXLVia

Campylobacter jejuni

Poultry

146

lEC

Campylobacter jejuni

Poultry

061

lEC

LXLVIl

Campylobacter jejuni

Poultry

063

lEC

LXLVIla

Campylobacter jejuni

Poultry

058

lEC

LXLVIl 1

Campylobacter coll

Poultry

099

lEC

LXLIX

Campylobacter coli

Poultry

209

lEC

C

Campylobacter jejuni

Poultry

051

lEC

Cl

Campylobacter jejuni

Poultry

304

UHB

Cll

Campylobacter jejuni

Poultry

035

lEC

Clll

Campylobacter jejuni

Poultry

055

lEC

CIV

Campylobacter jejuni

Poultry

097

lEC

CV

Campylobacter jejuni

Poultry

098

lEC

CVa
CVb

Campylobacter jejuni

Poultry

331

UHB

Campylobacter jejuni

Poultry

121

lEC

CVI

Campylobacter spp

Poultry

328

UHB

evil

Campylobacter jejuni

Poultry

091

lEC

CVIII

Campylobacter jejuni

Poultry

233

lEC

evix
CX

Campylobacter jejuni

Poultry

192

lEC

Campylobacter jejuni

Poultry

164

lEC

CXI

Campylobacter coli

Poultry

184

lEC

CXIl

Campylobacter coli

Poultry

234

lEC

CXIII

Campylobacter jejuni

Poultry

196

lEC

CXIV

Campylobacter coll

Poultry

092

lEC

cxv

Campylobacter coli

Poultry

022

lEC

CXVI

Campylobacter coli

Poultry

307

UHB

CXVIa

Campylobacter coli

Poultry

309

UHB

CXVIb

Campylobacter coli

Poultry

027

lEC

CXVIc

Campylobacter coli

Poultry

050

lEC

CXVIl

Campylobacter coli

Poultry

020

lEC

CXVIll

Campylobacter coli

Poultry

210

lEC

CXVIlla

Campylobacter coll

Poultry

327

UHB

CXIX

Campylobacter coli

Poultry

329

UHB

CXIXa

Campylobacter coli

Poultry

085

lEC

CXIXb
CXIXe

Campylobacter coli

Poultry

332

UHB

Campylobacter coll

Poultry

190

lEC

CXIXd

Campylobacter coli

Poultry

189

lEC

CXIXd

Campylobacter spp.

Poultry

321

UHB

CXIXe

Campylobacter spp.

Poultry

308

UHB

CXIXf

Campylobacter coli

Poultry

056

lEC

exx

Campylobacter coli

Poultry

057

lEC

eXXa

Campylobacter coll

Poultry

060

lEC

eXXb

Campylobacter coli

Poultry

069

lEC

CXXI

Campylobacter coli

Poultry

066

lEC

exxia

Campylobacter coli

Poultry

021

lEC

CXXII

Campylobacter coli

Poultry

305

UHB

CXXI la

Campylobacter jejuni

Poultry

004

lEC

CXXIII

Campylobacter coli

Poultry

019

lEC

CXXIIIa

Campylobacter coli

Poultry

186

lEC

CXXIV

Campylobacter coli

Poultry

188

lEC

CXXIV

Campylobacter coli

Poultry

016

lEC

exxv
CXXVi

Campylobacter jejuni

Poultry

238

lEC

Campylobacter jejuni

Poultry

231

lEC

exxvil

Campylobacter jejuni

Poultry

086

lEC

CXXVIll

Campylobacter coli

Poultry

007

lEC

CXXIX

Campylobacter coli

Poultry

015

lEC

CXXIXa

Campylobacter coli

Poultry

014

lEC

exxx

Campylobacter coli

Poultry

071

lEC

CXXXI

Campylobacter coli

Poultry

070

lEC

CXXXI

Campylobacter coli
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Figure 2 (overleaf): DNA amplification fingerprint (DAF) patterns of isolates CIT-001
to CIT-378 typed using the 10-mer primer HLWL85 (Mazurier et al., 1992). For
detection an aliquot of 10 pL from each reaction mix was combined with 2 pL of loading
dye and electrophoresed on a 1.5% conventional agarose gel for 1.5 h at 100 V. Lane M
in all gels contains molecular weight markers grade Ill and V (Roche). The following
isolates showing 100% similaity are marked: CITy-296andy -318; CIT ♦-248
and 4-333; CIT q -326, q-353 and q -355. Note: print quality varies somewhat
between photographs.
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8.1. Abstract
A collection of 145 Campylobacter isolates comprising 100 human and 45 poultry strains
which were isolated during the year 2000 was assessed for susceptibility to tetracycline.
When tested by disc diffusion and E-test methods, a total of 29% (42) of these isolates
were resistant to tetracycline. This corresponded to 31 % (31) resistance among clinical
isolates and 24.4% (11) resistance among the poultry-derived isolates. Overall resistance
among C. jejuni isolates was 27.7%, compared to 40% for C. coli isolates. A subset of 74
isolates (50 human and 24 poultry) was further tested for the presence of the tetO gene, by
polymerase chain reaction (PCR). Sixty-eight isolates (91.9%) were PCR positive and in
agreement with antimicrobial susceptibility tests. Of the remaining six isolates (8.1%),
all of which were identified as C. jejuni, a single isolate phenotypically confirmed as
being resistant to tetracycline failed to generate the 171 bp amplicon, and the remaining
five isolates generated the 171 bp amplicon, but on testing were susceptible to
tetracycline. Two of these isolates showed MICs of six and eight pg/mL by E-test,
respectively, which signifies low-level resistance. Tetracycline resistance among
Campylobacter spp. has been associated with the presence of plasmids of various sizes.
Analysis of this collection showed that 30.1% of isolates possessed plasmids, and that
plasmids were more frequently isolated from poultry (49%) than from human sources
(13%). Furthermore, plasmids were more commonly isolated from C. coli of poultry
origin (73.7%) than from C. jejuni (33.3%). Plasmid sizes ranged from approximately
two to 23 kbp, and two or more plasmids were commonly isolated from a single isolate.
However, a 23 kbp plasmid was isolated from eight of the nine human and poultry
isolates (both C. jejuni and C. coli) that harboured plasmids and that were resistant to
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tetracycline. The remaining isolate contained a 12 kbp plasmid. A 23 kbp plasmid was
isolated from only four of the 11 human and poultry isolates (C. jejuni and C. coli) that
harboured plasmids and that were sensitive to tetracycline. Among the subset of poultryand human-derived tetracycline-resistant isolates tested, the tetO gene was located
variously to the chromosome and to a 23 kbp plasmid.
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8.2. Introduction
Campylobacter is recognised as a leading cause of human bacterial enteritis worldwide
(Solomon and Hoover, 1999). Poultry products are believed to account for the majority
of these infections in humans (Harris et ai, 1986; Jacobs-Reitsma, 2000).

The use of antimicrobial chemotherapy in the management of human Campylobacter
enteritis is indicated only in cases of severe or recurrent infection. Erythromycin has
remained the drug of choice in these cases (Blaser et al., 1995), and ciprofloxacin is also
frequently recommended, and has been used prophylactically for foreign travel, as the
tluoroquinolones have also been shown to have good in-vitro activity against the
Enterobacteriaceae (Wistrom and Norrby, 1995). Tetracycline, which is a broadspectrum antimicrobial agent, has also been suggested as an alternative therapy for
treating Campylobacter enteritis in adults (Williams et al., 1989). Increasing
antimicrobial resistance to these and other agents is a cause of concern, however, and
empiric treatment of enteric infection now carries a significant possibility of failure.
Since their introduction in the 1950s, tetracyclines have not only been widely used in
human medicine, but have also been heavily used in veterinary medicine, as growth
promoters in the animal industry, and for prophylaxis in plant agriculture and aquaculture
(Aminov et al., 2001).

Antimicrobial resistance profiling of Campylobacter spp. in Ireland during the period
1996-1998 demonstrated tetracycline resistance rates of 14 and 19% among human and
poultry isolates, respectively (Lucey et al., 2000). Tetracyclines inhibit protein synthesis
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by preventing the binding of aminoacyl-tRNA molecules to the 3OS ribosomal subunit
(Schnappinger and Hillen, 1996). Resistance in C. jejuni and C. coli is most commonly
facilitated by the production of the soluble ribosomal protection protein TetO, which
appears to inhibit the binding of tetracycline to the functioning ribosomes involved in
protein synthesis (Taylor and Chau, 1996). A lesser-known and uncommon mechanism
by which tetracycline resistance can occur in Campylobacter is through an energydependent efflux of tetracycline brought about by an integral membrane protein (Levy,
1992). Tetracycline resistance has been associated with the presence of plasmids in both
C. jejuni and C. coli. One study in India (Prasad et al., 1994) noted tetracycline
resistance rates of 6.7 and 13.3% among human and poultry C. jejuni isolates,
respectively, which was linked in all cases to the presence of a 23 kbp plasmid. An
Israeli study (Schwartz et al., 1993) noted that 80% of tetracycline-resistant C. jejuni
isolates carried up to five plasmids of various sizes, and that the presence of plasmids in
tetracycline-sensitive isolates was uncommon. Tenover et al. (1985) isolated tetracycline
resistance plasmids ranging in size from 2 to 162 kbp among Campylobacter spp., all
showing a surprisingly high degree of nucleotide sequence similarity with one another. A
variety of plasmid isolation rates has been reported, ranging from 16% (Aquino et al.,
2002) to between 44% for clinical isolates and 91% for poultry in a study by Lee et al.
(1994), in Taiwan. In the same study by Lee et al., it was reported that 98% of poultryderived C. jejuni and C. coli (tetracycline-resistant) isolates hybridised with a tetO probe,
and that 87% of hybridisation reactions occurred on plasmids, while 11% occurred on the
chromosome. However, while 88% of the resistant clinical C. jejuni and C. coli isolates
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hybridised with the tetO probe, only 47% of hybridisation reactions occurred on
plasmids; the remaining 41% occurred on the chromosome.

The aim of this study was to investigate the molecular basis underlying tetracycline
resistance among a population of Campylobacter spp., isolated during the year 2000 in
Ireland, from human and poultry sources. These data may provide the basis to develop a
suitable assay aimed at monitoring the dissemination of resistance to this valuable
antimicrobial agent.
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8.3. Materials and Methods
8.3.1. Bacterial isolates
The study collection was comprised of Campylobacter strains from human and poultry
sources, all of which were isolated during the year 2000 and which were submitted to the
Molecular Diagnostics Unit (MDU) by Cork University Hospital and The Irish Equine
Centre. Three reference strains (C. jejuni NCTC 11351, C. coli NCTC 11353 and C. lari
NCTC 11352 were included as controls. All isolates were preserved on cryostat beads at
-80°C for long-term storage. Isolates were sub-cultured onto Preston Agar consisting of
Campylobacter Agar Base, Oxoid CM689 (Oxoid, Basingstoke, UK), containing Oxoid
Campylobacter Modified Selective Supplement SR204E and 5% (v/v) Lysed Horse
Blood). Subcultures were incubated at 42"C for 48 h in a microaerophilic environment
generated by using a BioMerieux GENbox gas generating kit (Marcy I’Etiole, France).

8.3.2. Bacterial identification
Bacteria were initially identified by examining for typical microscopic and colonial
morphology, and were then subcultured onto Columbia Blood Agar (Columbia Agar Base
Oxoid CM331, with 5% (v/v) defibrinated horse blood) for biochemical testing. Having
been assessed for purity, all cultures were tested for positive oxidase and catalase
reactions and for their ability to hydrolyse hippurate (hippurate diagnostic tablets, Rosco
Diagnostica, Taastrup, Denmark). Hippurate hydrolysis tests were performed according
to the manufacturer’s instructions. The detection of glycine (as a by-product of hippurate
hydrolysis) was achieved by the addition of ninhydrin 3.5% (v/v) solution (Rosco
Diagnostica). All isolates were further characterised by PCR amplification of 23S rRNA
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C. jejuni- and C. c*o/z-specific gene fragments, according to the method of Eyers et al,
(1993). Isolates not definitively identified by the first combination of tests were subjected
to further testing using the following methods: C /ar/-specific PCR using Eyers’s
method, PCR amplification of the ceuE gene for the specific identification of C. jejuni
and C. coli, using the method of Gonzalez et al. (1997), and hippuricase gene PCR, by
the method of Linton et al. (1997). All speciation PCR reactions were performed
according to the authors’ instructions.

8.3.3, Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed using the agar disc diffusion method
on IsoSensitest Agar (Difeo, Dublin, Ireland) with 5% (v/v) lysed horse blood (LHB)
according to the method of Reina et al. (1994), using tetracycline discs (containing 10 and
30 pg of the antibiotic). Agar plates containing the required antibiotic discs were
incubated at 37°C in microaerophilic conditions for 24 h or, where necessary, for 48 h.
Inhibition zone sizes were recorded in accordance with the guidelines of the National
Committee for Clinical Laboratory Standards, (NCCLS) (1981, 1999). The disc diffusion
method was selected after research by Gaudreau and Gilbert (1997) demonstrated
complete correlation between disc diffusion and agar dilution methods for susceptibility
testing of C. jejuni and C. coli to tetracycline. All isolates exhibiting resistance to
tetracycline were further tested for antimicrobial susceptibility using the tetracycline
E-test, according to the manufacturer’s instructions (AB Biodisc, Solna, Sweden).
Interpretation of results was according to the NCCLS guidelines (1981, 1999), [i.e: a
Minimum Inhibitory Concentration (MIC) to tetracycline of >16 pg/mL is interpreted as a
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resistant isolate].

8.3.4. DNA isolation
Isolates were cultured on Preston Agar at 42°C for 48 h under microaerophilic conditions
as outlined previously. Cultures were suspended in 1 mL 0.85% (w/v) NaCl (attaining a
turbidity of McFarland 6 turbidity standard) and were treated according to the method of
Gibson et al. (1994) to inhibit any DNAse activity, prior to DNA extraction. DNA
extraction was performed as described previously (Lind et al., 1996). DNA
concentrations were measured at 260 and 280 nm, and the integrity of the purified
template was assessed by testing a 10 pL aliquot in a conventional 1.5% (w/v) agarose
gel. DNA was stored at 4°C.

8.3.5. PCR-based detection of the tetO gene
Primers tetO FW (5’-ACG GAR AGT TTA TTG TAT ACC-3’) and tetO RV (5’-TGG
CGT AT TAT AAT GTT GAC-3’) were used in accordance with the method of Aminov

et al. (2001), where R denotes a purine. These primers were derived from the tetO gene
sequence previously published by Manavathu et al. (1988), [Accession No. Ml 8896], and
produced an amplicon of 171 bp in size.

PCR amplification was performed in 20 pL reaction volumes containing 200 ng of
purified template DNA, 2.5 pL of lOX buffer (100 mmol/1 Tris-HCl, [pH 8.3], 500
mmol/1 KCl), a 100 pM concentration of each deoxynucleoside triphosphate, 2.5 mM
MgCb, 1 Unit Tag DNA polymerase and 100 pmol of each primer (above). Thermal
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cycling conditions were as follows: 94°C for 5 min, 25 cycles of 94°C for 30s, 60°C for
30s and 72°C for 30s, followed by a final extension step of 72°C for 7 min.

8.3.6. Plasmid isolation and restriction endonuclease digestion
Plasmids were purified from cultures grown on Campylobaeter (Preston) Agar using the
Wizard®P/w5 SV Minipreps DNA purifieation system (Promega, Madison, WI).
The contents of each of the above plates containing a pure 48 h Campylobacter culture
was emulsified in 1.5 mL 0.85% (w/v) NaCl and the cell suspension introdueed into a 2
mL mierocentrifuge. The turbidity was set to correspond to McFarland 6 turbidity
standard. Plasmid isolation was performed in aeeordance with the manufacturer’s
reeommendations. All isolations were performed in duplicate, to ensure reprodueibility
of results.

A restriction digest of purified plasmid DNA was performed with the following
restrietion enzymes: BamWl, BglW, EcoK\, EcoK\, //mdlll, and Nci\, All digests were
earned out aceording to the manufaeturer’s instruetions (Promega).

8.3.7. Conventional agarose gel electrophoresis
For detection, 10 pL of PCR product were combined with 2 pL of loading dye and
eleetrophoresed in a 2% (w/v) agarose gel in IX Tris-EDTA-acetate (TAE) buffer
containing 0.1 pg/ml ethidium bromide at 90 V for 90 min. Plasmids were deteeted by
eombining 20 pL of product with 4 pL of loading dye, followed by electrophoresis in a
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0.8% (w/v) agarose gel at 100 V for 1.5 h in a IX TAE buffer as for PCR products. Gel
images were captured on a UV transilluminator using GrabiE^ software (Phoretix, UK).

8.3.8. Labelling of tetO FW probe for Southern blotting
Incorporation of a DIG label was achieved for the tetO sequence by including 1 pL DIGlabelled dUTP (DIG-11-dUTP) from Roche Diagnostics (East Sussex, UK) in the above
PCR reaction. Probe-labelled DNA fragments were recovered by precipitating 40 pL of
each product in a mixture containing 4 pL 4M LiCl and 150 pL of cold (absolute)
ethanol. The probe was incubated at -20°C, cind was then centrifuged at 12,000 rpm for
15 min. Supernatant was aspirated using a suitable pipette and the DNA pellet was
washed gently (by pipetting) 50 pL volumes of 70% (v/v) ethanol over the pellet. When
the 70% ethanol was aspirated, the pellet was air dried for 10 min. Finally, the pellet was
re-suspended in 50 pL TE Buffer, and incubated at 37°C for 30 min to aid in dissolving
the labelled probe in the pellet. The entire probe mixture was then transferred to 10 mL
of hybridisation solution and stored at -20°C until required.

8.3.9. Pulsed-Field Gel Electrophoresis (PFGE)
A “one-day standardised laboratory protocol for the molecular subtyping of
Campylobacter spp. by PFGE” (adapted for Campylobacter spp. from the PulseNet
Method for non-typhoidal Salmonella, 2000) was applied in this study. All isolates were
formaldehyde-treated prior to the generation of agarose plugs according to the method of
Gibson et al. (1994). Plugs containing total cellular DNA were digested using the
enzyme Sma\ (Promega). Following digestion, samples and molecular weight markers
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were loaded onto a 1% SeaKem® Gold (SKG) Agarose gel (FMC BioProducts,
Vallesbaek Strand, Denmark). Molecular weight markers consisted of low range and
mid-range PFG markers (New England BioLabs, Hertfordshire, UK). An electric current
of 200 V was applied to perform electrophoresis of the PFGE products. DNA fragments
were separated using a ramped pulse switching every 0.5 to 25 s for 20 h, at 10.5°C
(Hanninen et al., 1998).

8.3.10, Southern blotting of plasmid and PFGE gels
DNA transfer from agarose gels to nylon membranes was achieved using vacuum blotting
with the Hybaid'*''^ Vacu-Aid apparatus (Hybaid, Middlesex, UK), according to the
manufacturer’s instructions.

8,3.11. Hybridisation of nylon membranes with labelled DIG-DNA probes
Hybridisation and any subsequent washing steps were all carried out in a Hybaid™
rotating oven and using a DIG-DNA hybridisation and detection kit (Roche), according to
the manufacturer’s instructions. Briefly, the nylon membrane was placed in a
hybridisation bottle with pre-warmed hybridisation solution and incubated in the
hybridisation oven for 1 h at 58°C. The probe was denatured by boiling for 10 min and
was then cooled rapidly in ice water. After removal of the hybridisation solution the
probe solution was added. Hybridisation was allowed to occur at 58°C overnight (18-24
h) in the rotating oven. After subsequent washing steps, colour detection was performed
for the detection of any hybridised probe-target complexes. A period of up to 24 h was
allowed for optimal colour development.
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8.4. Results
8.4.1. Tetracycline susceptibility profiles of the collection
A total of 145 isolates were assessed for susceptibility to tetracycline by disc diffusion
and E-test methods. The isolates investigated included 100 human isolates (96 C. jejuni
and 4 C. coli) and 45 poultry isolates (34 C. jejuni and 11 C. coli). Table 1 provides a
summary of isolate antimicrobial susceptibility to tetracycline. In total, 29% (42) of the
isolates in this collection were found to be resistant to tetracycline. This corresponded to
31 % (31) resistance among clinical isolates and 24.4% (11) resistance among the poultryderived isolates. Overall the resistance among C. jejuni isolates was 21.1%, while that
for the smaller population of C. coli isolates (15) amounted to 40% (data not shown).

8.4.2. Molecular confirmation of the presence of the tetO gene in Campylobacter spp.
Aminov el al. (2001), previously investigated tetracycline resistance genes (that encoded
ribosomal protection proteins), among swine faecal streptococci and C. jejuni. These
authors developed a set of primers tetO FW and tetO RV to generate a 171 bp amplicon,
consistent with the presence of the /e/(9-encoding gene. This amplicon could be detected
in an isolate phenotypically confirmed to be resistant to tetracycline. In this study a
subset comprising 54 human (53 C. jejuni and a single C. coli isolate) and 20 poultry
isolates (including 10 each of C. jejuni and C. coli) was tested. Figure 1 provides a
representative sample of the data obtained after PCR; several isolates produced the
expected 171 bp amplicon, confirming the presence of the /e/O-encoding gene.
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Table 2 shows a composite of all results obtained for this subset, including tetracycline
susceptibility/resistance status and its correlation with the absence/presence of the
amplicon. Of the 45 isolates determined to be sensitive by phenotype-based methods
(Table 2, corresponding isolates shaded in turquoise), five contained the /e?/0-encoding
gene (Table 2, corresponding isolates shaded in turquoise and white), following PCR.
Similarly, 29 isolates were resistant after analysis by disc diffusion and of these 28
produced the 171 bp amplicon, showing evidence of good correlation between the two
methods (Table 2, corresponding isolates shaded in grey and yellow). Table 3 shows an
analysis of these results. In summary, a total of 68 isolates (or 91.9% of this subset)
generated PCR results that were concordant with phenotypic sensitivity/resistance to
tetracycline. Of the remaining six isolates some discrepancies were noted and these
included the following: one C. jejuni isolate that was determined to be resistant to
tetracycline (CIT-297) failed to generate the 171 bp amplicon; in contrast the remaining
five C. jejuni isolates, CIT-017, -245, -264, -288 and -290 repeatedly produced the 171 bp
amplicon, despite appearing phenotypically sensitive. E-tests were performed on these
isolates to investigate further this discrepancy, and MICs ranging from 0.5 to 8 pg/mL
were measured. The isolates CIT-288 and -290 showed E-test MICs of 6 and 8 pg/mL,
respectively.

8.4.3. Plasmid analysis of Campylobacter isolates - evidence for plasmid-mediated
tetracycline resistance
Several authors have clearly shown the involvement of plasmids of various
incompatibility groups, in the dissemination of drug resistance. Bacon et al. (2000)
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provided evidence of an association between the presence of a 35 kbp plasmid and the
tetO gene in a strain of C. jejuni. Furthermore, Prasad et al. (1994) showed that
tetracycline resistance was frequently linked to the presence of a 23 kbp plasmid.

The same subset of 74 strains (described above) was investigated for the presence of
similar plasmids. In addition, a further 29 poultry isolates were included. Plasmids
ranging in size from approximately 2 to 23 kbp were detected after agarose gel
electrophoresis. Table 2 provides a composite of all the results available for the subset
tested, including a detailed summary’ of the plasmid content of these isolates. For the
total number of isolates tested, hov/ever, (103) the following results were obtained: of the
49 poultry isolates investigated, 24 (49%) carried plasmids of various sizes, and plasmids
were more commonly detected in C. coli isolates (14 out of 20) compared with C. jejuni
(wherein 17 out of 83 contained plasmids). Similarly, human isolates contained fewer
plasmids (7 from a total of 54 isolates or 13%) compared to the poultry-derived isolates.

Several plasmid sizes were noted after gel analysis, as shown in Figure 2. A 23 kbp
plasmid was isolated from eight of the nine human and poultry isolates including both C.
jejuni and C. coli (78%) that contained plasmids and that were resistant to tetracycline
(indicated in Table 2 by the pink and green shading). The presence of plasmids
consistent with phenotypic tetracycline resistance amounted to 12.2% among the subset
of 74 isolates. A total of 11 (of 45) human and poultry isolates {C. jejuni and C. coli36%) that were sensitive to tetracycline contained plasmids. Only four isolates contained
a 23 kbp plasmid, however. The proportion of isolates that were tetracycline sensitive.
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did not contain a tetO signal and that did not contain plasmids amounted to 45.9% (these
are indicated by the turquoise shaded cells in Table 2 in ail conesponding columns).
Non-correlation between the isolation of plamids and the susceptibility result occurred for
41.9% of the collection of 74 isolates. A total of 27% of isolates were phenotypically
resistant and did not appear to contain plasmids. This included an isolate that failed to
generate a product with PCR, perhaps indicating a separate resistance mechanism. The
remaining 14.9% of isolates were tetracycline sensitive and contained plasmid(s).

8.4.4. Mapping the tetO gene on chromosomal and plasmid DNA
Southern blotting was performed in duplicate on a subset of the isolates to determine
whether or not the /c/O-encoding gene could be mapped to their plasmids. A
representative data set is shown in Figure 2A. Hybridisation to the DIG-labelled tetO
probe occurred for two isolates only, CIT-009 and -020, both identified as C. coli and
carrying a 23 kbp plasmid (see Figures 2B and 2C). Both of these isolates were
phenotypically resistant to tetracycline (see Table 2, green shaded cells). A further three
isolates, CIT-004, -005 and -016 were also resistant and carried 23 kbp plasmids,
however, but hybridisation was not detected in any of these cases. Other isolates (Table
2, marked in purple) including CIT-007, -021 and -022 C. coli isolates contained 23 kbp
plasmids but were found to be phenotypically sensitive to tetracycline.

Southern blotting was also performed, using PFGE digest profiles, on a selected subset of
isolates, as shown in Figure 3. This strategy was included in the study in order to explore
the possibility that the resistance marker could map to the chromosome. Chromosomal
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hybridisation was detected for four isolates, including CIT-245, -252, -254 and -261 (see
Figures 3B and 3C, also Table 2, ceils marked in orange colour). With the exception of
CIT-245 (which exhibited phenotypic sensitivity whilst testing positive for the tetO PCR
product), the remaining three isolates exhibited phenotypic-confirmed tetracycline
resistance, along with the tetO PCR product. One isolate CIT-017, while appearing
sensitive to tetracycline, also generated the tetO amplicon, and contained a 5 kbp plasmid
only. Furthermore, CIT-263 was phenotypically sensitive, generated the tetO amplicon,
and did not contain a plasmid. This isolate could also have been expected to hybridise
with the tetO probe. These latter isolates were all identified as C. jejuni.
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8.5. Discussion
Antimicrobial susceptibility to tetracycline of this collection of Campylobacter isolates
demonstrated a moderate increase in resistance rates from 14 and 19% for human and
poultry isolates respectively, for the period 1996-1998, to 31 and 24.4% for human and
poultry isolates during the year 2000, as seen in Table 1. It was interesting to note the
more marked rate of increase among the human isolates. This finding correlates with a
Danish study by Moller Aarestrup et al. (1997), which reported tetracycline resistance
rates of 11 and 2% among human and animal isolates, respectively. Resistance rates in
Denmark were low, however, in contrast to Spain where 36% of C. jejuni (human)
isolates demonstrated tetracycline resistance in 1993 (Reina ei al., 1994), or in Canada,
where 56% resistance was observed among Campylobacter spp. during the period 19951997 (Gaudreau and Gilbert, 1998). Lee et al. (1994) observed tetracycline resistance
rates of 100% among poultry isolates and 78% among human isolates in Taiwan. World
wide antimicrobial resistance rates have an increasing significance as a result of increased
globalisation of food animals and products, and may influence current rates of resistance
in Ireland (Lucey et al., 2002).

A study by Bacon et al. (2000) isolated a 35 kbp plasmid carrying the tetO gene from a
clinical tetracycline-resistant C. jejuni isolate. The largest plasmids isolated in this study
were approximately 23 kbp in size, however. The tetO primer designs proposed by
Aminov et al. (2001) showed a strong correlation with phenotypic resistance among
Campylobacter spp. in this study. An apparent discrepancy, however, was observed in
only 8.1% of cases (six isolates). For five isolates the generation of a 171 bp amplicon
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did not correlate with resistance by disc diffusion and E-test methods. Two of these
isolates demonstrated E-test MICs of 6 and 8 |ag/ml respectively (where resistance is
defined by a MIC result of >16 pg/ml), which may indicate low-level expression of the
tetO gene, but which would not technically preclude the use of this antibiotic to treat
infection. Another isolate hybridised with the tetO probe after Southern blotting of a
pulsed-field gel, despite being sensitive. This may be due to the non-expression of a
resident tetO gene. Of the remaining two isolates, (one, from which a 5 kbp plasmid was
isolated) none hybridised with the tetO probe when their corresponding plasmid or PFGE
gels were tested. Data for the final isolate which did not contain a plasmid remain
inconclusive. The final discrepant result occurred for a single isolate that was
phenotypically resistant to tetracycline and that did not generate the tetO arnplicon, but
this may suggest a separate mechanism of resistance.

The PCR method used by us was originally described for a single C. jejuni isolate, and
had not been assessed to date for the detection of the tetO gene among a population of
isolates that included C. coli. In this study, amplification occurred equally among C. coli
and C. jejuni and the effectiveness of this PCR method for tetO detection extends to C.
coli, for which no anomalous results were noted.

The isolation rates for plasmids among Campylobacter spp. have varied greatly between
studies. It was noted in this study that a 1.5 mL bacterial suspension corresponding to a
McFarland turbidity standard >6 was required to ensure plasmid isolation, due to an
observed low plasmid copy number among the collection. For this reason, it was also
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deemed necessary to perform plasmid isolations in duplicate. The isolation rate for
plasmids among poultry isolates (49%) far exceeded that of clinical strains (13.2%). All
clinical strains tested were identified as C. jejuni with the exception of one C. coli isolate,
which did not harbour plasmids. The highest plasmid isolation rate occurred for C. coli
strains isolated from poultry (73.7%), corresponding to 14 of the 19 isolates tested.
However, the plasmid isolation rate among C. jejuni poultry isolates, at 33%, far
exceeded that obser\^ed among the clinical strains. These figures contrast with the
tetracycline resistance rates among the collection. Tetracycline resistance among human
isolates was 31 %, whereas only 13.2% of these isolates carried plasmids. Tetracycline
resistance among poultry isolates was 24.4%, but 49% contained plasmids. A variety of
plasmid sizes has previously been isolated from tetracycline-resistant isolates, as
observed in an Israeli study that demonstrated plasmids in 80% of tetracycline-resistant
isolates (Schwartz et al., 1993). It was apparent in this study, however, that the presence
of plasmids does not correlate with tetracycline resistance and that the tetO gene is not
always plasmid-bome. Plasmid sizes ranged from 2 to 23 kbp in size, and a total of 11
plasmid combinations were observed; between 1 and 5 plasmids were isolated from
individual isolates. In this study hybridisation with the tetO probe occurred only for the
23 kbp plasmids, in agreement with an Indian study (Prasad et al., 1994). Furthermore, a
23 kbp plasmid was isolated from 8 of the 9 human and poultry isolates (both C. jejuni
and C. coli) that were resistant to tetracycline and from only 4 of the 11 human and
poultry isolates (C. jejuni and C. coli) that were sensitive to tetracycline. It is possible
that not all 23 kbp plasmids associated with Campylobacter spp. carry the tetO gene.
Southern blotting was performed on chromosomal DNA using PFGE on a subset of
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isolates, followed by hybridisation with the tetO probe. The tetO gene was located to the
chromosome of four clinical C. jejuni isolates (from which no plasmids had been
isolated).

The presence of plasmids among Campylobacter spp. has been associated not only with
tetracycline resistance, but also with kanamycin resistance (Tenover et al., 1992), and
with virulence (Bacon et al., 2000). The host range of Campylobacter-associaXcd
plasmids and the gain and loss of plasmids has not been extensively studied. However,
/£?/0-related sequences, which were first determined in plasmids from Campylobacter
(Sougakoff e/ al, 1987; Taylor et al, 1987), were subsequently detected in streptococci
(Widdowson et al, 1996), and more recently in a rumen bacterium, Butyrivibrio
fibrisolvens (Barbosa et al., 1999). These findings suggest that the exchange of DNA
among different species may occur during colonisation of the animal intestine. This
probability, combined with observed increasing rates of resistance to antibiotics such as
tetracycline, make further study of the dissemination of antimicrobial resistance
imperative.
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8.7. Tables and Figures
Table 1. Antimicrobial susceptibilities of human and poultry Campylobacter isolates,
from the year 2000, to tetracycline.
Total resistance (%)

41 (29)

Human

31 (31)

Poultry

11 (24.4)
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Table 2. A subset of isolates (taken from a collection of 378) that were assessed for
phenotypic resistance to tetracycline, the presence of product(s) after PCR, and the
presence or absence of piasmid(s), together with approximate plasmid sizes.
Isolate No.

CIT-002
CIT-003
ClT-004
CIT-005
: CIT-006
^ CIT-007
CIT-009
; CIT-OIO
CIT-011
LCIT-012
CIT-013
' CIT-014
CIT-016
CIT-017
[ CIT-018
CIT-019
CIT-020
j CIT-021
1 CIT-022
[ CIT-023
1 CIT-241
CIT-242
i CIT-243
CIT-244
CIT-245
CIT-246
CIT-247
CIT-248
CIT-249
CIT-250
CIT-251
CIT-252
CIT-253
CIT-254
CIT-255
CIT-256
CIT-257
CIT-258
CIT-259
CIT-260

Origin

P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
P
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H

Species

Tetracycline
phenotype

Cj
Cj
Cc
Cc
Cj
Cc
Cc
... Cj.....
Cj
Cj
Cj
Cc
Cc
Cj
Cj
Cc
Cc
Cc
Cc
Cj
<3
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Ci
Cj
Cj

S
S
R
R
S
S
R
S
R
S
R
S
R
S

Cj

s

Cj
Cj

R
R
S
R
R
R
R

Cj
Cj
Cj
Cj
Cj

tetO gene

Plasmid sizes (kbp)
(Approx.)

Plasmid

[171 bp]
i

J

-

|

+

23,12,5,3,2.5
23,12,5.3,2.5
23,22

]

+

-f

+
“
-

+

+
_____-

+

+

-

+

-

-

+

+

-

-

+

•T

+

s

R
R
S

-

+

+

-1-

18,5,3

23
23.5.2,5
5
5
12

+

s
s
s

R

s
R
S

s
s
s
s
s
R
R
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+
+
+
+
+
+
+

+
+
+
+
-

-

+

+
+
+
+

-

23
23

23

12, 5,3

-

-

-

23

CIT-261
CIT-262
crr-263
CIT-264
CIT-265
CIT-266
CIT-267
CIT-268
CIT-269
CIT-270
CIT-271
CIT-272
CIT-273
CIT-274
CIT-275
CIT-276
CIT-277
CIT-278
CIT-279
CIT-280
CIT-281
CIT-283
CIT-284
CIT-285
CIT-286
CIT-287
CIT-288
CIT-289
CIT-290
CIT-292
CIT-293
CIT-295
CIT-297
CIT-299

H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H
H

Cj
Cc
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj
Cj

+
+
+
+
+
+

R
s
R
s
s
s
s
s
s
s
s
R
s
s
R
R
R
s
s
s
s
R
s
s
S
S
S
R
S
R
S
S
R
R

+
+
+
+
+
+

'

"
+
+
+
+
-

23

12, 7, 5,3

5,4.5

3, 2.5, 2.2, 2

Colour coding: turquoise denotes isolates that are phenotypically sensitive and that do
not contain plasmids; grey denotes isolates that are phenotypical ly resistant; yellow
denotes confirmation of a PCR positive tetO gene along with phenotypically determined
resistance; white denotes confirmation of a PCR positive tetO gene lacking a resistance
profile by disc or E-test; purple denotes the presence of plasmid(s) in a confirmed
resistant isolate; red denotes a mapped resistant determinant to the chromosome; green
denotes a 23 kbp plasmid in a phenotypically resistant isolate and shaded green denotes
a mapped resistant determinant.
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Table 3; Correlation of phenotypic tetracycline resistance with tetO PCR
Phenotypic
tetracycline result
Sensitive

tetO PCR product

Resistant

Present

5 (6.8)

Sensitive

Present

1(1.3)

Resistant

Absent

No. of Campylobacter isolates
(%)
p? ■ ■
: 40(54.1)
' ~ 28 (37^
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Figure 1. Amplification of the tefO gene by PCR (Animov el al., 2001). Lanes marked
M contain grade V molecular weight marker (Roche). CIT- 248 to 264 are isolates of
human origin. Lane marked Neg contains the negative control. (See also Table 2).
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Figure 2. Tetracycline-resistance encoding {tetO) gene mapping in plasmids isolated from
selected (and C. coli isolates.
Figure 2A. A selection of plasmids isolated from C. jejuni and C. co/i strains of poultry
origin. .After plasmid isolation 20 pL of plasmid product combined with 4 pL of loading dye
was loaded onto a 0.8% agarose gel in 1X TAE buffer containing 100 pg/L ethidium
bromide. Samples were electrophoresed at 100 V for 1.5 h. Lane M refers to grade 111
molecular weight marker (Roche). ClT-004, -005, -007, —009, -020, -021 and -022 contain a
plasmid appro.ximately 23 kbp in size.
Figure 2B. Following electrophoresis the plasmid products were transferred to nylon
membranes. A tetO probe was then used to probe the membrane. The Southern blot shows
results from the gel seen in Figure 2a. The lanes marked M contain DIG-Iabelled molecular
weight marker grade 111 (Roche).
Figure 2C. A schematic diagram outlining the presence of a 23 kbp plasmid for ClT-004, 005, -007, -009, -020, -021 and -022 (orange).
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Figure 3. Tetracycline-resistance encoding {tetO) gene mapping in selected C. jejuni and C.
coli isolates.
Figure3A. Sma\ generated PFGE patterns of poultry- and human-derived C. jejuni and C. coli
isolates. An electric current of 200 V was applied to perform electrophoresis. DNA fragments
were separated using a ramped pulse switching every 0.5 h to 25s for 20 h, at 10.5""^ l.anes
MRM contain mid-range PFG markers (New England BioEabs). and lane LRM contains lowrange PFG markers (New England BioEabs).
Figure 3B. Following PFGE, the Sma\ macrorestricted DNA fragments were transferred to
nylon membranes. A telO probe was then used to probe the membrane. Unlabelled MRM and
ERM were used for fragment size estimation before Southern transfer.
Figure 3C. A schematic diagram outlining the hybridisation of tetO probe and CIT-254, -245,
-252 and -261. C IT-245 alone of these four isolates appeared phenotypically sensitive to
tetracycline, but like the other isolates generated a 171 bp product with re/O-derived PCR.
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Conclusions

Conclusions
•

The increased number of notifications of clinical Campylobacter enteritis in Ireland
since 1995 signifies not only an increase in morbidity, but also a significant increase
in associated healthcare costs. Therefore, the importance of monitoring, and
ultimately preventing, infection with this organism cannot be overstated.

•

This study has demonstrated that C. jejuni and C coli comprise over 99% of humanassociated Campylobacter in Ireland. Nevertheless, the identification of these two
species is not straightforward. Biochemical tests are inoculum dependent, and their
interpretation is subjective. In addition, the organism may not always express the
phenotype being assessed. Molecular identification methods offer advantages in these
respects. However, due to genomic variability among these species, it has also been
shown that no single molecular method is likely to reliably identify all strains tested.
Therefore, it is advisable to use at least two identification methods for the speciation
of thermophilic Campylobacter spp. one of which should include a molecular
protocol.

•

DAT analysis has demonstrated the heterogeneity of Campylobacter spp. from
human, poultry and porcine sources. This suggests that Campylobacter is widespread
in the environment, making the elimination of these species from the food chain
difficult. It also demonstrates that a large number of different strains are capable of
causing human infection, and that human infection appears to be mainly sporadic.
Nevertheless, DAT cluster analysis appears to suggest that certain strains are more
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pathogenic to humans than others. This genomic plasticity may reflect an ability to
adapt to different conditions and environments.

•

The increasing rates of antimicrobial resistance shown in this study over the period
1996-2000, particularly among antimicrobial agents that are useful in treating severe
or recurrent Campylobacter infection, give cause for concern. The empirical use of
these agents can in the future be expected to lead to increased treatment failure. This
is of particular significance in enteric Campylobacter infection, as diagnosis cannot
be made on clinical grounds alone, and isolation and antimicrobial susceptibility
testing of the organism in the clinical laboratory takes a minimum of four days.

•

Where the molecular basis for antimicrobial resistance is known, molecular-based
techniques provide an important means of monitoring resistance rates among large
populations of isolates, particularly as part of an epidemiological investigation (which
already necessitates DNA isolation). In these cases, molecular techniques are easier
and faster compared to agar- or broth-based methods. Furthermore, these techniques
provide a useful adjunct to protocols currently under review by the BSAC and the
NCCLS.

•

This study demonstrated that plasmids are more frequently isolated from poultrythan from human-derived Campylobacter, and furthermore, that isolation rates are
higher among C. coli than among C. jejuni. Plasmid sizes ranged from approximately
2 to 23 kbp. Tetracycline resistance, which has previously been associated with
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plasmids of different sizes, was not consistently associated with plasmids in this
study. Among the subset of poultry- and human-derived tetracycline-resistant
isolates, the tetO gene was located variously to the chromosome and to a 23 kbp
plasmid.

•

The identification of the aadA2 gene from a class 1 integron in Campylobacter spp.,
having almost complete homology with aadA2 genes demonstrated for other enteric
pathogens, provides evidence for the ability of integrons to spread antimicrobial
resistance.

•

Experimental measures applied during the course of this project have been
demonstrated to facilitate real-time surveillance by statutory authorities. In this way
protection of the food chain is underpinned/supported by scientific endeavour.

Future direction

•

The investigation of the collection for the presence of integrons showed that a number
of the isolates contained gene cassettes consisting of open reading frames whose
function remains unknown.

•

Integrons have previously been located on transposons in studies of
Enterobacteriaceae and pseudomonads. Their location remains to be established in
Campylobacter.
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•

Little information is emerging to provide an insight into the potential virulence of this
apparently genomically unstable organism. It remains to be established whether or
not a link exists between characterised isolates and their ability to cause human
disease.

The application of biological control measures including an investigation of the
efficacy of phage-mediated control should be undertaken in an attempt to reduce the
incidence of these foodbome pathogens.

An investigation as to why the genome is so plastic.
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AUTHORS
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AUTHORS
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JOURNAL
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NDLGVGSRSAYKKSARIVGDVIGKYHPHGDIAVYDALVRMAQDFSMRYPSIDGQGNFG
SIDGDG"
BASE COUNT
98 a
48c
75g
ORIGIN
1 ttgaacttat agatatagaa aattctatta
61 ttattatcgg tcgtgcactt cctgacgcta
121 tactttatgc tatgaatgat cttggcgtag
181 gtatagtagg ggatgttatc ggtaagtatc
241 ccttagtaag aatggcacaa gatttctcta
301 actttggttc tatcgatggt gatggcg

106 t
aaagtagtta tttagattat tctatgagcg
gagatggctt aaagcctgtt cacagaagaa
gaagtagaag tgcatataaa aaatctgctc
atccacatgg cgatattgct gtttacgatg
tgcgttatcc aagtatcgat ggacaaggaa

//

Revised: October 24, 2001.

1 of 1

09/07/02 22:40

Appendix 9
GenBank record; Accession number: AY043272

http://www.ncbi.nlin.nih.gov:80/entrez/q...leotide&list__uids= 15215560&dopt=GenBank
NCBl Sequence Viewer

^

geleotide

TTACTAACv

J axpnorny

______ j I Go j Clear

Search NucteoWe _Bfor
Display

detauH _B[ Save I Text

History

Preview/Index

Limits

|

ACCESSION
VERSION
KEYWORDS
SOURCE
ORGANISM
REFERENCE
AUTHORS
TITLE
JOURNAL
REFERENCE
AUTHORS
TITLE
JOURNAL

Details

Add to Clipboard

Related Sequences, Protein, Taxonomy

_J 1: AY043272. Campylobacter col...[gi: 15215560]
LOCUS
DEFINITION

Clipboard

AY043272
328 bp
DNA
linear
BCT 20-AUG-2001
Campylobacter coli strain CIT015 gyrase subunit A (gyrA) gene,
partial cds.
AY043272
AY043272.1 GI:15215560
Campylobacter coli.
Campylobacter coli

Bacteria; Proteobacteria; epsilon subdivision; Campylobacter group;
Campylobacter.
1
(bases 1 to 328)
Lucey,B., O'Halloran,F. and Fanning,S.
Shifting trends in antimicrobial susceptibility among Campylobacter
spp. isolates in Ireland: emergence of ciprofloxacin resistance
Unpublished
2
(bases 1 to 328)
Lucey,B., O'Halloran,F.
Direct Submission

and Fanning,S.

Submitted (02-JUL-2001) Biology, CIT, Rossa Avenue, Bishopstown,
Cork, Ireland
Location/Qualifiers

FEATURES
source

1..328
/organism*"Campylobacter coli"

/strain="CIT015"
/specific_host="chicken"

/db_xref="taxon:195"
/note="ciprofloxacin sensitive"
<1..>328
/gene“"gyrA"
<1..>328

gene
CDS

/gene»="gyrA"

/codon_start“3
/transl_table=*ll
/product="gyrase subunit A"
/protein id="AAK91512.1"
/db xref="GI:15215561"
/translation="ELIDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAM
NDLGVGSRSAYKKSARIVGDVIGKYHPHGDTAVYDALVRMAQDFSMRYPSIDGQGNFG
SIDGDGA'
106 t
75 g
4 9c
98 i

BASE COUNT
ORIGIN
1 ttgaaettat
61 ttattategg
121 tactttatgc
181 gtatagtagg
241 cettagtaag
301 actttggttc

agatatagaa
tegtgeaett
tatgaatgat
ggatgttatc
aatggcacaa
tatcgatggt

aattetatta
cctgatgcta
ettggegtag
ggtaagtatc
gattteteta
gatggege

aaagtagtta
gagatggett
gaagtagaag
atccacatgg
tgcgttatcc

tttagattat
aaagcctgtt
tgcatataaa
cgatactgct
aagtategat

tetatgageg
cacagaagaa
aaatctgctc
gtttacgatg
ggacaaggaa

//
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Appendix 10
GenBank record; Accession number: AY043273

http://www.ncbi.nlin.nih.gov:80/entrez/q...leotide&list_uids=l 5215562&dopr»GenBank
NCBl Sequence Viewer

JNucleotide
TaxpRomy

Search

Nucleotide

_______________________ 11 Go j Clear

FI for
Limits

I Display

default __ 01 Save I Text

Preview/Index

|

ACCESSION
VERSION
KEYWORDS
SOURCE
ORGANISM

Clipboard

Details

Add to Clipboard

_J 1: AY043273. Campylobacter col...[gi: 15215562]
LOCUS
DEFINITION

History

Related Sequences, Protein. Taxonomy

AYC43273
328 bp
DNA
linear
BCT 20-AUG 2001
Campylobacter coli strain CIT016 gyrase subunit A (gyrA) gene,
partial cds.
AY043273
AY043273.1 GI:15215562
Campylobacter coli.
Campylobacter coli

Bacteria; Proteobacteria; epsilon subdivision; Campylobacter group;
Campylobacter.
1
(bases 1 to 328)
REFERENCE
Lucey,B., O'Halloran,F. and Fanning,S.
AUTHORS
Shifting
trends in antimicrobial susceptibility among Campylobacter
TITLE
spp. isolates in Ireland: emergence of ciprofloxacin resistance
Unpublished
JOURNAL
2
(bases 1 to 328)
REFERENCE
Lucey,B., O’Halloran,F. and Fanning,S.
AUTHORS
Direct Submission
TITLE
Submitted (02-JUL-2001) Biology, CIT, Rossa Avenue, Bishopstown,
JOURNAL
Cork, Ireland
Location/Qualifiers
FEATURES
1..328
source
/organism*="Campylobacter coli"
/strain="CIT016"
/specific_host="chicken"
/db_xref="taxon:195"
/note-"ciprofloxacin resistant"
<1. .>328
gene
/gene="gyrA"
<1..>328
CDS
/gene="gyrA"
/codon_start=3
/transl table=l1
/product=”"gyrase subunit A"
/protein id="AAK91513.1"
/db xref="GI:15215563"
/translation="ELIDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAM
NDLGVGSRSAYKKSARIVGDVIGKYHPHGDIAVYDALVRMAQDFSMRYPSIDGQGNFG
SIDGDGA"
106 t
75 g
49
98
BASE COUNT
ORIGIN
1 ttgaacttat agatatagaa aattctatta aaagtagtta tttagattat tctatgagcg
61 ttattatcgg tcgtgcactt cctgacgcta gagatggctt aaagcctgtt cacagaagaa
121 tactttatgc tatgaatgat cttggcgtag gaagtagaag tgcatataaa aaatctgctc
181 gtatagtagg ggatgttatc ggtaagtatc atccacatgg cgatattgct gtttacgatg
241 ccttagtaag aatggcacaa gatttctcta tgcgttatcc aagtatcgat ggacaaggaa
301 actttggttc tatcgatggt gatggcgc
//
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Appendix 11
GenBank record; Accession number: AY043274

http:/Avww.ncbi.nlin.nih.gov;80/entrez/q...lcotidc&list_uids= 152 \ 5564&dopt=GenBank

NCBI Sequence Viewer
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Search
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Preview/Index
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_11: AY043274. Campylobacter col...[gi: 15215564]
LOCUS
DEFINITION

History

Related Sequences, Protein, Taxonomy

AY043274
328 bp
DNA
linear
BCT 20-AUG-2001
Campylobacter coli strain CIT019 gyrase subunit A (gyrA) gene,
partial cds.
Ay043274
AY043274.1 GI:15215564

Campylobacter coli.
Campylobacter coli
Bacteria; Proteobacteria; epsilon subdivision; Campylobacter group;
Campylobacter.
1
(bases 1 to 328)
REFERENCE
Lucey,B., O'Halloran,F. and Fanning,S.
AUTHORS
Shifting trends in antimicrobial susceptibility among Campylobacter
TITLE
spp. isolates in Ireland: emergence of ciprofloxacin resistance
Unpublished
JOURNAL
2
(bases 1 to 328)
REFERENCE
Lucey,B., 0'Halloran,F. and Fanning,S.
AUTHORS
Direct Submission
TITLE
Submitted (02-JUL-2001) Biology, CIT, Rossa Avenue, Bishopstown,
JOURNAL
Cork, Ireland
Location/Qualifiers
FEATURES
1..328
source
/organism="Campylobacter coli"
/strain="CIT019"
/specific_host="chicken"
/db_xref="taxon:195"
/note="ciprofloxacin resistant"
<1..>328
/gene='"gyrA"
<1..>328
CDS
/gene="gyrA"
/codon_start=3
/transl_table-ll
/product="gyrase subunit A"
/protein id="AAK91514■1"
/db xref=-"GI: 15215565"
/translation="ELIDIENSIKSSYLDYSMSVIIGRALPDARDGLKPVHRRILYAM
NDLGVGSRSAYKKSARIVGDVIGKYHPHGDIAVYDALVRMAQDFSMRYPSIDGQGNFG
SIDGDGA"
106 t
75 g
49 c
98 a
BASE COUNT
ORIGIN
tttagattat tctatgagcg
aaagtagtta
1 ttgaacttat agatatagaa aattctatta
61 ttattatcgg tcgtgcactt cctgacgcta gagatggctt aaagcctgtt cacagaagaa
121 tactttatgc tatgaatgat cttggcgtag gaagtagaag tgcatataaa aaatctgctc
181 gtatagtagg ggatgttatc ggtaagtatc atccacatgg cgatattgct gtttacgatg
241 ccttagtaag aatggcacaa gatttctcta tgcgttatcc aagtatcgat ggacaaggaa
301 actttggttc tatcgatggt gatggcgc
//
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Appendix 12
GenBank record; Accession number: AF530636

hltp;//www.ncbi.nlm.nih.gov;80/entrez/q...lcotidc&list_uids=2232468l&dopt=GenBank

NCBl Sequence Viewer

^Nucleotide
Taxonomy,

Nucleotide

Search

NudeotMe

p]

j|Go
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Limits

I

Display

defauH

R | Save

| Text

Preview/Index
|

History

I Clear
Details

Cliptward

A^to Clipboard

Protein, Taxonomy

_| 1: AF530636. Campylobacter jej...[gi:22324681]

LOCUS
AF530636
1009 bp
DNA
linear
BCT 20-AUG-2002
DEFINITION Campylobacter jejuni CIT134C class I integron aminoglycoside
adenyltransferase (aadA2) gene, complete cds.
ACCESSION
AF530636
VERSION
AF530636.1
GI:22324681
KEYWORDS
SOURCE
Campylobacter jejuni.
ORGANISM Campylobacter jejuni
Bacteria; Proteobacteria; epsilon subdivision; Campylobacter group;
Campylobacter.
REFERENCE
1
(bases 1 to 1009)
AUTHORS
O'Halloran,F., Lucey,B., Fanning,S. and Buckley,T.
TITLE
Characterization of class I integrons carrying aad genes in
Campylobacter jejuni species
JOURNAL
Emerging Infect. Dis. (2002) In press
2
(bases 1 to 1009)
REFERENCE
AUTHORS
O'Halloran,F., Lucey,B. and Fanning,S.
TITLE
Direct Submission
JOURNAL
Submitted (18-JUL-2002) Biological Science, Cork Institute of
Technology, Rossa Avenue, Bishopstown, Cork, Ireland
FEATURES
Location/Qualifiers
source
1..1009
/organ!sm“"Campylobacter jejuni"
/isolate="CIT134C"
/db_xref=''taxon: 197"
<1. .>1009
repeat reqio
/transposon="class I integron"
107..898
/gene="aadA2"
CDS
107..898
/gene="aadA2"

BASE COUNT
ORIGIN
1
61
121
181
241
301
361
421
481
541

of2

/note="streptomycin/spectinomycin resistance"
/codon_start=l
/transl_table=ll
/product="aminoglycoside adenyltransferase"
/protein_id="AAM95633.1"
/db_xref="GI:22324682"
/translation="MRVAVTIEISNRLSEVLSVIERHLESTLLAVHLyGSAEDGGLKP
YSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLWHDDIIPWRYP
AKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQ
DLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPA
QYQPVLLEAKQAYLGQKEDHLASRADHLEELIRFVKGEIIKSVGK"
254 a
251 c
276 g
228 t
ggcatccaag cagcaagcgc
cgatgttacg cageagggea
gaccategaa atttcgaacc
atcaacgttg ctggccgtgc
cagegatatt gatttgttgg
attgctcaat gacettatgg
tatagaagtc acccttgtcg
cgagctgcaa tttggagaat
catgategae attgatetag
ggtaggtccg gcageggagg

gttacgccgt
gtcgccctaa
gactatcaga
atttgtacgg
ttactgtggc
aggettegge
tgeatgaega
ggcagcgcaa
ctatcctgct
aattctttga

gggtcgatgt
aacaaagtta
ggtgctaagc
ctccgcagag
cgtaaagctt
tttccctggc
catcatcccg
tgacattett
tacaaaagca
cccggttcct

ttgatgttat
gacatcatga
gteattgage
gatggeggee
gatgaaaega
gagagegaga
tggcgttatc
gcgggtatct
agagaacata
gaacaggatc

ggagcagcaa
gggtagcggt
gccatctgga
tgaagccata
cgcggcgagc
cgctccgcgc
eggetaageg
tcgagccagc
gegttgeett
tattegagge
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NCBI Sequence Viewer

601
661
721
781
841
901
961

gctgagggaa
tgtagtgctt
ggatgtcgct
tgaagctaag
cttggaagaa
tctaacaatt
cactaagcac

accttgaagc
acgttgtccc
gccgactggg
caagcttatc
cttattcgct
cgttcaagcc
ataattgctc

tatggaactc
gcatttggta
caataaaacg
tgggacaaaa
ttgtgaaagg
gaccgcgcta
acagccaaac

gcagcccgac
cagcgcaata
cctacctgcc
agaagatcac
cgagatcatc
cgcgcggcgg
tatcaggtca

tgggccggcg
accggcaaaa
cagtatcagc
ttggcctcac
aagtcagttg
cttaactccg
agtctgctt

atgagcgaaa
tcgcgccgaa
ccgtcttact
gcgcagatca
gtaaatgatg
gcgttagatg
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Appendix 13
GenBank record; Accession number: AF530637

http i//www.Dcbi-nlm.nih.gov:80/enlre2/q...leoiide&lisl_uids=^22324683&dopt—Gen Bank

NCBl Sequence Viewer

5 Nucleotide
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Search
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I Go
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I Display
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PI I Save | Text
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Clipboard

Clear
Details

Add to Clipboard

J1: AF530637. Campylobacter jej...[gi:22324683]
LOCUS
DEFINITION

History

Protein, Taxonomy

AF530637
1009 bp
DNA
linear
BCT 20-AUG-2002
Campylobacter jejuni CIT325C class I integron aminoglycoside
adenyltransferase (aadA2) gene, complete cds.
AF530637
AF530637.1 GI:22324683

ACCESSION
VERSION
KEYWORDS
SOURCE
Campylobacter jejuni.
ORGANISM Campylobacter jejuni
Bacteria; Proteobacteria; opsilon subdivision; Campylobacter group;
Campylobacter.
REFERENCE
1
(bases 1 to 1009)
AUTHORS
O'Halloran,F., Lucey,B., Fanning,S. and Buckley,T.
TITLE
Characterization of class I integrons carrying aad genes in
Campylobacter jejuni species
JOURNAL
Emerging Infect. Dis. (2002) In press
REFERENCE 2
(bases 1 to 1009)
AUTHORS
O'Halloran,F. andLucey,B.
TITLE
Direct Submission
JOURNAL
Submitted (18-JUL-2002) Biological Science, Cork Institute of
Technology, Rossa Avenue, Bishopstown, Cork, Ireland
FEATURES
Location/Qualifiers
source
1. . 1009
/organism="Campylobacter jejuni"
/isolate="CIT325C"
/db_xref*"taxon:197"
<1..>1009
repeat region
/transposon="class I integron"
107..898
/gene="aadA2"
107..898
CDS
/gene="aadA2"
/note="streptomycin/spectinomycin resistance"
/codon_start=l
/transl_table=ll
/product="aminoglycoside adenyltransferase"
/protein id="AAM95634.1"
/db xref="GI:22324684"
/translation="MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLyGSAVDGGLKP
YSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYP
AKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPER
DLFEALRETLKLWNSQPDWAGDERNWLTLFRIWYSAITGKIAPKDVAADWAIKRLPA
QYQPVLLEAKQAYLGQEEDHLASRADHLEEFIRFVKGEIIKSVGK"
BASE COUNT
252 a
250 c
277 g
230 t
ORIGIN
1 ggcatccaag cagcaagcgc gttacgccgt gggtcgatgt ttgatgttat ggagcagcaa
61 cgatgttacg cageagggea gtcgccctaa aacaaagtta gacatcatga gggtagcggt
121 gaccategaa atttcgaacc aactatcaga ggtactaage gteattgage gccatctgga
181 atcaacgttg ctggccgtgc atttgtacgg ctccgcagtg gatggeggee tgaagccata
241 cagegatatt gatttgttgg ttactgtggc cgtaaagctt gatgaaaega cgcggcgagc
301 attgctcaat gacettatgg aggettegge cttccctggc gagagegaga cgctccgcgc
361 tatagaagtc acccttgtcg tgeatgaega catcatcccg tggcgttatc eggetaageg
421 cgagctgcag tttggagaat ggcagcgcaa tgacattett gcgggtatct tcgagccagc
481 catgategae attgatetag ctatcctgct tacaaaagca agagaacata gegttgeett
541 ggtaggtccg gcageggagg aattctttga cccggttcct gaacgggatc tattegagge
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601
661
721
781
841
901
961

gctgaggqaa
tgtagtgctt
ggatgtcgct
tgaagetaag
cttggaagaa
tctaacaatt
cactaagcac

acettgaage
acgttgttcc
gccgactggg
caagettate
tttatteget
cgttcaagcc
ataattgctc

tatggaactc
gcatttggta
caataaaacg
tgggacaaga
ttgtgaaagg
gaccgcgcta
acagccaaac

gcagcccqac
cagcgcaata
cctacctgcc
agaagatcac
egagatcate
cgcgcggcgg
tatcaggtea

tgggccggcg
accggcaaaa
cagtatcage
ttggcctcac
aagtcagttg
cttaactccg
agtctgctt

atgagegaaa
tcgcgccgaa
ccgtcttact
gcgcagatca
gtaaatgatg
gcgttagatg
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